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ABSTRACT 
 Epigenetics is the study of heritable biological variation not related to 
changes in DNA sequence. Epigenetic processes are responsible for 
establishing and maintaining transcriptional programs that define cell identity. 
Defects to epigenetic processes have been linked to a host of disorders, 
including mental retardation, aging, cancer and neurodegenerative diseases. The 
ability to control and engineer epigenetic systems would be valuable both for the 
basic study of these critical cellular processes as well as for synthetic biology. 
Indeed, while synthetic biology has made progress using bottom-up approaches 
to engineer transcriptional and signaling circuitry, epigenetic systems have 
remained largely underutilized. The predictive engineering of epigenetic systems 
could enable new functions to be implemented in synthetic organisms, including 
programmed phenotypic diversity, memory, reversibility, inheritance, and 
hysteresis. This thesis broadly focuses on the development of foundational tools 
and intellectual frameworks for applying synthetic biology to epigenetic regulation 
in the model eukaryote, Saccharomyces cerevisiae.  
  viii 
 Epigenetic regulation is mediated by diverse molecular mechanisms: e.g. 
self-sustaining feedback loops, protein structural templating, modifications to 
chromatin, and RNA silencing. Here we develop synthetic tools and circuits for 
controlling epigenetic states through (1) modifications to chromatin and (2) self-
templating protein conformations. On the former, the synthetic tools we develop 
make it possible to study and direct how chromatin regulators operate to produce 
distinct gene expression programs. On the latter, we focus our studies on yeast 
prions, which are self-templating protein conformations that act as elements of 
inheritance, developing synthetic tools for detecting and controlling prion states in 
yeast cells. This thesis explores the application of synthetic biology to these 
epigenetic systems through four aims:  
Aim 1. Development of inducible expression systems for precise temporal 
expression of epigenetic regulators 
Aim 2. Construction of a library of chromatin regulators to study and program 
chromatin-based epigenetic regulation. 
Aim 3. Development of a genetic tool for quantifying protein aggregation and 
prion states in high-throughput 
Aim 4. Dynamics and control of prion switching 
Our tools and studies enable a deeper functional understanding of epigenetic 
regulation in cells, and the repurposing of these systems for synthetic biology 
toward addressing industrial and medical applications. 
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1. INTRODUCTION 
 
1.1. Synthetic Biology 
1.1.1. Studying cellular regulation using synthetic biology 
Synthetic biology is an emerging biological engineering discipline with a 
bottom-up approach to understand biological function1. The main goal of 
synthetic biology is to study cellular regulation and to understand the necessary 
and sufficient components for biological functions to emerge. Given our limited 
knowledge about regulation in biological systems, synthetic biology follows an 
iterative working principle2. First, the desired behavior is defined, suitable 
components are selected and a genetic circuit with the desired behavior is 
designed using these components. Next, the circuit is built, and implemented in a 
host organism. Finally, the behavior of the circuit is tested. If the behavior 
matches the target behavior, the iteration concludes. However, due to the 
complexity of biological circuits and interactions with the host, in most cases 
modifications are necessary to the initial design, followed by building and testing. 
Bottom-up approaches build from basic components to more complex 
systems. In contrast, top-down approaches employed in systems biology observe 
a complex behavior and aim to deconstruct the network from how it responds to 
perturbations. In synthetic biology, we are recreating simple cellular behaviors 
with well characterized components, and then integrate these simple systems 
into multilayered circuits ultimately aiming to recapitulate tissue and organism 
  
2 
level functions. Synthetic bottom-up approaches test the boundaries of 
mechanistic understanding of biological regulation by starting the reconstruction 
with the known necessary components and adding complexity until the natural 
behavior is recapitulated. 
One of the founding examples of synthetic biology was the construction of 
a genetic toggle switch in E.coli. Toggle switches are used in electronics, and 
have two stable states, and switching is actuated by an outside intervention. One 
application of toggle switches is in reversible memory elements as the two states 
can be assigned 0 and 1 bit values, and switching back and forth is supported. 
The physical implementation of a genetic circuit with toggle switch behavior was 
a double negative transcriptional feedback loop between lacI E.coli repressor and 
cI, a lambda phage repressor3. The production of cI was inhibited by lacI, and 
vica versa, the production of lacI was inhibited by cI. Production of cI and the 
GFP reporter were coupled, and showed two stable states. The addition of IPTG 
small molecule inducer to the media induced derepression by lacI, and switching 
of the toggle switch to the cI producing state. Application of heat to the culture 
inactivated cI, and the toggle switch switched back to the lacI producing state. 
This design was inspired by the lambda phage lysis-lysogeny life cycle switch. 
Using this synthetic circuit, the requirements for memory and bistability could be 
explored via modeling coupled with experiments. 
Synthetic biology to date most commonly encompasses genetic circuits 
that transcriptionally control target genes4-7. Different functions are achieved via 
  
3 
different regulatory connections. These circuits aim to either recapitulate the 
basics of biological regulation for deeper understanding of a natural process8-11 
or to produce a biomolecule12-14. Simple systems, where the production of a 
single gene product is increased or temporally varied are easily achievable with 
current synthetic systems. More complex behaviors, which correspond to the 
next level of complexity to be achieved in this bottom-up approach, with multiple 
inputs, and the output not being the direct readout of the input are more 
challenging to engineer. 
A set of behaviors that are associated with cellular level decision making -
such as phenotypic switching, stem cell differentiation, environmental response- 
require higher complexity circuitry. Cellular decision making circuits have a 
couple key characteristics: bistability, reversibility, memory and stochasticity. 
Bistability means that the cells can either be in one state or in the other, there is 
no intermediate state, which is a requirement for a decision to be stable. 
Reversibility means that each transition throughout the decision process is 
molecularly reversible, although the entire decision has to be unidirectional. 
Memory means that the cell remembers a previous fate decision event and 
keeps on the expression of genes corresponding of the chosen fate long after the 
decision was made. Stochasticity means that prior to the decision, a cell can 
choose either of the states according to a random process – which could be 
biased by its environment. A couple of studies have explored such processes so 
far. For example, to time yeast sedimentation at the end of a fermentation, an 
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incoherent type II negative feed-forward loop network was built using engineered 
promoter libraries6. To date the only successful transcriptional toggle switch 
memory element in S.cerevisiae is controlled by a long noncoding RNA that 
regulates expression of the FLO11 flocculation gene15. Synthetic biology 
developed technologies16 to record information in living cells17 and to record a 
stochastic stress event in a population of cells18. 
1.1.2. Lack of well-characterized regulatory parts 
In order to engineer successful connections between various 
transcriptional regulators, synthetic biology employs standardized parts that are 
well characterized components with predictable behaviors in different contexts. In 
order for a human to exert control over the genetic circuits, parts responsive to 
external stimuli such as small molecules, heat or light are essential. Only a 
handful of such well characterized parts and inducible systems were available in 
the single cell eukaryote baker’s yeast, S.cerevisiae5. These were either bacterial 
regulators or the host’s natural regulatory systems. An example of a natural 
inducible system is the GAL1 promoter which is activated by galactose due to the 
Gal4p transcriptional activator and repressed by glucose due to Mig1p repressor. 
This system has extensive characterization data as it was widely utilized in yeast 
two hybrid screens and also in the Drosophila melangoster GAL4-UAS system. 
Using a natural inducible system automatically means that some of the host 
transcriptional programs are also activated, which could result in high metabolic 
load19. Microorganisms producing unnecessary proteins will be unfit and 
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outcompeted by microbes carrying mutated nonfunctional versions of these 
circuits. 
To avoid such interactions with the host network, purely synthetic parts 
are preferred7. A set of artificial transcription factors (aTFs) were introduced in 
yeast20, which enabled engineering transcriptional programs, interactions 
between TFs and investigating the effects of TF recruitment at different positions 
in the transcriptional cassette. These aTFs are synthetic fusion proteins between 
a zinc finger DNA binding domain and a VP16 viral acidic transactivation domain. 
Zinc finger proteins are small DNA binding domains that can be engineered to 
target different arrays of nucleotides21. Other programmable DNA binding 
domains include TALE repressor and Cas9 proteins, which were also harnessed 
for yeast synthetic biology5, 22. 
Synthetic biology aims to reconstruct complex biological regulation. 
However, there is serious limitation on the number of characterized parts 
available even in the best understood model organism, E.coli. New challenges 
emerge once the complexity of circuits reaches multiple regulators and more 
than two layers as the host’s transcriptional and translational machinery become 
limiting. In these cases circuit components will not be available in excess 
contrary to how characterization data was collected, which invalidates 
mathematical predictions of circuit behavior, and results in circuit failure. Another 
challenge lies in the gap of knowledge between our understanding and what is 
necessary to predictably engineer more complex eukaryotic or non-model 
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bacterial cells and mammalian tissues. Attempts to engineer such systems will 
inevitably yield understanding of their working principles2. 
Specifically, engineering systems that exert dynamic behaviors such as 
bistability, memory and stochasticity, requires precise spatiotemporal regulation 
of the components. Such control systems are rare in eukaryotic model organisms 
and completely missing in non-model bacteria and eukaryotes. 
1.1.3. Engineering epigenetic regulation and cellular memory 
Epigenetic changes are heritable changes not related to the order of DNA 
nucleotides. Epigenetic regulation is important in fine tuning gene expression 
programs in cells using DNA methylation, chromatin regulation, RNA-based 
regulation or structural templating. Epigenetic regulation is important in 
delineating tissue specific gene expression such that isogenic cells express a 
different set of genes resulting in a variety of different phenotypes23. 
Misregulation of epigenetic processes are often associated with cancer. Since 
epigenetic regulators affect the expression of a large number of genes, a minor 
genetic change during evolution in an epigenetic regulator could result in vastly 
different gene expression programs, phenotypes. Moreover, epigenetic 
processes are present in all kingdoms of life. For example DNA methylation is 
widespread in bacterial restriction methylation systems and also present in the 
mammalian genome in CpG islands. 
There have only been a handful synthetic biology studies using epigenetic 
regulation to date, despite great interest in properties of epigenetic systems such 
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as stochasticity24, bistability, memory25, 26 and reversibility27. DNA methylation 
was induced28 and removed29 at a given target sequence. Human polycomb 
protein was sequence specifically recruited to reverse chromatin silencing30. The 
dynamics of heterochromatin formation31 and reactivation32 has been explored 
with a handful of chromatin modifiers in synthetic systems where these 
components are under tight spatiotemporal control. Exploring epigenetic 
regulation in synthetic biology could serve the dual function of learning about the 
mechanisms of these systems through a bottom-up approach and harvesting 
regulators from natural systems to engineer desired behaviors such as bistability, 
memory, stochasticity and reversibility. 
 
The most characterized forms of epigenetic regulation are associated with 
chromatin. The genetic content of cells without compaction would not fit into 
micron sized vesicles, cells. Chromatin is the compaction of DNA to regulate 
gene expression, prevent DNA damage and to allow mitosis. The first layer of 
chromatin is the wrapping of DNA around histones, which are called 
nucleosomes. Histones are proteins rich in positively charged amino acids, eight 
of them bind together to wrap around 146 basepairs of DNA33. The composition 
of the histone octamer (typically two of each H2A, H2B, H3, H4) may vary, for 
example H2AX histone replacing H2A is associated with DNA damage and 
repair. The tails of histone proteins are subject to chemical modifications such as 
methylation, acetylation, phosphorylation and ubiquitinylation, which are carried 
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out by histone associated proteins. DNA itself is subject to methylation. 
Nucleosomes are associated with the open, transcriptionally active euchromatin 
state. The closed heterochromatin state is associated with further packaging of 
nucleosomes into 30 nm chromatin fibre, solenoids and chromosomes. 
Chromatin contains regulatory RNA besides DNA and protein, which is much 
less understood but generally believed to have a role in silencing gene 
expression. 
A diverse and large set of chromatin regulators write, erase and are 
recruited through chemical modifications on DNA and histones. These processes 
enable and maintain chromatin memory, one type of epigenetic memory. 
Synthetic biology could aid the identification and functional characterization of 
chromatin factors via direct recruitment under tight spatiotemporal control. This 
strategy can be expanded to co-recuitment of multiple factors to study their 
interactions with different chromatin marks and each other. Synthetic biology 
itseld could also benefit from such investigations by mining chromatin regulators 
as parts that naturally perform complex functions such as bistability, reversibility, 
memory and stochasticity. 
 
1.2. Prion-like domains are protein-based epigenetic elements 
1.2.1. Introduction to prions and chaperones 
Prions are infectious self perpetuating protein conformations. Once the 
prion is formed, it readily converts the native conformation to its own template34. 
  
9 
This assembly continues, and high molecular weight protein polymers are 
formed. The prion polymer is amyloid fiber conformation in most cases. When the 
fibers are severed, new starting points of polymerisation are created. Low 
molecular weight seeds are transmissible between cells, which causes the 
infectivity of prions. 
Prions are most widely known in mammalian diseases, such as scrapie in 
sheep, bovine spongioform encelopathy in cattle, kuru and Creutzfeldt-Jakob 
disease in humans. They have also been identified in bacteria35 and plants36 and 
they are prevalent and well studied in yeast37. Two bona fide yeast prions are 
[PSI+] and [RNQ+], where brackets denote non-Mendelian inheritance and capital 
letters mean dominance in genetic crosses. 
The best studied yeast prion protein is Sup35. Sup35p is the translation 
termination factor eRF3, its role is to release the ribosomes upon reaching a stop 
codon on the mRNA. Sup35p has three domains, N’ Q/N repeat prion domain, M 
middle domain involved in chaperone interactions, and the C’ functional domain, 
which is necessary and sufficient for translational termination. Sup35p forms the 
prion [PSI+] which is stably maintained through mitosis and meiosis by the 
chaperone machinery, Hsp40, Hsp70 and Hsp10438. The formation of [PSI+] 
results in partial loss of function of Sup35p, which produces a translational read-
through phenotype. Translational read-though becomes visible in several 
laboratory yeast strains that have a stop codon mutation in adenine biosynthesis 
ADE1 or ADE2 genes. When ade1 or ade2 cells are grown in media low on 
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adenine, they accumulate a red pigment as byproducts of a deficient adenine 
biosynthesis accumulate. Colonies of ADE1 and ADE2 genotype are white, and 
partial recovery of ADE1 or ADE2 function in [PSI+] cells results in pink colonies. 
Rnq1p is rich in glutamine and asparagine protein 139, a prion, in 
Saccharomyces cerevisiae. Its N’ domain contains three alpha helices and 
Ser143 phosphorylation site, and may be involved in protein interactions. Its C’ 
domain, amino acids 153-402, forms the prion domain that is unstructured, and 
converts to parallel in register beta sheets in the prion form40. Rnq1p localizes to 
the cytoplasm41. Multiple pieces of in vitro and in vivo experimental evidence 
suggests that Rnq1p fibrils act as nucleating factors for the aggregation of other 
prion proteins (e.g. Sup35p) and polyglutamine proteins such as exon 1 of 
human huntingtin (Htt) gene in yeast42. Rnq1p fibrils seed the aggregation of 
Sup35p, and the two proteins coaggregate43. The causes of de novo [RNQ+] 
formation are unknown. Sis1p Hsp40 co-chaperone binds to [RNQ+] aggregates 
and is necessary for [RNQ+] formation44 and maintenance45. When Sis1p is over-
expressed, it inhibits the formation of smaller SDS-soluble toxic aggregates and 
facilitates the formation of large amyloid fibrils. 
Rnq1p is a protein of unknown function. Its deletion produces 1.8% 
atypical asci with more than 4 spores following mitosis46. However, RNQ1 
deletion reduces expression of the divergently transcribed BIK1 gene, which is a 
microtubule associated protein47. Bik1p is responsible for assembly, stability and 
function of microtubules during mitosis and mating. Bik1p is important in mitotic 
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spindle alignment and spindle pole body inheritance 47. Rnq1p over-expression is 
toxic in [RNQ+] cells due to sequestration of a spindle pole body component48. 
Specifically, Rnq1p over-expression results in SPC42 mislocalization, which 
inhibits spindle pole body duplication, which triggers MAD2 cell cycle arrest. 
Since [RNQ+] has no growth or other easy to screen phenotype, it is 
studied via a fusion protein RRP, where Rnq1p is fused to the middle and C’ 
domains of Sup35p49. [RNQ+], similarly to [PSI+], has different variants or prion 
strains that have different efficiencies in seeding Sup35p aggregation, different 
aggregate sizes, aggregate stabilities, mitotic stabilities and aggregate 
distributions inside cells. 
The prion conformation enables the assembly of multiple proteins in a 
conformationally flexible manner, resulting in different fiber assembly 
conformations for a single prion protein. Unseeded, de novo prion formation 
therefore yields an ensemble of monomer assembly solutions. Seeded prion 
aggregation yields the conformation of the seed. The different aggregate 
conformations are termed prion strains, and prion strains occur with all prion 
proteins but they are easiest to study with yeast prions. For example, the [PSI+] 
prion has a phenotype associated: light pink colony color, which corresponds to 
the decreased activity of Sup35p protein determinant of [PSI+]. In vitro 
polymerized Sup35p yields different prion conformations depending on the 
temperature of polymerization, and the different prion strains yield different 
colony colors when transformed into yeast cells. The prion strains are distinct in 
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the frequency of fiber branching, infectivity, dynamic regions of the monomer 
protein and molecular weight. Fibers assembled at 4°C are more compact, higher 
molecular weight, have less branching, are less infectious, the monomers have 
smaller dynamic regions, and this prion strain yields a strong phenotype in yeast. 
Fibers assembled at 37°C on the other hand are less compact, smaller molecular 
weight, have more branching, more infectious, the monomers are more dynamic, 
and this prion strain yields a weak [PSI+] phenotype in yeast. 
Chaperone proteins are ATP dependent molecular folding machineries. 
They are responsible for maintaining the proteostasis network, and have 
essential functions in the propagation of yeast prions50. Specifically, Hsp104p, a 
hexameric disaggregase with no human ortholog, severes the prion fibers 
creating seeds for transmission into daughter cells. Prions in yeast are therefore 
reliant on the activity of Hsp104p for maintenance in a growing population of 
cells. Guanidine hydrochloride is an inhibitor of Hsp104p, therefore treatment 
with 3-5 mM guanidine results in prion curing. Other chaperones are also 
important for prion maintenance51, but their activity is more specific for certain 
prions. Certain prions rely on the Hsp40 system, while others are associated with 
the Hsp70 system, and a few are associated with Hsp90s. Yeast prions and 
chaperone remodeling factors form an interacting network52, therefore a single 
prion may be a substrate of several chaperone systems, and become unstable 
when either of the remodeling machineries change their activity levels. 
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1.2.2. Molecular characteristics of prions 
The yeast proteome is enriched for prion-like protein domains compared 
to other eukaryotes. Predictions of prion-like behavior based on primary 
sequence similarities to known bona fide prions yield prion candidates53. Such 
prediction algorithms54, 55 can only identify prion candidates that have similar 
amino acid properties to prions that were included in the model training data and 
would miss known prions such as the Podospora anserina fungus heterokaryon 
incompatibility prion [Het-s], the human prion protein PrP and the yeast prion 
Mod556. Therefore, empirical testing is necessary to identify new prions and to 
verify prion properties from the list of candidates produced by bioinformatic 
predictions. 
To verify that a candidate is indeed a prion57, a set of assays needs to be 
fulfilled. To show aggregation propensity, the protein is expressed in and purified 
from bacteria, and its aggregation is monitored in the presence of an amyloid 
sensitive dye, thioflavin T. The in vitro polymerized aggregates need to be 
retained on a non-protein binding filter, proving that they are high molecular 
weight. To show in vivo prion formation, the protein is fused to Sup35p C’ domain 
and expressed in the absence of wild-type Sup35p. If the protein forms prions 
upon over-expression, it would result in partial loss of function of Sup35 
translational read-through activity, resulting in colony color change and survival 
on selective plates. In the case of a prion, which is dependent on Hsp104p 
chaperone activity for mitotic propagation, the read-though phenotype is 
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eliminated when Hsp104p activity is blocked. SDD-AGE is a biochemical assay 
to prove the presence of high-molecular weight SDS-insoluble aggregates. Cells 
are lysed in the presence of low concentration of SDS, and the lysates are run on 
large pore agarose gels to separate protein assemblies by molecular weight, and 
finally blotted and probed with an antibody. The putative prion protein may also 
be fused to a fluorescent protein at high expression levels, and it localizes in foci 
if it is indeed aggregation-prone, and perivacuolar foci or ribbons if it is a true 
prion. Some candidates58 may only partially fulfil these criteria, which could mean 
that they are prion-like but not bona fide prions, or that they have some 
propensity to aggregate. 
1.2.3. Hypotheses on the functional and evolutionary role of yeast 
prions 
Understanding the functional and potential evolutionary roles of yeast 
prions is an active area of investigation, which yielded several different 
hypotheses59, 60. One hypothesis is that prions are diseases in yeast alike to 
prions in higher order eukaryotes61. A different set of hypotheses predict that 
prions in yeast have evolutionary roles57. Since prion formation is increased in 
the presence of environmental changes -specifically in stressful environments 
where endoplasmic reticulum stress causes perturbation of the proteostasis 
network, which results in widespread protein aggregation and prion formation62- 
prions have been hypothesized to act as environmental stress response 
elements. One idea is that their aggregation status senses a change in 
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environment, and actuates a new phentypic program as a response63. This 
notion is supported by the fact that most bona fide yeast prions known to date 
are important transcriptional and translational regulators. One example is the 
yeast short lived actin-associated protein Lsb2, which forms [LSB+] prion in 
response to thermal stress64. [LSB+] is able to seed the aggregation of other 
prions, it is a PIN factor. Another example is FLO11 flocculation gene that result 
in multicellular behavior such as invasive growth, complex colony architecture, 
colony differentiation, flocculation. The FLO11 promoter is regulated by three 
prion transcription factors, Swi1p65, Mot3p66 and Ssn6p67. Mot3p itself is an 
environmentally responsive prion, induced by ethanol and eliminated by 
hypoxia66. Another hypothesis, termed the bet-hedging hypothesis, is based on 
the stochastic nature of prions. It assumes that stochastic prion state switching 
results in the emergence of new phenotypes in an isogenic population68. These 
new phenotypes might represent better traits for certain stressful environments 
than the bulk of the population, while being less fit in the present environment. In 
this hypothesis prions phenotypically diversify the population in a reversible 
manner, which is adventageous in rapidly changing environments69. The bet-
hedging hypothesis is supported by the observation that some of the prion 
phenotypes are associated with partial loss of function of regulators, therefore 
relaxed regulation of metabolite utilization. For example, [URE3+] cells are able to 
utilize poor nitrogen sources even in the presence of ammonium70, [GAR+] cells 
utilize poorer carbon sources even in the presence of glucose71. The third 
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hypothesis states that prions are evolutionary capacitors, which enables 
accummulation of genetic variation that does not implement in phenotypic 
changes at first as the capacitor masks their effect. All the accummulated genetic 
variation is released at once when the capacitor changes. Evolutionary 
capacitors aid evolution as they allow for the accummulation of genetic variation 
at no phenotypic cost at first, and induce sudden selection once the capacitor 
loses functionality. [PSI+] supports the evolutionary capacitance hypothesis as 
[psi-] cells can accummulate mutations in the 3’ UTR region without phenotypic 
consequences. However, when [PSI+] forms, codons after the stop codon are 
also translated, enabling the genotypic diversity to translate to phenotypic 
diversity. Certain environmental changes may trigger this evolutionary capacitor 
as Sup35 methionine oxidation leads to de novo [PSI+] formation72, [PSI+] is 
induced in oxidative stress73, and Sup35p phase separation is dependent on 
intracellular pH74. These hypotheses are compelling, yet experimental proof of 
their validity is difficult to obtain. The first experimental bet-hedging system in 
yeast, estradiol inducible expression of the counter selectable URA3 marker, has 
only recently been reported75. A synthetic biology approach, combining prion 
biology and synthetic control systems in the absence of environmental and 
genetic complexity, could bring the field closer to direct testing of hypotheses on 
the evolutionary role of yeast prions. 
Protein conformations are dynamic and reversible, and the prion state is 
thought to be dynamically switching. It has been of interest to identify 
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environmental or genetic factors that switch prion state or environments that 
provide fitness advantage to prion versus soluble state. Fitness cost-benefit 
associated with prion state strongly depended on the genetic background76. The 
largest effects seen in a genome-wide deletion screen77 were tenfold decrease or 
increase in de novo [PSI+] formation, which is on the order of 10-6 to 10-7. 
Environmental conditions increased de novo [PSI+] formation by hundred fold. 
The functional properties of prions such as environmental sensing, bet 
hedging, dynamic switching between soluble and prion states and reversible 
memory are desirable properties in synthetic control systems. In order to harness 
these properties, new mechanisms have to be developed such that desired prion 
behaviors becomes controllable by external stimuli in a predictable manner. 
1.2.4. Prion-like phenomena are widespread 
Certain neurodegenerative diseases are also associated with prion-like 
aggregation, where the molecular characteristics of aggregation are similar to 
prion disease, but the disease does not spread from one individual to the next. 
Prion-like aggregation is observed for the polyglutamine protein of huntingtin in 
Huntington’s disease, aggregation of abeta and tau in Alzheimer’s disease or 
aggregation of FUS and TDP-43 in amyotrophic lateral sclerosis. Amyloid-
forming proteins also exhibit the properties of prions in the sense of the 
pathology resembling the pathology of the initiating assembly78. Increased 
expression of polyglutamine proteins results in inhibition of the ubiquitin-
proteaosome system (UPS) and therefore toxicity, both of which are relieved by 
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Hsp40 co-chaperones Sis1p or DNAJBI79. Hsp104 in yeast remodels prions as 
well as disease aggregates such as Abeta, Tau and alpha synuclein80. Recent 
advances in the field of protein aggregation suggest that aggregation may be a 
natural, reversible protein conformation conversion gone wrong. Certain proteins, 
for example RNA binding proteins, undergo reversible phase separation and form 
liquid droplets within the cytoplasm as part of their normal function or when cells 
experience stress. Amyloid-like aggregation of RNA binding proteins controls 
gametogenesis81 in yeast. The thale cress Arabidopsis thaliana flowering master 
regulator undergoes prion-like aggregation which enables commitment to the 
molecular decision of flowering in the plant36. CPEB, an RNA binding protein, has 
a prion-like state that stabilizes long term memory in the sea slug Aplysia82, the 
fruit fry Drosophila melangoster83, 84 and the same is true for the mammalian 
CPEB385-87. Reversible protein liquid droplets may have a function in temporary 
signaling protein storage until the stressful condition resolves or in organizing 
protein signaling centers78. In conclusion, prion-like aggregation has beneficial 
functional roles throughout several eukaryotic kingdoms. 
 
1.2.5. Techniques for identifying and studying protein aggregation in 
cells are lacking 
Studies on protein aggregation have been limited in part due to the lack of 
in vivo tools to study protein aggregation88. Protein conformation may be 
monitored using single molecule fluorescence resonance transfer if small 
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changes in conformation need detection. Most in vivo tools are not amenable for 
high-throughput screens on thousands of cells. Monitoring subcellular localization 
of a protein fused to a fluorescent protein is the most common method, however, 
requires imaging, and is only suitable for well-expressed proteins which are not 
altered by the genetic fusion. Thioflavin S dye staining can detect amyloid 
aggregates inside intact cells, but does not detect non-amyloid aggregates and 
phase separated proteins. Solid state NMR and FTIR are spectroscopic methods 
of whole bacterial cells with inclusion bodies, and have only been demonstrated 
in a few cases; these methods strongly depend on the protein of interest. 
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2. MATERIALS AND METHODS 
2.1. Molecular biology 
2.1.1. Restriction digestion and DNA ligation based cloning 
Plasmids were maintained in Escherichia coli strains. Backbone 
preparations were made using 2-5 mL Escherichia coli cultures grown for 6-16 
hours at 37°C. Plasmid DNA was extracted from the cultures using Epoch 
plasmid miniprep kit according to manufacturer’s recommendations. 5 mL 
overnight cultures were lysed with double volumes of MX1, MX2, MX3 buffers. 
Sticky ends were created on the backbones by digesting 5 µg backbone 
plasmid preparation with a set of restriction endonucleases from New England 
Biolabs (1-2 µl each) in their corresponding compatible buffer in 50 µl total 
volume, and incubation at 37°C for 2-3 hours. 
Backbone ends were dephosphorylated using calf intestinal phosphatase 
(0.5 µl enzyme directly added to the digestion reaction) for 5-10 min at 37°C. 
For some reactions, backbone ends were blunted using mung bean 
nuclease from New England Biolabs (0.5 µl enzyme directly added to the 
digestion reaction) for 30 min at 30°C. 
The digested backbone was separated from undigested backbone and the 
insert on 5-15 cm 0.5-0.7% agarose gel in TAE buffer via agarose gel 
electrophoresis at 120-150 V for 30-60 min (Thermo Scientific Owl Easycast B1, 
B1A). The gels were imaged using 0.5 µg/mL ethidium bromide added to the gels 
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and a Syngene U:Genius gel documentation system, and the appropriate length 
DNA pieces were cut out from the gels. 
DNA was isolated from gel slices using Epoch gel cleanup kit using 
manufacturer’s recommendations. For DNA pieces shorter than 1000 bp or 
longer than 10,000 bp, 350 µl isopropanol was added after dissolving the gel 
piece in 800 µl GEX buffer at 72°C, prior to loading the ion exchange columns. 
Insert DNA was amplified using Phusion or Q5 polymerases from NEB 
according to manufacturer’s protocol (20-50 µl reaction volume). We designed 
the primers with matching melting temperatures both in their template 
homologous regions and for their total length. We added 1 M betaine to reactions 
for Gibson assembly due to long non template homologous sequences. The 
polymerase chain reaction included two phases: first with a melting temperature 
corresponding to the homology region of the primers for 5 cycles, and a second 
cycling phase with the melting temperature corresponding to the full primer 
length for 30 cycles. The PCR reactions were analyzed on 1-2% agarose gels, 
correct length insert DNA pieces were cut and isolated from the gels similarly to 
backbone digestion reactions. 
Insert DNA for ligation based cloning was digested with the same pair of 
restriction endonucleases as backbone DNA (1 µg PCR product with 1 µl of each 
restriction endonuclease in 50 µl total volume at 37°C for 1-2 hours). The 
digested DNA fragments were removed using Epoch PCR cleanup kit following 
digestion according to manufacturer’s protocol. 
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For some inserts, PCR assembly (SOE PCR) was required where PCR 
products with overlapping ends were joined to form a larger product. First each 
segment was PCR amplified with minimum 30 bp overlap, followed by gel 
purification. Then the SOE PCR reaction was performed for 15 cycles without 
primers on an equimolar mixture of the two to three segments to be joined with a 
melting temperature that corresponds to the homology regions. This was 
immediately followed by a purification PCR for 20 cycles using primers binding to 
the outside ends of the final product with a melting temperature of 72°C. The final 
product was gel purified. 
Short inserts were cloned using oligo drop-in cloning, where a pair of 
overlapping oligos with digestion overhangs were designed. 200 pmol oligos 
were phosphorylated using polynucleotide kinase (10 µl total volume, 1 µl T4 
DNA ligase buffer, 0.5 µl PNK enzyme, 37°C 1 hour). Following phosphorylation, 
the complementary oligos were mixed equimolarly (5 µl of each oligo from 
phosphorylation reaction in 40 µl DI water), and their temperature was brought up 
to 95°C and slowly decreased to room temperature. 1 µl of this reaction was 
used to ligate with 50-100 ng digested backbone DNA. 
Blunt and sticky DNA ends were ligated using T4 DNA ligase from NEB. 
50 ng backbone DNA was ligated to threefold molar excess insert using 1 µl T4 
DNA ligase in 10 µl total volume buffered by 1 µl T4 DNA ligase buffer. The 
reaction was cyclically ramped between 16°C and 30°C for 30 min – 16 hours, 
and 4 µl reaction was transformed into 20-50 µl chemically competent E.coli 
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cells. Negative control omitting insert DNA was always included to assess the 
fraction of clones with undigested or religated backbone DNA. 
Certain sticky DNA ends were more efficiently ligated with T7 DNA ligase 
(10 µl T7 DNA ligase buffer, 1 µl T7 DNA ligase, 50 ng backbone with threefold 
molar excess insert in 20 µl total volume). Negative control excluded insert DNA. 
The reaction was cyclically ramped between 16°C and 30°C for 30 min, and 10 µl 
reaction was transformed into 50 µl chemically competent E.coli cells. 
2.1.2. Gibson assembly 
DNA backbone preparations for Gibson assembly were digested with a 
pair or restriction endonucleases. The resulting DNA ends were either 
dephosphorylated by calf intestinal phosphatase treatment (0.5 µl CIP enzyme / 
reaction, 37°C 10 min incubation) or blunted by mung bean nuclease digestion 
(0.5 µl MNB enzyme / reaction, 30°C 30 min incubation), and purified via agarose 
gel electrophoresis and gel extraction. 
Inserts were PCR amplified in two step PCR protocol using Q5 enzyme to 
incorporate 25-35 bp homology arms between DNA pieces to be joined. The 
reactions contained 1 M betaine additive. Correct length PCR fragments were 
purified via agarose electrophoresis and gel extraction. 
To assemble the DNA pieces, 50 ng backbone DNA was mixed with 
threefold molar excess of each insert. The negative control was same 
composition and treatment as the sample, except for omission of the smallest 
insert. This DNA mixture was then gently mixed on ice with 2x assembly master 
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mix (320 µl 5x isothermal reaction buffer, 300 µl water, 160 µl 40 U/µl Taq ligase, 
20 µl 2 U/µl Phusion DNA polymerase, 0.64 µl 10 U/µl T5 exonuclease; 5x 
isothermal reaction buffer contains 1.5g PEG 8000, 3 mL Tris·HCl pH 7.5, 300 µl 
1M MgCl2, 300 µl 1M dithiotreitol, 600 µl 50 mM NAD+, 600 µl 10 mM dNTP mix 
(dGTP, dATP, dTTP, dCTP 10 mM each) in 6 mL volume), and incubated at 
50°C for 60 min. The reaction was then transformed into competent E.coli cells. 
2.1.3. Gateway recombination 
pENTR insert encoding plasmids were cloned using traditional cloning 
methods, and selected for using kanamycin selection. pDEST backbone 
plasmids were cloned using traditional cloning methods, propagated in ccdA TG1 
or gyrase mutant DB3.1 strains of E.coli under dual carbenicillin and 
chloramphenicol selections at 30°C to minimize recombination. pEXPR final 
expression clones were propagated in TOP10 or NEB10 beta E.coli in 
carbenicillin selection. 
To perform the in vitro Gateway recombination, 300 ng pENTR plasmid 
was mixed with 500 ng pDEST plasmid and 1 µl 5x LR Clonase in 5 µl total 
volume with TE buffer pH 8.0. Reactions were incubated at 25°C overnight, and 
treated with 1 µl 2 g/L Proteinase K at 37°C for 10 min. The reaction was then 
transformed into competent E.coli TOP10 or NEB10 beta ccdB sensitive cells, 
and the resulting pEXPR clone selected for using carbenicillin antibiotic. 
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2.1.4. Preparation and transformation of chemically competent and 
electrocompetent E.coli cells 
Escherichia coli TG1 strain was used for cloning, DB3.1 for propagating 
Gateway destination vectors, TOP10 for selection of the final product after 
Gateway LR reactions, NEB10beta for electrocompetent cell preparation and 
electroporation. 
To prepare chemically competent E.coli, cells were streaked on LB broth 
agar (10 g/l casein peptone, 5 g/l yeast extract, 10 g/l sodium chloride, 15 g/l 
agar) plates and incubated 12-16 hr at 37°C. 5 mL liquid LB broth was inoculated 
with a single E.coli colony, and grown for 16 hr at 37°C 300 rpm. 1-2 L LB broth 
was inoculated with this overnight culture, and grown to OD = 0.6 at 37°C 300 
rpm. The cultures were then chilled on ice for 20 min in prechilled 250-500 mL 
centrifuge tubes, and then centrifuged at 3000xg for 10 min at 4°C. The cell pellet 
was then resuspended in 25-50 mL ice cold TSS solution (100 g/L PEG 8000, 30 
mM MgCl2, 5% DMSO in LB broth), and 100 µl aliquots were snap frozen in liquid 
nitrogen, stored at -80°C. 
To transform chemically competent E.coli cells, 50-100 µl chemically 
competent cells were thawed on ice, mixed gently with ice cold KCM solution (0.1 
M KCl, 0.03 M CaCl2, 0.05 M MgCl2) and 4 µl ligation reaction or 10 µl Gibson 
assembly reaction or 5 µl LR reaction. The cells were then heat shocked at 42°C 
for 90 seconds, followed by incubation on ice for 2 min, and plating on LB agar 
plates containing 50 µg/ml carbenicillin. If the plasmid encoded kanamycin or 
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chloramphenicol resistance genes, the cells were recovered in 1 mL SOC media 
(20 g/L tryptone, 5 g/L yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 
mM MgSO4, 20 mM glucose) at 37°C for 1 hour, followed by concentration by 
centrifugation at 8600xg 2 min and resuspension in 100 µl SOC media prior to 
plating on LB agar plates containing 50 µg/ml kanamycin or 34 µg/ml 
chloramphenicol. 
To prepare electrocompetent E.coli cells, cells were streaked on LB agar 
plates, and incubated 16 hr at 37°C. All glassware was rinsed with DI water to 
remove residual surfactants from dishwashing. 5 mL LB broth was then 
inoculated with a single NEB10 beta E.coli colony, and grown 16°C at 300 rpm 
for 16 hr. 500 mL LB broth was inoculated with this culture, and grown at 37°C 
300 rpm to OD = 0.4-0.6. The culture was then transferred to prechilled 50 mL 
centrifuge tubes and incubated on ice for 30 min, followed by centrifugation at 
4°C 3000xg 20 min. Each pellet was gently washed with 40 mL ice cold sterile 
distilled water, and centrifuged at 4°C 3000xg 20 min. Each pellet was gently 
washed with 20 mL ice cold sterile distilled water, combined into four tubes, and 
centrifuged at 4°C 3000xg 20 min. Each pellet was resuspended in 10 mL ice 
cold sterile 10% glycerol in DI water, 40 mL total. Cells were centrifuged at 4°C 
3000xg 20 min, and resuspended in 500 µl ice cold sterile 10% glycerol, 
distributed to prechilled tubes in 50 µl aliquots, snap frozen in liquid nitrogen, and 
stored at -80°C. 
  
27 
To transform electrocompetent cells, transforming DNA was purified using 
the PCR cleanup protocol, and eluted in 50 µl distilled water. Cuvettes with 1 mm 
gap were prechilled on ice, 50 µl cells were gently mixed with purified DNA, 
electroporated at 1800V using BTX ECM 630 electroporator with approximately 5 
ms exponential decay. Following electroporation, cells were immediately rescued 
in 1 mL prewarmed SOC media at 37°C for 1 hr. Cells were then centrifuged at 
8600xg 2 min and resuspended in 100 µl SOC media prior to plating on LB agar 
plates containing selective antibiotics. 
Transformation efficiency was assessed by transforming 1 pg pUC19 
plasmid into one vial of cells, and calculating the number of transformants per 
microgram DNA. 
2.2. Saccharomyces cerevisiae culture 
2.2.1. Growth and selections in liquid and on agar media 
Saccharomyces cerevisiae YPH500, W303, BY4741, 74D-694 strains and 
their derivatives were streaked on YEP agar (20 g/L peptone, 10 g/L yeast 
extract, 20 g/L agar) media supplemented with 20 g/L glucose and incubated at 
30°C for 2-3 days until colonies were formed. A single colony was then grown in 
liquid YEP broth containing 2% glucose (YPD). 
In experiments where the activity of the GAL1 promoter was assessed, 
cells were grown in YEP liquid broth supplemented with 2% raffinose for 20-24 hr 
prior to growth in YEP liquid broth supplemented with 2% galactose. 
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Selection for certain metabolic genes was carried out on complete 
synthetic medium lacking a single nutrient (6.71 g/L yeast nitrogen base with 
ammonium, 0.79 g/L complete supplement mixture, 20 g/L glucose, 20 g/L agar). 
Estradiol induction experiments were carried out on cells exponentially 
growing in complete synthetic medium supplemented with 80 mg/L adenine 
hemisulfate. 
To freeze yeast cultures, 700 µl early stationary phase yeast culture was 
mixed with 300 µl sterile glycerol in a screwcap cryotube, and stored at -80°C. 
For 96-well plate freezing 210 µl yeast culture was mixed with 90 µl 50% sterile 
glycerol in a U-bottom clear plate, and covered with aluminium seal, stored at -
80°C. 
2.2.2. Genomic integration of linear DNA, transformation with 
plasmid DNA 
To yield linear DNA for genomic integration, the pRS and pNH series of 
plasmid backbones were used, which result in very low frequency of incorrect 
targeting or false positive transformants. 10 µg plasmid DNA was digested with 2 
µl linearizing enzyme for 3-4 hr at 37°C in 50 µl total volume. 
S.cerevisiae cells were grown in YPD broth for 16-20 hr at 30°C 300 rpm. 
The culture was diluted to OD = 0.1 in 2 mL/reaction 2xYPAD broth (40 g/L 
peptone, 20 g/L yeast exract, 80 mg/L adenine hemisulfate, 40 g/L glucose), and 
grown to OD = 0.6. Cells were then centrifuged at 1000xg for 5 min at room 
temperature, resuspended in 40 µl/reaction TE buffer, and added to a 
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transformation master mix. The yeast transformation master mix was freshly 
prepared minutes before use by vortexing 240 µl 50% PEG 3350, 36 µl 1 M 
lithium acetate, 50 µl 2 mg/mL single stranded salmon sperm DNA and 5 µl 
linearized plasmid DNA to be integrated. Negative control reaction for each cell 
line was handled the same way as samples, but did not receive integrating 
pieces of plasmid DNA. Following complete homogenization of cells and master 
mix, the reactions were heat shocked at 42°C for 35 min. The cells were then 
separated from the transformation mix by centrifugation at 2000xg for 5 min at 
room temperature, and aspiration of the supernatant. The pellet was then 
resuspended in corresponding liquid selection media, and plated on selective 
plates. Colonies formed after 2-3 day incubation at 30°C, and were inoculated 
into corresponding selective liquid media. Biological replicates were clones 
resulting from such an integration reaction. 
In the case of kan, hph, nat selection markers, the cells were recovered in 
1 mL YPD media for 4-16 hr prior to plating on YPD agar plates containing 200 
µg/mL geneticin, 50 µg/mL hygromycin B, 100 µg/mL nourseothricin, 
respectively. 
2.2.3. Continuous culture 
Continuous culture instruments were custom built in the laboratory. Briefly, 
each reactor is 25 mL in volume, maintains temperature at 30°C with 0.1°C 
precision, is stirred with a magnetic stir bar at 1000 rpm, which provides aeration. 
OD is continuously monitored, and once it reaches the upper limit of a 
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predetermined range (0.3-0.4), fresh media is pumped into the vial to bring the 
OD to the lower limit along with pumping out excess volume. This mode of 
operation is called a turbidostat. 
Prior to turbidostat growth, cultures were grown in 5 mL media for 12-16 hr 
at 30°C 300 rpm in YPD or synthetic complete medium to yield sufficient cell 
mass. Their optical density was assessed by measuring absorbance at 600 nm in 
300 µl volume on a flat bottom 96-well plate on Spectramax M5 instrument, and 
subtracting the absorbance of a media only well. At the beginning of each 
experiment, the culture vials were filled with 20 mL inducing or non-inducing 
media, and the inoculum was directly added to this at starting OD = 0.1-0.05. 
Samples were taken every 4-12 hr for flow cytometry and recovery. 
Recovery was carried out in noninducing, non stress YPD or synthetic complete 
media following 10000-fold dilution of the cultures to provide ~15 generations 
growth under non prion switching conditions. In each experiment, a 
corresponding sample with and one without the prion to be studied was included 
for setting up flow cytometry gates that clearly separate the two populations 
under the growth conditions in the experiment. 
2.2.4. Culture on PDMS microfluidic chips and time-lapse 
fluorescence microscopy 
To fabricate PDMS microfluidic chips, 6ST2 SU-8 control and flow layer 
molds were used. 30 grams of sylgard 184 elastomer base was vigorously mixed 
with 0.3 grams of sylgard 184 silicone elastomer curing agent for 3 min, and 
  
31 
poured directly into the mold. The mixture was degassed under vacuum for 20 
min, and baked at 80-90°C for 2 hours. The PDMS chips were then cut into 
shape, and control valve pressure inputs punched using a 0.25 mm biopsy 
punch. To fabriacate the flow layer, 5 grams of sylgard 184 silicone elastomer 
base was vigorously mixed with 0.5 grams of sylgard 184 silicone elastomer 
curing agent for 3 min, and degassed for 20 min. 70 µl chlorotrimethylsilane was 
dispensed around the edges of a 100 mm glass petri dish containing the SU-8 
flow layer, and incubated for 10 min. The Petri dish was opened for 3-5 min, and 
the sylgard mix was poured onto the wafer, further degassed, and spincoated for 
60 seconds at 3500 rpm. The flow layer was prebaked for 14 min at 85-90°C, 
and the control layer aligned on top using a dissecting microscope. The two layer 
device was cured at 85-90°C for 4-16 hours, individual devices separated from 
the mold, media inlets were punched using 0.25 mm biopsy punch. Prior to 
bonding to glass, the chips were baked at 80°C for 1-2 hours, cleaned with 
scotch tape to remove particles, washed isopropanol and water and dried with 
nitrogen gas. The bottom of the flow layer and a glass coverslip was plasma 
treated for 45 seconds prior to bonding at 85-90°C for 4-16 hours. The device 
was secured in an acrylic holder and mounted into the stage (Figure 2.1) of a 
Nikon Ti-E Eclipse inverted microscope with an environmental chamber at 30°C 
(Figure 2.2). Filters and light sources were automatically controlled by the 
supplier’s software (NIS-Elements Advanced Research). 
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Cells were grown in synthetic complete media with and without inducer or 
stress agent in the device for 4-36 hr using external fluid reservoirs (Figure 2.4). 
The valve layers were filled with DI water, and actuated with 15 psi pressure 
(Figure 2.3) and a custom built valve control program. The flow layers were 
flushed with a culture of exponentially growing cells concentrated 5-10-fold to 
capture cells in the growth chambers prior to the start of media flow in the device 
at 5 psi. Cells were incubated in the device for 2-5 hours prior to treatment. 
Images were collected every 15 min on bright field and GFP channels at 100x 
magnification (Plan Apo Lambda 100X oil objective, NA 1.45) using a CCD 
camera (Andor technology). The imaging frequency was 15 minutes to avoid 
photo bleaching and make lineage tracing still possible. 2-3 cell chambers were 
imaged over time per condition which accounts for at least 20 cells analyzed at 
each time point. 
 
Figure 2.1 Microfluidic device mounted in the microscope stage. 
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This device is suitable for long term time lapse imaging of yeast cells. Media and waste are 
continuously flushed through the growth chambers while cells are growing in a monolayer. The flow 
of different media is controlled by pneumatic valves, which allows for switching between two 
different types of media. Images of the growth chambers are collected at 15 minute intervals to gain 
dynamic time dependent fluorescent readout from single cells. 
 
 
Figure 2.2 Microscope setup for long term time-lapse imaging with motorized stage and 
environmental chamber. 
This setup enables automated imaging of an experiment incubated at a constant temperature. The 
environmental chamber and the heater attached keep the samples, the microscope stage and the 
objective at the user defined temperature. This prevents temperature fluctuations during an 
experiment, which could induce biological responses in the cells. The motorized stage allows for 
automated moving of the microscope stage to predefined points of investigation. In one experiment, 
multiple chambers may be imaged at once over time. The motorized stage also allows for automated 
fine-tuning of the focal distance for precise imaging over long periods of time. 
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Figure 2.3 Pressure regulator setup for microfluidic experiments. 
The pressure regulator controls the pressure of the control and media lines in the microfluidic 
device. The higher the pressure in the media lines, the faster the media flow. The control lines 
determine which media input is used at a given time. This setup operates with house air, and the 
regulator shown decreases house air pressure to 25 psi, which is further decreased to 15 psi for 
control channels and 5 psi for media flow. The pressure regulator system shown above enables long 
term reliable control of media flow in microfluidic devices with up to 10 media lines and 15 control 
lines. 
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Figure 2.4 Media reservoir for long term microfluidic experiments. 
The pressurized reservoir above can continuously supply media for microfluidic experiments for 3 
or more days. This enables long term experimentation compared to the traditional method of filling 
up tubing with media, which only lasts for less than 8 hours before media runs out. The thick tubing 
inputs pressurized air, which forces the media out on the thin silicone tubing, which are connected 
to the channels on the microfluidic device. 
 
2.3. Fluorescence measurements 
2.3.1. Flow cytometry 
Flow cytometry samples were fixed with 10 µg/ml cycloheximide in PBS 
and stored up at 1 hour - 5 days at 4°C prior to analysis. The samples were 
measured on Attune NxT VBYR flow cytometer with autosampler or BD Fortessa 
LSR SORP VBYGYR flow cytometer with high-throughput sampler. Flow rates 
were 25 -500 µl / min, 1-3 mixing cycles and 800 µl rinse were used, flow rate 
was adjusted to keep event rates under 5000 events / second. 
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2.3.2. Fluorescence microscopy with nuclear staining 
Cells were grown for 8 hours in fresh media starting at OD=0.05 to reach 
exponential growth phase. Then concentrated by centrifugation at 700xg for 5 
min, resuspended in live cell imaging solution (20 mM HEPES pH 7.4, 140 mM 
NaCl, 2.5 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 20 mM glucose), stained with 5 
µM Vybrant DyeCycle Violet for 20 min at room temperature, and imaged a 1 µl 
sample between coverlips on a Nikon Ti-E Eclipse inverted microscope at 100x 
magnification (Plan Apo Lambda 100X oil objective, NA 1.45) using a CCD 
camera (Andor technology). Cell viability was necessary to be maintained for 
proper protein localization.  
 
2.4. Computational methods 
2.4.1. Flow cytometry data processing using FlowJo software 
Flow cytometry data was exported as FCS files from the data acquisition 
software (BD FACSDiva 7 or Attune NxT Flow Cytometer Software). The files 
were then imported into FlowJo 10 software. Yeast cells were gated on FSC-
SSC scatterplot to include ~70% of the single cells and exclude particles and cell 
clumps. If propidium iodide was used a viability dye, the live cell population was 
gated on Texas Red or YL-2 channels. This sub-population was then analyzed 
on SSC-GFP or SSC-BL1 scatterplot for yTRAP signal. The prion carrying and 
prion free population gates were determined based on [prion-] and [PRION+] 
samples under the same growth conditions. For other reporters, geometric 
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means of single cell fluorescent signals was calculated and exported. In each 
experiment biological triplicates or quadruplicates were analyzed, and samples 
with less than 20,000 live yeast cells were excluded. GraphPad Prism software 
was used for data visualization and error bar generation. 
2.4.2. Growth curve fitting for growth rate measurements in 
continuous culture 
Continuous culture reactors record optical density measurements every 30 
seconds. This data was used for determining growth rate of the different cultures 
over time using custom built mufit algorithm (https://github.com/peterkomar-
hu/mufit). Briefly, the algorithm excludes dilution events and noisy sensor 
readings, then exponential growth curves are fit globally with user determined 
tightness of fit. Since this growth rate measure is dependent on the sensitivity of 
the optical density readings, differences between reactors in terms of OD 
sensitivity will result in inaccurate relative growth rates. 
 
2.4.3. Image segmentation and lineage tracing in microfluidic experiments 
 
Images of each fluorescent and BF channel and each timepoint were 
exported as TIFF files, and processed using custom built software in Matlab 
running on Boston University Shared Computing Cluster. Briefly, the 
segmentation software identifies cells as white circles on the bright field image, 
and adds up the GFP signal within the cell area on the GFP image. Lineage 
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tracing identifies which daughter cell originates from which mother, and 
generates lineage trees based on this information. 
2.4.4. Automated primer design 
For traditional cloning, manual primer design was complemented with a 
custom primer design algorithm (https://github.com/SzilviaKiriakov/Cloning-
Primer-Designer). Briefly, the algorithm determines a sequence of homology from 
the beginning and end of gene of interest that has a melting temperature of 63°C 
with NEB’s Q5 enzyme. Then Kozak sequence and restriction endonuclease 
recognition sites are added. Finally, a 3-6 bp overhang is added to match the 
melting temperatures of the primer pair and to avoid secondary structures and 
primer dimers. Melting temperature matching is based on length of the added 
sequence and GC content. The order of nucleotides is screened using IDT’s 
Oligocalc algorithm to avoid secondary structures. 
2.4.5. Mathematical model of anti-prion drive spreading in a 
population 
Prions are inherited in non-Mendelian dominant fashion, similarly to gene 
drives. Anti-prion drives reverse this inheritance, and semi-drives alter the prion 
inheritance to regular Mendelian fractions. We modeled under what 
circumstances would anti-prion drives cure prions from a population of sexually 
reproducing yeast cells. 
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The model assumed that the population is synchronized, every cell finds a 
mating partner and produces four spores, two of which have the same genotype. 
Population fractions, not population size, were modeled and Hardy-Weinberg 
equilibrium was assumed. Population composition was updated iteratively after 
each reproduction cycle. The two possible ‘alleles’ of [prion-] (a) and [PRION+] 
(A) were supplemented with the third drive (D) allele. The genotypes were then 
interpreted according to prion and anti-prion drive inheritance rules. For example, 
the progeny of a [prion-] and [PRION+] cell become [PRION+] (aA → A). Full anti-
prion drive cures all progeny, AD → aD, where D drive phenotype is [prion-]. 
Semi drive phenotype is [PRION+], otherwise it behaves the same way as full 
drive. 
Simulations were run for 50 generations where the population composition 
does not change between generations any further. 
2.4.6. Four state mathematical model of prion switching dynamics 
Models that describe the molecular details of prion aggregation such as 
folding and oligomerization intermediates (e.g. Nowak model) provide molecular 
insight. However, the number of parameters in such models makes them 
unfeasible to fit to experimental data as many of the intermediate states are not 
experimentally tractable. Therefore, we chose a state model where transition 
between states happens with first order kinetics, but certain transitions are only 
allowed when a prion state inducer or eraser is externally supplied. The first 
order kinetics is substantiated89 by experimental findings that show that 
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aggregation is a first order process where small aggregates in cells need to 
reach a critical size to become fibrils. 
The simplest two state model (aggregated and soluble) would not describe 
the behavior of yTRAP signal during prion switching experiments. Since 
establishing and erasing the prion state are symmetrical processes in our 
observation, we developed a four state model in which prion establishment 
happens via a transiently aggregated state, and prion erasing happens via a 
transiently soluble state. Transition from soluble state to transiently soluble state 
is reversible, but only allowed in the presence of a prion inducer, while transiently 
soluble state to aggregated state transition is irreversible. Similarly, aggregated 
to transiently soluble transition is reversible but only in the presence of a prion 
eraser, and transiently soluble to soluble is an irreversible transition. 
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3. INDUCIBLE SYSTEMS TO ACHIEVE TEMPORAL CONTROL OF 
EPIGENETIC REGULATORS 
 
The expression and activity of epigenetic elements is tightly regulated in living 
cells. To study epigenetics in yeast, we are applying molecular devices to perturb 
the epigenetic state, and observe the outcome of these perturbations. Tight 
molecular control systems are necessary for high temporal control of the 
epigenetic regulators. These molecular control systems convert the concentration 
profiles of small molecule inputs into transcriptional activity profiles of the gene of 
interest. We aimed to design our systems to utilize non-metabolite inputs and to 
achieve simultaneous control over multiple genes. The synthetic inducible 
systems developed here are well characterized with known induction kinetics and 
drug sensitivity profiles, which allows immediate deployment in applications. 
 
3.1. Introduction 
3.1.1. Requirements and challenges in controlling epigenetic 
regulators 
Epigenetic regulators in eukaryotic cells are under strict regulation by 
transcription factors, microRNAs and long noncoding RNAs. To study an 
epigenetic regulator’s function in isolation, with a temporal pattern and at 
adjustable doses, externally controlled regulators are required. Tuning gene 
expression in yeast is possible via plasmid or chromosomal location, promoter 
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and terminator choices, and using synthetic transcription factors21. We developed 
small molecule controllable transcriptional regulator systems to be able to control 
multiple epigenetic elements simultaneously and independently. 
Eukaryotic artificial transcription factors are modular, consisting of a DNA 
binding domain and a regulatory domain with specifically designed linkers in 
between and appropriate trafficking signals90. DNA binding domains that do not 
interfere with yeast regulation may originate from bacteria or are designer DNA 
binding domains21. Bacterial transcription factors that have been deployed in 
yeast synthetic circuits are tetR91, lacI and lexA92 as wild type or fusion proteins. 
Designer DNA binding domains that have been used in yeast circuits are zinc 
finger domains20, TALEs93 and CRISPR Cas9 activators94, 95. Zinc finger DNA 
binding domains are compatible with VP16 and p65 transactivation domains96. 
dCas9 has been successfully fused to VP64 and KRAB domains to yield 
targetable synthetic activators and repressors in yeast22. Ligand binding domains 
enable the artificial transcription factors to respond to small molecule external 
stimuli. Previous research has utilized estrogen and progesterone binding 
domains97 of human nuclear receptors in yeast. The estrogen binding domain 
has the potential to yield mutants that bind other molecules as seen with ERT1 
and ERT298 in mammalian cells. In yeast, a mutant of estrogen receptor was 
developed to bind DHB instead of estradiol99. Ligand binding transcription factors 
are not merely suitable for small molecule dependent activation of certain 
transcriptional programs. In a recent example, digoxin and progesterone 
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responsive ligand binding domains100 were combined to yield small molecule 
biosensors in yeast101. 
3.1.2. Temporal, dose dependent control of artificial transcription 
factors 
A library of artificial zinc finger based transcription factors was developed20 
with independent, non-cross reacting recognition sequences. These are fusion 
proteins of artificial DNA binding domains, nuclear localization sequences and 
transactivation domains. The DNA binding domains are engineered variants of 
the Zif268 mouse EGR1 Cys2His2-type zinc finger protein, where the DNA 
binding alpha helices have been mutated and screened in a library format to bind 
certain sequences. The strong nuclear localization signal sequence is derived 
from the SV40 virus large T-antigen. The activation domain is VP16, which is the 
Herpes simplex virus protein vmw65, an acidic peptide that recruits 
transcriptional machinery. 
The transcription factors are targeted to a synthetic enhancer composed 
of a zinc finger binding site array upstream of a minimal CYC1 yeast promoter. 
The CYC1 gene in yeast encodes cytochrome c isoform 1, which is an electron 
carrier in the mitochondrial intermembrane space. The minimal CYC1 promoter 
has been modified to remove upstream regulatory sequences of endogenous 
transcription factors that would result in induction by oxygen, heme and lactate 
and repression by glucose. 
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The expression of the artificial transcription factors was controlled by 
promoters responding to the small molecule dependent bacterial repressors lacI 
and tetR. The binding sites of these repressors were inserted in the TATA-box 
region of a GAL1 promoter. GAL1 encodes galactokinase in yeast, therefore the 
GAL1 promoter is activated by galactose and repressed by glucose. The cells 
were grown in galactose media, and IPTG (inducer molecule for lacI) or aTc 
(inducer molecule for tetR) was added in different doses for different amounts of 
time to induce expression of the artificial transcription factors. 
The transcription factors produced small molecule dependent temporal 
responses according to the synthetic circuit such as logical AND or OR gates. 
This proved that the artificial zinc finger proteins are functional in yeast and that 
the artificial transcription factors are capable of recruiting the transcriptional 
machinery to a given location in the genome. The next question were how more 
complex assemblies of transcription factors regulate transcription, if synthetic 
transcriptional circuits with time dependent outputs can be constructed, the 
behavior of site specifically recruited chromatin regulators. To answer these 
questions, better regulatory systems coupled with faster, more modular 
construction were becoming necessary. 
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3.2. Three parallel inducible systems using bacterial and eukaryotic 
components 
3.2.1. Introduction 
Traditional small molecule control of gene expression in yeast often 
involves major changes to the cell’s metabolism. The most commonly used 
induction system is the GAL1 promoter, which is repressed in glucose and 
activated in galactose. Fully induced cells grow on 2% galactose as a sole 
carbon source following a 24-hour preconditioning in 2% raffinose as a sole 
carbon source. Not induced cells grow on 2% glucose. Since the carbon 
metabolism is a central part of the yeast cell’s physiology, when induced and not 
induced cells are compared, the gene expression differences can be much more 
extensive than the expression of the gene of interest. Other traditional inducible 
systems include MET25 methionine dependent promoter, CUP1 copper 
dependent promoter. These unfortunately have high basal expression even when 
not induced, and as a result, small fold induction. Additionally, laboratory yeast is 
traditionally grown on glucose and most gene expression datasets were collected 
on glucose media. Therefore, glucose based induction medium is strongly 
preferred. Our goal was to develop non-metabolite small molecule dependent 
inducible systems to avoid nutrient differences between induced and uninduced 
cells for at minimum two independent inputs. 
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3.2.2. Components 
In addition to the two previously used bacterial repressors, we included a 
third small molecule dependent eukaryotic activator. This protein is a fusion of 
the yeast Gal4p transcription factor DNA binding domain and the ligand binding 
domain of human estrogen receptor to the VP16 transactivation domain (GEV). 
GEV binds to GAL4 UAS sequence upon addition of 17β-estradiol to the media. 
17β-estradiol, aTc and IPTG are independent small molecule inputs. GAL4 UAS, 
tetO and lacO are also independent binding sites. GEV, tetR and lacI do not 
recognize each other’s small molecule inputs or binding sites, they are 
orthogonal induction systems that can be used in parallel without cross-
activation. 
The reporting promoters are insertions of the lac operator (lacO) and tetR 
repressor binding sites (tetO2) in the TATA-box region of the yeast GAL1 
promoter. The resulting reporter is activated by estradiol and IPTG or estradiol 
and aTc, respectively. Repression of pGAL1 in glucose can be overcome by the 
addition of estradiol due the GEV activator. 
Yeast chromosomal integration is driven by homologous recombination, 
therefore, external DNA can be targeted to specific locations in the genome. 
There are four easily selectable biochemical markers in yeast, which makes 
complex circuit construction challenging. We clustered the inducible systems in a 
single drug selectable locus to preserve the biochemical markers for functional 
circuit elements. Decoupling inducible system expression and functional circuit 
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elements makes plasmid construction modular and faster. The homology arms 
used in the inducer expression plasmid target for ends-out integration, which 
results in purely single integrant clones decreasing the need for screening 
individual clones.  
 
3.2.3. Control systems 
We optimized the expression levels of the three inducible regulators by 
expressing each one of them from strong to medium strength constitutive 
promoters pTDH3, pTEF1, pADH1 and pSOD1. The goal was to find three 
different promoters for the three regulators such that the final construct would not 
suffer from homologous recombination instability. After individual testing of each 
regulator, we arrived at the optimal promoter selection on Figure 3.1, where GEV 
is driven by the strongest TDH3 promoter, tetR by the second strongest TEF1 
promoter, and lacI by the third in strength ADH1 promoter. The reporters were 
the same as the ones in Khalil et al., Cell 2012, except for having removed the 
tetR and lacI expression cassettes (Figure 3.1). 
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Figure 3.1. Design of the inducible system integration cassette and its reporters (left). 
Characterization of constitutive promoter strengths (right). 
Left. The final optimized design of expression cassette integration for the three small molecule 
transcription factors. 
The cassette (top) is integrated in the homing endonuclease, HO, locus in the yeast genome, and is 
selected for using the drug hygromycin. The HO gene is mutated in all laboratory haploid yeast 
strains to maintain the haploid state. The lacI and GEV transcriptional units have the same 
directionality, while the tetR transcriptional unit is in the opposite direction. We incorporated a 500 
bp long insulating sequence between the TEF1 and ADH1 promoters to avoid promoter interference. 
The eukaryotic estradiol responsive GAL1 promoter activating GEV fusion protein is expressed from 
the strongest yeast promoter, pTDH3. The IPTG responsive bacterial repressor lacI is expressed 
from the medium strength ADH1 promoter, and the aTc responsive bacterial repressor tetR is 
expressed from the strong TEF1 promoter. The regulators were individually tested with the different 
combinations of constitutive promoters, and the configuration depicted here provided the highest 
fold activation values. 
The yeast enhanced GFP reporters (bottom) are modified versions of the native yeast GAL1 
promoter, which is activated by galactose and repressed by glucose. The promoters have tet (red) 
and lac (blue) operator insertions in their TATA-box region, making them repressible by tetR and 
lacI, respectively. The reporter transcriptional cassettes end with the CYC1 terminator, and are 
inserted in the URA3 locus in the haploid yeast genome. 
Right. Different strength constitutive promoters were tested to yield optimal expression levels for 
the different regulators. 
The mean fluorescence intensities of a small library of different strength constitutive promoters 
driving yeast enhanced GFP are shown. The reporters were integrated in the LEU2 locus and cells 
were exponentially growing in synthetic complete media supplemented with adenine for 8 hours 
prior to flow cytometry measurement. TEF1 and ADH1 promoters showed strong expression, while 
CHO1 and BIO2 promoters showed medium expression. We used the stronger expressing TEF1 and 
ADH1 promoters for driving the expression of the regulators, and used the weaker BIO2 and CHO1 
promoters to build repressible reporters. pCYC1 is the minimal CYC1 promoter used in previous 
studies20 to construct inducible reporters. 
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3.2.4. Behavior and characterization 
After the full circuit was constructed, we characterized the behavior of the 
components. The reporter promoters (pGAL1) are repressed in glucose, 
reactivated by addition of estradiol. They are also repressed by tetR and lacI, 
therefore in glucose estradiol and aTc or IPTG show AND logic (Figure 3.2 top). 
In galactose media the bacterial repressors are the only regulators preventing 
transcription. This repression is relieved upon addition of aTc or IPTG to the 
media (Figure 3.2 bottom). 
We characterized the dynamic behavior of this system in glucose and 
galactose media to explore the parameter space under which the concentration 
of the reporter output can be modulated. Different levels of estradiol (Figure 3.3) 
produce non-allosteric output in glucose. The system reaches saturation at 1 µM 
estradiol with 120-180 nM half maximum concentrations. 
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Figure 3.2. The cassette produces AND logic behavior in glucose, and repression logic in galactose. 
Top. The cassette produces AND logic in glucose. 
Cells that only have the reporter and cells with both the cassette and the reporter are compared in 
different inducer media conditions. Cells were induced for 8 hours in synthetic complete media 
supplemented with 2% glucose. On the left graph, the first two bars correspond to cells without the 
reporter, the first bar is unmodified cells, the second bar is cells with the cassette alone, and both 
have low fluorescence, which we attributed to autofluorescence. The second four bars correspond 
to IPTG and estradiol uninduced and induced cells with the reporter. These do not turn on the 
reporter as they do not express the GEV activator, and the pGAL1 promoter is repressed in glucose. 
The last four bars correspond to cells that carry both the reporter and the cassette. Addition of 
estradiol in the absence of IPTG increases reporter output a little bit, but full activation is only 
achieved when both the GEV activator is induced and the lacI repressor is inactivated (green bar). 
The graph on the right summarizes the results when the same experiment is conducted using the 
pGAL1(tetO2) reporter and aTc as inducer. 
Bottom. The cassette produces repressible logic in galactose. 
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Cells that only have the reporter and cells with both the cassette and the reporter are compared in 
different inducer media conditions. Cells were induced for 16 hours in YEP media supplemented 
with 2% galactose. On the left graph, the first two bars correspond to cells without the reporter, the 
first bar is unmodified cells, the second bar is cells with the cassette alone, and both have low 
fluorescence, which we attributed to yeast autofluorescence. The second two bars correspond to 
IPTG uninduced and induced cells with the reporter. They both turn on the reporter as there is no 
repressor being expressed in these cells. The last two bars correspond to IPTG uninduced and 
induced cells that carry the cassette and the pGAL1(lacO) reporter. When IPTG is not added, lacI 
repressed the reporter (blue bar), while the reporter is fully activated when IPTG is added (grey bar). 
The same is on the right graph, but with the pGAL1(tetO2) reporter and aTc inducer. 
 
Reporter output as a function of time (Figure 3.4) linearly increases signal 
in glucose for 11 hours, except for a 2 hours long lag phase. The lag phase may 
be shortened by growing cells to exponential phase prior to induction. Uninduced 
and control cells did not accumulate GFP. Reporter output saturated at 16 hours 
with a 2 hours lag phase in galactose, and uninduced controls showed higher 
basal expression than in glucose. 
Growth, a measure of fitness detriments due to circuit component 
expression or inducer, was not affected in induced cells compared to uninduced 
control or cells that do not carry the cassette (Figure 3.4). More rigorous fitness 
testing would require fluorescent tagging and competitive co-culture with control 
cells, and RNA-seq to determine if there are misregulated genes102. 
 
 
Figure 3.3. Characterization of reporter induction as a function of estradiol concentration yields 
saturation at 1 µM estradiol with no allostery. 
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Cells carrying pGAL1(lacO) or pGAL1(tetO2) reporter (‘YPH500’) and cassette (‘pro’) were grown for 8 
hours in the presence of inducers in synthetic complete medium at varying 17β-estradiol levels, 
prior to fixing and flow cytometry measurement. IPTG induced pGAL1(lacO) reporter with the 
cassette is shown in red, same IPTG uninduced cells are shown in light red. aTc induced 
pGAL1(tetO2) reporter with the cassette is shown in blue, same cells without aTc are plotted in light 
blue. IPTG and aTc uninduced cells do not produce measureable output due to the AND logic 
discussed above. Controls such as reporter only, cassette only (‘YPH500 pro’) do not produce 
significant reporter output since they do not have expression cassettes for both the GEV activator 
and the pGAL1 based reporter. The fitted model is allosteric Hill: 𝒀 =
𝑽𝒎𝒂𝒙∙𝑿
𝒉
𝑲𝒉𝒂𝒍𝒇
𝒉 +𝑿𝒉
, where pGAL1(tetO2) 
reporter estradiol dose response shows minimal allostery 
1.3441.344
1.344
X120.9
X15368


Y
 with a Hill coefficient of 
1.3, and pGAL1(lacO) reporter estradiol dose response also shows minimal allostery 
1.3361.336
1.336
X173.8
X10252


Y
 
with a Hill coefficient of 1.3. 
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Figure 3.4. Time dependent reporter output and cell growth shows linear accumulation of reporter 
output in glucose, reporter saturation at 10-12 hours in galactose, and no growth defect due to the 
cassette. 
Left. Reporter output as a function of time in cells with (‘pro’) and without the cassette (‘YPH500’) 
with different reporters. IPTG induced pGAL1(lacO) reporter with the cassette is shown in red, same 
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IPTG uninduced cells are shown in light red. aTc induced pGAL1(tetO2) reporter with the cassette is 
shown in blue, same cells without aTc are plotted in light blue. Control cells are shown in black and 
grey. Reporter output accumulates linearly in estradiol and IPTG or estradiol and aTc double 
induced cells in glucose for 11 hours. Reporter output saturated in IPTG and aTc induced cells in 10-
12 hours in galactose. 
Right. Optical density as a function of time in the same cells from the same experiment. Induced and 
uninduced cells with and without the cassette grew similarly to control cells, suggesting no fitness 
detriment from the expression of the cassette or induction of the regulators and the reporter. 
 
3.2.5. Reporter engineering 
To expand the compatible reporter repertoire, we aimed to engineer 
galactose independent tetR and lacI repressible promoters. Promoter 
engineering has four approaches: (1) utilizing natural promoters, (2) 
mutagenizing them to achieve different expression levels and (3) creating hybrid 
promoters from a minimal promoter and a transcription factor binding array 
synthetic enhancer103. The design of (4) purely synthetic eukaryotic promoters 
only has a few104 successful examples due to chromatin context dependence. 
Hybrid promoters with combinations of repressor binding sites have successfully 
been employed in engineering gene expression noise in yeast91. 
Our hypothesis was that if we insert tet and lac operators in regulatory 
regions of strong and medium strength constitutive promoters, the bacterial 
repressors will compete with the natural transcriptional machinery, and repress 
these promoters. Constitutive promoters deliver fairly even expression under 
varied nutrient and stress conditions105, which makes them excellent candidates 
for synthetic studies. 
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We identified the promoter regions and regulatory motifs –such as TATA-
box, transcriptional start site, transcription factor binding sites– based on 
genome-wide datasets in the Yeast Genome Database. Then we inserted the 
repressor binding sites as singlets, doublets, quadruplets or sextuplets in these 
regulatory regions and measured promoter output under inducing and non-
inducing conditions in cells carrying the expression cassette (Figure 3.5, Figure 
3.6). In summary, we engineered three libraries of promoters that are repressible 
by tetR and a pADH1 library repressible by lacI. Some library members showed 
no difference between inducing and non-inducing conditions. Some members 
were repressible, as expected, and there were some members that became 
activated upon repressor recruitment. Different library members deliver different 
behaviors on the three measures of inducible systems: basal expression, 
maximum output, fold change. This makes the library palatable for different 
applications and their specific performance requirements. 
 
  
56 
 
 
Figure 3.5. Rational design of tetO insertions in constitutive promoters yields a library of tetR 
repressible promoters. 
Three constitutive promoters of different strength were modified, strong pADH1 on top, medium 
pCHO1 in the middle and the medium-weak pBIO2 on the bottom. The x axis represents the three 
yeast promoters with their regulatory regions highlighted. The bar charts are positioned where tet 
operators were inserted. The y axis is reporter output under inducing (aTc, light blue and light green 
bars) and uninducing (dark blue and dark green bars) conditions. Blue bars represent data from 
duplicate tet operator insertions, green bars from four tandem repeats of the tet operator. The height 
of the darker bars is basal reporter activity (uninduced), and the lighter bars represent maximum 
output (induced). In some cases, if the promoter became inducible not repressible, the dark bars are 
taller than the light bars. Error bars represent standard deviation of biological triplicate samples. 
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Figure 3.6. Rational design of lacO insertions in constitutive promoters yields a library of lacI 
repressible promoters. 
The x axis is ADH1 promoter sequence with its regulatory regions highlighted. The bar charts are 
positioned where the tet or lac operators were inserted. The y axis is reporter output under inducing 
(aTc or IPTG) and uninducing conditions. Blue bars represent data from duplicate tet operator 
insertions, red bars correspond to lac operator insertions. Error bars are standard deviation of 
biological triplicate samples. 
 
3.2.6. Advantages and limitations 
The cassette developed enables dynamic non-metabolite small molecule 
regulation of two to three reporter genes. Additionally, it enables rapid 
multilayered synthetic circuit construction as it readily and constitutively 
expresses the small molecule inducible regulators. The induction systems 
perform well in glucose media, which enables comparisons without metabolic 
differences between induced and uninduced cells. The induction can be carried 
out in 8 hours, which is two times faster compared to 16 hours in galactose 
media. 
Uninduced TetO2
aTc Induced TetO2
Uninduced LacO
IPTG Induced LacO
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The reporters used in the characterization deliver AND logic gate 
behavior. To expand the number of independent reporters, the newly developed 
tetR and lacI repressible constitutive promoters along with an unmodified GAL1 
promoter could provide an orthogonal three input regulatory system. 
There are some limitations to the cassette. The dynamic range of the 
reporters is limited to the currently available tetR and lacI repressible promoter 
libraries. Additionally, GEV activates the synthetic reporter construct, as well as 
every gene where Gal4p binds, which could be a major perturbance to the host’s 
physiology. 
 
3.3. Five human ligand binding domains to create a library of small 
molecule inducible transcription factors in S.cerevisiae 
 
3.3.1. Introduction 
Our next goal was to further increase the number of regulatory nodes 
using eukaryotic building blocks. To best serve the various application stemming 
from this research we aimed to gather a library of well characterized parts that 
can be mixed and matched to achieve the desired output characteristics for each 
application. To achieve this goal, we were looking for new ligand binding 
domains that are versatile, and compatible with zinc finger DNA binding 
domains20 and a variety of transactivation domains. 
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Human type I nuclear receptors106 are five small molecule responsive 
transcription factors that are orthogonal to yeast. Their ligands are steroid 
hormones, lipids synthesized from cholesterol capable of penetrating 
membranes. Nuclear receptors undergo conformational change upon ligand 
binding, and consequently dissociate from chaperones. As a result, their nuclear 
localization signals get exposed, and they shuttle to the nucleus. In the nucleus, 
they bind as homodimers to hormone responsive elements (HREs). Type I 
nuclear receptors show major similarities to each other in their protein 
architectures. Typically, the N’ domain contains a transactivation domain, the 
middle region is a C4 zinc finger DNA binding domain, the C’ domain is 
responsible for hormone binding and interaction with other proteins. There are 
five type I nuclear receptors in human cells: estrogen receptor (ER), 
progesterone receptor (PR), androgen receptor (AR), mineralocorticoid receptor 
(MR) and glucocorticoid receptor (GR). ER is the best studied, however, all have 
pharmaceutical importance in cancer such as head and neck carcinomas, breast 
and ovarian cancer, lung cancer, bladder and prostate cancer107. 
The ligand binding domain of estrogen receptor has been utilized in yeast 
as part of an artificial transcription factor108. ER LBD fusion to the DNA binding 
domain of Gal4p or to artificial zinc finger DBDs resulted in estradiol responsive 
TFs102, 109, 110. There is some evidence in the literature that this may translate to 
other human type I NR LBDs97, 111, 112. We hypothesized that the ligand binding 
domains of all five type I nuclear receptors could be used to yield small molecule 
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responsive regulators. This would yield a set of ligand binding domains that when 
combined with zinc finger DNA binding proteins and transactivation domains 
yield a library of components that can mixed and matched to gain controllers with 
different output characteristics. 
 
3.3.2. A well characterized mix-and-match library of eukaryotic 
inducible transcription factors 
To test our hypothesis, we built fusion proteins of zinc finger DNA binding 
domains (ZF) to the ligand binding domains of human type I nuclear receptor 
proteins (NR) and transcriptional transactivation domains (AD). The ZF-NR-AD 
fusion protein does not have additional nuclear localization sequence (NLS), it 
enters the nucleus upon ligand binding, followed by activation of the reporter. We 
tested if the human protein LBD could act a ligand dependent NLS by comparing 
to a fusion protein of the same ZF, AD and the strong SV40 nuclear localization 
signal (Figure 3.7). The ligand induced ZF-NR-AD produced similar output as the 
ZF-NLS-AD, which confirms that the ligand binding domains of the human 
nuclear receptors function as ligand dependent nuclear localization signals in 
yeast. 
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Figure 3.7 Human nuclear receptor ligand binding domains function as ligand dependent nuclear 
localization signal in yeast. 
Cells carrying both expression and reporter cassettes for the artificial activators were induced with 
100 nM 17β-estradiol for 16 hours in synthetic complete media supplemented with adenine, following 
exponential pregrowth. The x axis is reporter output measured by flow cytometry. Artificial zinc 
finger 92-1 was fused to the transcriptional activator VP16 and a nuclear localization signal on the 
top and human estrogen receptor on the bottom. Estradiol induced cells are shown in black, 
uninduced cells are shown in grey. The induced estradiol inducible synthetic transcription factor 
produces as much or more output as the constitutively nuclear control, while uninduced cells 
produce much less reporter output. This shows that the ligand binding domain of estrogen receptor 
is a functional, ligand dependent nuclear localization signal in yeast. 
 
We tested the modularity of DNA binding domains in the context of ZF-
NR-AD fusion proteins. Using ER LBD and VP16 transactivation domain, we 
screened a library of artificial three and six finger zinc finger proteins. We found 
that all of these fusion proteins yielded ligand inducible transcription factors 
(Figure 3.8), albeit each one with a unique activation pattern (basal and 
maximum expression, fold change). This suggest that mixing and matching the 
different zinc finger proteins with ligand binding domains could yield a highly 
tunable control system. 
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Figure 3.8. A library of different zinc finger proteins functions in the ZF-NR-AD context. 
Left. A schematic representing how the small molecule dependent artificial transcription factor 
translates user input to a desired output. A small molecule ligand (red) is the concentration and time 
dependent user defined input, which is bound by the ligand binding domain (light red). The ligand 
binding domain determines if the artificial transcription factor is active. When it is, the DNA binding 
domain (grey) finds its binding site upstream of a minimal promoter driving expression of a gene of 
interest (GOI). Transcription is initiated due to the sequence specific recruitment of the 
transactivation domain (blue) to the promoter. 
Right. Artificial three finger zinc finger proteins 37-12, 92-1, 93-10, 97-420, artificial six finger zinc 
finger proteins ZF116, ZF127 were fused to the ligand binding domain of estrogen receptor and the 
transactivation domain of Msn2p protein to yield estradiol inducible transcription factors. The 
reporter in the case of Zif268 natural zinc finger protein was a modified GAL1 promoter with five 
insertions of Zif268 binding sites. The reporter in the case of the artificial zinc fingers was minimal 
CYC1 promoter with eight zinc finger operator sites upstream in a synthetic enhancer, with the 
exception of ZF116, ZF127 which are 10x, 37-12 which is 4x, 97-4 which is 7x repeats of the binding 
site. The y axis is fold induction of the reporter gene in response to estradiol addition. All tested 
artificial zinc finger proteins yielded inducible transcription factors as the fold induction values 
greatly exceeded 1. 
 
The next question we asked was whether the LBDs of all five type I NRs 
could be used in yeast. We fused the LBDs to Zif268 and ZF 92-1 DNA binding 
domains and to Msn2p transactivation domain (Figure 3.9). We found that 
Zif268-PR-Msn2 only activates its reporter if it is expressed from a different locus 
than where the reporter cassette is. GR and AR fusions were only responsive to 
the small molecule ligand when fused to artificial three finger proteins 92-1 and 
93-10. 92-1-AR-Msn2 reaches good fold change values due to its low basal 
expression, therefore ZAM provides tight molecular control of the reporter. 92-1-
GR-Msn2 achieves poor induction in the current setup. This might be due to the 
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low bioavailability of its ligand, which is added at high concentration (100 µM, 
close to its water solubility), yet it does not saturate the dose response curve. 
One way to address this issue is to use the cyclodextrin complex of 
dexamethasone or to test other GR ligands for induction. Zif268-MR-Msn2 and 
other MR fusion proteins achieved high fold activation due to both high reporter 
output when ligand is added and low basal expression in the absence of ligand. 
In summary, all five human type I NR LBDs can be used to build small molecule 
inducible artificial transcription factors when some design constrains are applied. 
 
 
 
Figure 3.9. All five human type I nuclear receptor LBDs can be used in zinc finger, nuclear receptor, 
activation domain fusion proteins to yield ligand dependent artificial transcription factors in 
S.cerevisiae cells. 
Zif268-ER-Msn2, 92-1-AR-Msn2, Zif268-MR-Msn2, Zif268-PR-Msn2, 92-1-GR-Msn2 expressing cells 
were treated with 100 nM estradiol, 20 µM testosterone, 10 µM aldosterone, 1 µM progesterone, 100 
µM dexamethasone, respectively, for 16 hours. Y axis shows fold induction values calculated by 
dividing with uninduced control. The x axis lists different nuclear receptors fused to zinc finger DNA 
binding domains and the same activation domain. All fusion proteins achieve greater than 1-fold 
activation, which means they are efficient activators. 
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Next we were interested if the choice of transactivation domain could 
modulate induction performance. To test this, we fused the 97-4-ER protein to a 
library of transactivation domains: Herpes simplex virus V16 acidic peptide 
(VP16) and its monotetramer fusion (VP64), Epstein-Barr virus R transactivator 
(rTA), human NF-κB p65 subunit (p65), yeast Msn2p transcription factor 
transactivation domain (Msn2), and the fusion of VP64 to p65 and rTA (VPR) 
(Figure 3.10). All these fusion proteins were active and yielded different reporter 
activation. rTA, VP64 and p65 were the strongest activators, while Msn2 and 
VP16 performed similarly to each other. The VPR fusion caused slow growth 
even in uninduced cells, and it became toxic upon induction. This might be the 
reason behind the low fold induction values with VPR. Toxicity was also 
observed with p65 induction in some experiments. In summary, the choice of 
activation domain, DNA binding domain and ligand binding domain influence the 
dynamic range of reporter output. Given this extensive characterization data, a 
fusion protein for the specific application could be designed. 
 
Figure 3.10. Transcriptional output is tunable by the choice of transactivation domains. 
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Left. A schematic representing how the small molecule dependent artificial transcription factor 
translates user input to a desired output. A small molecule ligand (red) is the concentration and time 
dependent user defined input, which is bound by the ligand binding domain (light red). The ligand 
binding domain determines if the artificial transcription factor is active. When it is, the DNA binding 
domain (grey) finds its binding site upstream of a minimal promoter driving expression of a gene of 
interest (GOI). Transcription is initiated due to the sequence specific recruitment of the 
transactivation domain (blue) to the promoter. 
Right. A small library of activation domains was tested to explore tunability through the choice of 
activation domain. 97-4-ER-AD activating 7x 97-4 operators with 12 nt spacing upstream of pCYC1-
mKate2 integrated in LEU2 locus, induced with 1 µM estradiol for 16 hours following 8 hours of 
exponential pre-growth. Fold induction depicted on the y axis was calculated by dividing the 
geometric mean fluorescence of induced and uninduced samples. Error bars represent standard 
deviation from biological quadruplicates. Fold induction values were highest for rTA and VP64 
activators. Msn2 and VP16 performed similarly. VPR showed strong toxicity and high basal 
expression, while p65 showed good induction along with some level of toxicity. In summary, the 
choice of activation domain tunes fold induction values between 3-fold to 280-fold. 
 
3.3.3. Reporter design criteria 
Reporter output is determined by both the ZF-NR-AD fusion protein and its 
reporter. In the previous subchapter we characterized how the different 
components of the fusion protein influence induction. In this subchapter we are 
exploring how modifications to reporter design change performance. 
First we replaced the minimal promoter with a set of weak and medium 
strength constitutive promoters (Figure 3.11). We found that the choice of 
minimal promoter strongly influenced reporter output, however, in a less 
predictable manner. The minimal CYC1 promoter proved to be the best inducible 
promoter with low basal expression and high maximum output. The other 
promoters either failed to become responsive to the ligand (pCHO1), had high 
basal expression (pPFY1, pSOD1) or became repressed (pBIO2) upon addition 
of ligand. To find more favorable behaviors, a larger library of promoters could be 
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tested. If higher output is required without the need for tight control under non-
inducing conditions, pCYC1 could be replaced with pSOD1. 
 
Figure 3.11. Transcriptional output is tunable by reporter design. 
Left. A schematic depicting reporter design used throughout this subchapter. Eight binding sites for 
the zinc finger protein is inserted upstream of a minimal promoter driving the expression of the 
reporter gene. In this screen different constitutive minimal promoters were tested (red). 
Right. A small library of minimal promoters was tested for activation using the estradiol inducible 
fusion protein. 97-4-ER-Msn2 activating 7x 97-4 operators with 12 nt spacing upstream of pCYC1-
mKate2 integrated in LEU2 locus, induced with 1 µM estradiol for 16 hours following 8 hours of 
exponential pre-growth. Error bars represent standard deviation resulting from biological 
quadruplicates. The y axis shows reporter output both in the presence (red) and absence (black) of 
estradiol inducer. pCYC1 yielded the best induction due to high activation in the presence of 
estradiol and almost undetectable basal levels in the absence of inducer. pPFY1 yielded high basal 
expression and similar maximum activation as pCYC1. pSOD1 had the highest maximum output and 
it was twofold inducible. It could be useful in applications where higher output is necessary without 
the requirement of low basal expression. pCHO1 did not show dependence on the inducer. pBIO2 
was repressed, and had low output even in the no inducer case. In summary, three inducible and 
one repressible promoter was identified, but the original design with pCYC1 proved to be the best 
inducible system. 
 
Another tunable property of reporter design is the number and spacing of 
zinc finger binding sites20. We found that the number of operators in the synthetic 
enhancer influenced both basal and induced state reporter output (Figure 3.12). 
Increasing the number of operators increased maximum output and in general 
decreased basal expression. However, DNA construction with eight tandem 
repeats already posed a challenge, therefore we did not further increase the 
number of binding sites in most of our constructs. We tested if operator spacing 
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mattered in the ZF-NR-AD context by decreasing operator spacing from 
basepairs to one basepair (Figure 3.12). As a result, basal expression increased 
while maximum output was stagnant, yielding lower fold change values. This 
might be due to a shorter sequence upstream of minimal pCYC1 when the 
operator spacing is shorter. In summary, reporter design strongly influenced the 
performance of our induction systems, but the original design with a synthetic 
enhancer of eight tandem zinc finger binding sites upstream of a minimal pCYC1 
was already optimal. 
 
Figure 3.12. Transcriptional output is tunable by the choice of operator number. 
Left. Schematic depicting reporter design used throughout this subchapter. Eight binding sites of 
the zinc finger protein is inserted upstream of a minimal promoter driving the expression of the 
reporter gene. In this screen different number of operators were tested with different spacing (red). 
Right. The effects of operator number and operator spacing were tested. 93-10-ER-VP16 activating N 
times 93-10 operators with 12 nt or 1 nt spacing upstream of pCYC1-mKate2 integrated in LEU2 
locus, induced with 1 µM estradiol for 16 hours following 8 hours of exponential pre-growth. Error 
bars represent standard deviation from biological quadruplicates. The y axis shows reporter output 
both in the presence (red) and absence (black) of estradiol inducer. We found the lowest basal 
expression with eight operators and twelve basepairs of spacing, and the highest expression with 
twelve operators and one basepair spacing. Reporter output is tunable by the number of operators 
and their spacing, but it creates difficulties with DNA construction. Other constructs throughout this 
subchapter are built with twelve basepairs spacing and eight tandem repeats of the zinc finger 
binding site. 
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Chromosomally integrated circuits might be influenced by chromatin 
compaction in the specific locus. To test this hypothesis, we integrated a 
constitutive promoter driving a reporter gene in six different loci (Figure 3.13 left). 
We found that indeed some loci express at different levels. These differences are 
amplified in a transcription factor activation circuit (Figure 3.13 right) compared to 
the constitutive probe. To achieve high reporter output, the YBR032W locus is 
recommended, and integration into HIS3 or HO could result in tighter control of 
basal expression. 
  
Figure 3.13. Transcriptional output is tunable by the choice of integration locus. 
Left. Four biochemical loci and two drug selectable loci were tested with a constitutively expressed 
fluorescent protein. TDH3 promoter driven mKate2 constitutively expressed reporter cassette was 
integrated in HIS3, TRP1, LEU2, URA3 loci along with their corresponding biochemical markers and 
into HO locus with hphMX6, YBR032W locus with NatMX4. Dark cell control carries no integration 
and it serves to measure auto-fluorescence of yeast cells. Twelve biological replicates were 
measured on flow cytometry and their geometric mean fluorescence values was plotted along with 
average and standard deviation. The LEU2 locus produced highly variable results between clones. 
HO locus expressed the lowest, followed by HIS3, LEU2, TRP1, URA3 in the order of increasing 
strength. YBR032W locus expressed the highest. This locus strength characterization result can be 
used to further tune expression levels and reporter output. 
Right. Two loci are compared using the same inducible construct. Artificial zinc finger 97-4 is fused 
to estrogen receptor ligand binding domain and Msn2 transactivation domain, and it is integrated 
either to the TRP1 or LEU2 locus along with its reporter. Red bars show data from induced biological 
quadruplicates, black bars show reporter output from the same clones without induction. In 
concordance with the graph on the left, the LEU2 locus expresses stronger, however, since both 
transcription factor and reporter levels are impacted by the locus expression strength, the difference 
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is hundred fold. This suggests that the differences observed on the graph on the left using a 
constitutive probe may be more dramatic once an inducible system is being inserted. 
 
3.3.4. Characterization of hormone inducible regulators 
After exploring all design parameters that can tune performance, we 
investigated experimental parameters that influence it such as drug 
concentration, length of induction and ligand cross-activation. First we 
characterized transcriptional output as a function of ligand concentration (Figure 
3.14). We found that concentrations higher than 1 µM of 17β-estradiol are 
negatively affeting cell growth. However, transcriptional output saturated at 100 
nM 17β-estradiol, therefore maximum induction could be achieved without major 
fitness detriment. ZEM and ZPM had high affiinites to their ligands (17-18 nM), 
ZMM had lower affinity (354 nM), and ZAM affinity was fairly high (20 µM). These 
differences may either be due to different LBD-ligand binding affinities or different 
ligand penetration into the yeast cytoplasm. We found that ZAM and ZGM dose 
responses did not saturate at lipid concentrations close to their water solubility 
limit. 100 µM dexamethasone was a minimal concentration that induced ZGM, 
which might be the reason for poor fold induction with GR compared to the other 
nuclear receptors in this study. ZEM, ZPM and ZMM were non-cooperative, had 
a Hill coefficient of close to one, which would suggest that the ZF-NR-AD protein 
binds to the operator as a monomer. AR had a Hill coefficient of two, which would 
suggest binding as a dimer. Type I nuclear receptors in human cells indeed bind 
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HREs as dimers, however, it is unclear how much of the mechanism is 
conserved when the ligand binding domain is used in a fusion protein in yeast. 
 
 
 
 Second, we characterized transcriptional output as a function of induction 
time (Figure 3.15).  Reporter output linearly increased over time in the first 8 
hours.  Reporter output was maximal after 20 hours of induction; fold induction 
saturated after 12 hours of induction. 
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Figure 3.14. Dose response profiles of the small molecule ligands inform about saturation 
concentrations and output linearity. 
Zif268-MR-Msn2, Zif268-ER-Msn2, Zif268-PR-Msn2, 92-1-AR-Msn2, 92-1-GR-Msn2 expressing cells 
were incubated in the presence of varying levels of aldosterone, estradiol, progesterone, 
testosterone and dexamethasone, respectively, for 16 hours, and the reporter output was measured 
via flow cytometry. The y axis is fold induction, which was calculated by dividing the geometric 
mean reporter output with the uninduced control. The error bars represent standard deviation for 
biological quadruplicate cultures. The top left graph shows that reporter of a fusion protein with ER 
ligand binding domain saturates at 1 µM estradiol, and has a linear dose response curve with a Hill 
coefficient of 0.9. The top right graph shows that a fusion protein with PR has a linear dose response 
curve with Hill coefficient of 1, and saturates at 1 µM progesterone. The bottom left graph shows that 
a fusion protein with MR ligand binding domain has linear response to different doses of 
aldosterone with 1.5 Hill coefficient and 1 µM saturation. The middle bottom graph shows that a 
fusion protein with AR ligand binding domain has a mildly allosteric response to different doses of 
testosterone with a Hill coefficient of 2.2 and 100 µM or higher saturation. The bottom right graph 
shows that fusion proteins with GR ligand binding domain produce up to 6-fold induction with 
dexamethasone ligand, and the dose response curve does not saturate at the water solubility limit of 
the ligand. 
 
Second, we characterized transcriptional output as a function of induction 
time (Figure 3.15). Reporter output linearly increased over time in the first 8 
hours. Reporter output was maximal after 20 hours of induction; fold induction 
saturated after 12 hours of induction. 
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HREs as dimers, however, it is unclear how much of the mechanism is 
conserved when the ligand binding domain is used in a fusion protein in yeast.  
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Figure 3.15 Estradiol induction activation kinetics shows fast kinetics with linear response until 10 
hours and saturation at 16 hours of induction. 
Cells were induced with 100 nM estradiol following exponential pre-growth. Standard deviation is 
calculated from biological quadruplicate cultures. The y axis is fold induction compared to 
uninduced cells, and shows up to 180-150-fold induction in this experiment. Induction kinetics is 
faster than galactose induction, and is linear in the first ten hours, and saturates after sixteen hours 
of induction. 
 
To build a set of orthogonal control systems, both DNA and ligand binding 
would need to be independent. The zinc finger DNA binding domains have 
previously been tested and designed not to cross-activate the reporters20. 
Orthogonal ligand binding would mean no activation if another ligand is added. 
We tested ligand selectivity of type I nuclear receptors in the ZF-NR-AD context 
by adding the five ligands to the five fusion proteins one by one at saturating 
concentrations (Figure 3.16). We found that ZEM and ZAM were highly selective, 
and only activated their reporter if their corresponding ligand was added. ZMM 
was also selective, however, it activated its reporter to a smaller extent when 
progesterone was added to the media. ZPM was fully activated by its ligand 
progesterone and testosterone, and to smaller degree by aldosterone. ZGM 
showed some activation by progesterone, but it was only significantly activated 
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by its dexamethasone ligand. Based on these results we can select a set of four 
orthogonal small molecule dependent synthetic transcriptional activators: ZEM, 
ZAM, ZMM and ZGM. 
 
 
Figure 3.16. Cross-activation test between ligands and ligand binding domains shows a set of four 
independent activators. 
Zif268-ER-Msn2, 92-1-AR-Msn2, Zif268-MR-Msn2, Zif268-PR-Msn2, 92-1-GR-Msn2 expressing cells 
were treated with 100 nM estradiol, 20 µM testosterone, 10 µM aldosterone, 1 µM progesterone, 100 
µM dexamethasone for 16 hours. Fold induction was calculated by dividing with uninduced control, 
and induction values were normalized for heat map representation. ZGM appears to be cross-
activated by other small molecules due to its small fold change, however only dexamethasone and 
progesterone have effect on reporter output. MR is activated by progesterone to a small extent, and 
PR is activated by aldosterone and progesterone. All other ligand-ligand binding domain 
interactions were specific to the corresponding ligand. Based on this data, we identify a set of four 
ligand orthogonal regulators with ER, AR, MR and GR ligand binding domains. 
 
3.3.5. Advantages, limitations and applications 
Our initial goal was to develop a library of well characterized domains that 
can be mixed and matched in the ZF-NR-AD architecture to yield orthogonal 
small molecule controlled regulators. We found that all five human type I NR 
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LBDs in cooperation with a library of seven zinc finger DBDs and five ADs work 
in this framework. This allows for the construction of 175 functional ligand 
dependent transcriptional activators. Additionally, we characterized the design 
characteristics that tune reporter output such as locus, reporter architecture, ZF, 
AD, NR strength. Finally, we characterized the experimental parameters that 
tune output of the regulators. 
Ligand level orthogonality applies to four out of five LBDs. A design level 
limitation is that AR and GR LBDs only produce a functional fusion when paired 
with certain zinc finger proteins, while ZF-PR-AD only activates if it is expressed 
from a separate locus than its reporter. Some of the ligands can only saturate 
reporter output at fairly high concentrations. Limitations with ligands could be 
addressed by testing out different lipids that activate the human nuclear receptor 
proteins. 
The ligand responsive synthetic transcriptional activators could aid the 
development and realization of complex control circuits with more than one or 
two dynamic regulatory inputs. Our design is suitable for such tasks as it 
harnesses human nuclear receptors and designer DNA binding domains, which 
are absent from the host. Such components allow for orthogonal regulation that 
would not perturb regulatory networks in the host. This is a significant advance 
over the state of the art where either two natural promoters or a natural DNA 
binding domain were used. 
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One potential application is controlling a multi-enzyme bioproduction 
pathway. Titrating the levels of some enzymes could shunt the pathway towards 
the production of different ratios of product and byproducts. To realize this 
application, the regulators should be integrated into different locations in the 
genome and the reporter gene replaced with the enzymes in the pathway. 
Another application is precise transcription level titration of regulators that 
affect a process in opposite directions. The simplest case is titration of 
transcription factors that activate and repress a promoter. More complex 
competitions are titration of chromatin regulators or regulators of prion 
aggregation. 
The third application is environmental biosensors. The yeast strains 
developed provide reporter output upon coming in contact with human hormones 
and xenobiotics. Therefore, if they came in contact with environmental samples, 
they could sense the presence of hormones and xenobiotics. Such an application 
might require improved sensitivity, which could either be achieved by using 
protoplasts to facilitate ligand entry into the cells or additional circuitry to amplify 
signal. 
The ZF-NR-AD system could be further generalized to include repression 
domains to create inducible repressors, and fusions of NR-AD to other type of 
DNA binding domains such as Cas9 proteins and TALE DNA binding proteins. 
Given the increasing number of orthogonal RNA guided DNA binding proteins, 
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fusions to these ligand binding domains could create a very powerful toolset for 
genome-wide transcriptional and chromatin regulation studies. 
 
  
  
76 
4. USING TARGETED CHROMATIN REGULATORS TO ENGINEER 
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4.1. Summary 
The transcription of genomic information in eukaryotes is regulated in 
large part by chromatin. How a diverse array of chromatin regulator (CR) proteins 
with different functions and genomic localization patterns coordinates chromatin 
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activity to control transcription remains unclear. Here, we take a synthetic biology 
approach to decipher the complexity of chromatin regulation by studying 
emergent transcriptional behaviors from engineered combinatorial, spatial, and 
temporal patterns of individual CRs. We fuse 223 yeast CRs to programmable 
zinc finger proteins. Site-specific and combinatorial recruitment of CRs to distinct 
intralocus locations reveals a range of transcriptional logic and behaviors, 
including synergistic activation, long-range and spatial regulation, and gene 
expression memory. Comparing these transcriptional behaviors with annotated 
CR complex and function terms provides design principles for the engineering of 
transcriptional regulation. This work presents a bottom-up approach to 
investigating chromatin-mediated transcriptional regulation and introduces 
chromatin-based components and systems for synthetic biology and cellular 
engineering. 
 
4.2. Individual contributions 
Szilvia Kiriakov contributed the tool and characterization detailed in chapter 
3.1 and assisted in revision experiments. Albert Keung designed the study and 
conducted experiments. Caleb Bashor assisted in the design of the study and 
revision experiments. James Collins and Ahmad Khalil supervised the work. 
 
4.3. Introduction 
Eukaryotic genomes are packaged into chromatin, a higher order structure 
of DNA, histones, and associated proteins. A diverse array of chromatin 
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regulators (CRs) form complexes that act on and modify chromatin in unique 
combinatorial, spatial, and temporal patterns, thereby regulating how the 
underlying genomic information is transcribed and vastly extending the 
information potential of the genome114-116 (Figure 4.1). Yet, despite being the 
subject of extensive studies, the relationships between CRs and gene regulation 
remain unclear 
There are a number of hypothesized mechanisms by which CRs modulate 
and control gene transcription. First, at each gene, chromatin can be 
combinatorially regulated by numerous CR proteins with different functions114, 116, 
117. Thus, processes ranging from forming and recruiting preinitiation complexes, 
remodeling and assembling nucleosomes, increasing chromatin accessibility 
through histone modifications, and promoting transcriptional elongation may act 
in concert to generate a wide range of transcriptional outputs and logic115, 118, 119. 
Relatedly, histone tails have numerous residues that can be 
decorated by a wide assortment of biochemical modifications. Genome-wide and 
gene expression profiling studies have correlated specific combinations of 
modifications120, 121 and associated CRs116, 117 with chromatin structure and gene 
expression state. These findings have lent support to the ‘‘histone code’’ 
hypothesis, which posits that specific combinations of histone tail modifications 
serve to recruit proteins that establish or alter transcriptional activity122. 
Uncovering the distinction between the simple presence of and the causal 
transcriptional function of chromatin marks (and CRs) remains an active area of 
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investigation123. In addition to the combinatorial patterning of chromatin 
modifications, histones121 and CRs116, 117 are found in distinct spatial patterns 
around and throughout genes, raising the compelling possibility that spatial 
organization underlies transcriptional control114, 124, 125. Methods for directly 
linking transcriptional function with the localization of CRs within and around 
genes are needed to establish these principles. 
Finally, spatial changes in chromatin modifications, such as spreading of 
DNA methylation and histone hypoacetylation marks, are believed to give rise to 
stable epigenetic states32, 126. Identifying specific CRs and conditions that drive 
these epigenetic changes is critical for understanding how gene expression 
memory is established and how genes and loci are stably activated or repressed 
during developmental or disease processes. 
Understanding these regulatory principles requires systematic approaches 
for investigating CR function, for example, to determine: (1) which CRs (or 
classes of CRs) can activate or repress transcription, (2) what forms of 
transcriptional logic are obtained from combinatorial regulation by multiple CRs at 
a single gene, (3) how transcriptional regulatory information is encoded in the 
spatial organization of CRs and genes, and (4) what potential epigenetic 
properties are associated with CRs. 
Current approaches to study chromatin function are largely based on 
pharmacological and genetic perturbations combined with genome-wide 
measurements of gene expression and chromatin state. These approaches have 
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yielded fundamental insights116, 127, but are limited in their ability to directly test 
CR function because of global and pleiotropic effects and context-dependent 
recruitment of CRs to different genomic loci. Furthermore, correlative 
measurements of chromatin structure and function make it difficult to distinguish 
downstream from causative perturbations123, 128. 
To address these limitations, synthetic biology approaches may provide 
unique and complementary advantages, such as the ability to decompose these 
complex systems into well-understood components and to directly test CR 
function through site-specific perturbations. Moreover, with the recent advent of 
programmable DNA-targeting platforms, CRs can be site-specifically recruited to 
defined genomic sequences, a feature that has been exploited to develop 
‘‘epigenome editing’’ tools for altering DNA methylation states and histone 
modifications29, 32, 129, 130. 
Here, we take a synthetic biology approach to study and classify 
transcriptional behaviors emerging from engineered combinatorial, spatial, and 
temporal patterns of targeted CRs. Specifically, programmable zinc fingers (ZFs) 
are fused to a library of 223 yeast CR proteins encompassing 45 known 
chromatin complexes (Figure 4.1). First, this library is site-specifically targeted to 
a minimal gene locus to identify factors that activate or repress transcription. CRs 
are clustered by gene ontology annotations in order to classify chromatin 
complexes and protein functions that causatively regulate transcription. We then 
recruit CRs in combination with the VP16 transactivator to reveal different forms 
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of transcriptional logic. Spatially recruiting CRs in distinct patterns and locations 
within single- and multigene loci identifies classes of engineered CRs capable of 
regulation from (nonpromoter) downstream positions, long-range transcriptional 
regulation, and gene expression memory. Taken together, our work motivates 
bottom-up experimental approaches for assigning CR function and uncovering 
rules governing chromatin-based gene regulation. This work also presents a 
class of regulatory components, locus architectures, and design principles for 
synthetic biology applications7, 131-134. 
 
Figure 4.1. A Synthetic biology approach to engineering chromatin-based transcriptional regulation. 
Eukaryotic gene transcription is regulated by diverse chromatin-regulating complexes and networks 
(top right). The complexes were decomposed into a library of subunit chromatin regulator (CR) 
proteins (top left). These subunits were fused to engineered zinc finger (ZF) proteins to enable site-
specific spatial and combinatorial targeting to designed gene loci (bottom). This modular framework 
allows the direct functional characterization of individual CRs as transcriptional regulators and for 
designing locus architectures that recruit different combinations of CRs to explore and engineer 
complex spatial and combinatorial transcriptional regulation. 
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4.4. Targeted transcriptional regulation at a synthetic reporter locus 
We introduced a synthetic transcriptional reporter into the Saccharomyces 
cerevisiae genome, in which expression of yEGFP is controlled by a minimal 
CYC1 promoter harboring upstream, tandem operator sites recognized by an 
engineered ZF protein (43-8, GAGTGAGGA)20 (Figure 4.2A, top). pCYC1 (183 
TSS +66) was chosen for its intermediate basal level of expression5, 20, 135. The 
core CYC1 promoter has also been used to identify both transcriptional 
repressors and activators136. Furthermore, the depletion of histone H4 has been 
shown to activate the core promoter 94-fold, indicating the importance of basal 
chromatin in its regulation and thus its potential utility in this study137. Finally, this 
minimal promoter lacks endogenous upstream regulatory sequences, including 
both the hemeresponsive activating sequence and the glucose-mediated 
repression site138, 139, thus reducing the effects of signaling crosstalk, noncoding 
RNAs, and endogenous recruitment of synthetic CRs. This reporter construct and 
others described below were genomically integrated into the URA3 locus. We 
also integrated copies of the reporter into the HIS3 and LEU2 loci to confirm that 
our results were similar in different genomic loci (see Figure 4.3, Figure 4.6, 
Figure 4.10E-F, Figure 4.14A and D, and Tables S1 and S4 available online). In 
order to test the ability of this reporter to recruit regulators and report on 
transcriptional activity, we fused canonical transcriptional activating (VP16) and 
repressing (Mig1, aa481–503) domains to the targeting ZF protein (43-8) as well 
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as to a nonspecific ZF (42-10, GACGCTGCT)20. Expression of these fusion 
proteins was driven by a small-molecule inducible version of the GAL1 promoter. 
Upon expression, only the targeted factors activated or repressed the locus 
(Figure 4.2A, bottom). 
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Figure 4.2. Direct recruitment of a library of 223 chromatin regulators identifies different 
transcriptional regulators such as repressors and activators. 
(A) Top: 223 CR proteins were fused to an engineered ZF protein (or nontargeting ZF) and placed 
under the control of an inducible GAL1 promoter. Each fusion protein was individually recruited to 
operators placed upstream of a minimal CYC1 promoter driving the expression of GFP. NLS, nuclear 
localization signal. Bottom: fold change in GFP expression induced by VP16 activation and Mig1 
repression domains fused to targeting or nontargeting ZF proteins. 
(B) Fold change in GFP expression for the library of 223 ZF-CR fusions (normalized to uninduced 
levels). Repressors (blue bars) were classified as having <0.7-fold change, while activators (red bars) 
have >2-fold change. 
(C) CRs grouped by complex and plotted according to the percentage of activators and repressors in 
each complex. Dot colors correspond to the general activities of each complex. Error bars are SD of 
three isogenic strains. 
 
4.5. Identifying functional transcriptional regulators from a library of 
targeted chromatin regulators 
A large body of work has identified correlations between the expression of 
specific CRs and global transcriptional activity. However, it is often unclear which CRs 
are causative of or merely associated with changes in transcriptional activity at specific 
loci. Therefore, we fused a library of 223 full-length putative CRs, comprising 45 
chromatin-regulating complexes127, to the targeting ZF and individually tested each 
protein’s ability to activate or repress transcription from the pCYC1 reporter (Figure 4.2A, 
top). As shown in Figure 4.2B, numerous repressors and activators were identified from 
the library, spanning 20-fold changes in repression and activation (Figure 4.2B, Figure 
4.3A and D; Table S1). We also observed expected changes in histone modifications at 
the reporter locus, measured by chromatin immunoprecipitation-quantitative PCR, upon 
expression of 17 CRs chosen for their predicted histone modifying catalytic 
domains/activities (Figure 4.4B). To confirm the changes in reporter expression were 
not simply a product of CR overexpression, we fused the 27 strongest repressors, 48 
strongest activators, and all CRs with histone-modifying catalytic domains to a truncated, 
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nonbinding ZF protein. The vast majority of these fusions generated negligible changes 
in yEGFP expression (Figure 4.12B). Rsc3, Ldb7, Sum1, and Tod6 were exceptions, 
exhibiting changes in yEGFP levels regardless of targeting, suggesting either ZF-
independent recruitment to the locus or global transcriptional regulation. We observed 
no correlation between transcriptional activation and the level of CR expression as 
measured by western blot (Figure 4.4C). 
 
4.6. Clustering chromatin regulators by chromatin complex and function 
We next asked if the targeted library could identify relationships between 
transcription and CR protein functions or complexes. Using gene ontology annotations, 
we first clustered all CRs by macromolecular complex (Table S2). Individual CRs were 
then conservatively classified as activators (Figure 4.2B, red bars, >2- fold change 
yEGFP) and repressors (blue bars, <0.7-fold change yEGFP). This classification 
excluded all nontargeted CRs, aside from the exceptions noted above (Figure 4.12B). 
When the percentage of activators in each chromatin complex was plotted against the 
percentage of repressors (Figure 4.2C and Figure 4.3B; Table S2), we discovered a 
number of clear patterns. Histone acetyltransferase (blue dots), H3K4 methyltransferase 
(‘‘COMPASS/ Set1’’), and RNA PolII transcription-related complexes (red dots) were 
mostly composed of activating CRs. Histone deacetylase complexes were primarily 
composed of repressive CRs (pink dots). Nucleosome remodeling complexes trended 
weakly toward having more activators than repressors (green dots). When clustered by 
protein function terms (Figure 4.3C and Figure 4.4A; Table S2), groups associated 
with the transcriptional complex (red dots), histone acetyltransferase (blue dot), and 
histone methyltransferase (brown dots) terms contained primarily activators, while 
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groups associated with chromatin binding (orange dots) and histone deacetylase (pink 
dots) terms contained primarily repressors. These results largely agree with the 
regulatory roles assigned to various complexes and protein functions through previous 
genome-wide and knockout/mutant strain studies116, 117, 127. 
 
Figure 4.3. Transcriptional regulation in alternative loci show similar activation pattern. 
(A–C) CR regulation of a LEU2-integrated reporter is similar to regulation at the URA3 locus. The 
GFP reporter with upstream ZF binding sites was integrated into the LEU2 locus. The full library of 
223 CRs was recruited to the reporter, and fold change GFP of induced to uninduced cells was 
measured by flow cytometry. (A) Fold change GFP measurements for URA3-integrated reporter 
plotted against those obtained from the LEU2-integrated reporter. Spearman’s rank correlation 
coefficient indicates strong correlation of reporter regulation by CRs between the two loci. CRs 
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grouped by complex (B) and function (C) and plotted according to the percentage of activators and 
repressors in each group. Dot colors correspond to the general activities of each complex. 
(D) The GFP reporter was integrated into the HIS3 locus. A representative subset of CRs were fused 
to non-targeting (left) and targeting ZFs (right). ZF-CRs displayed in the same order and coloring 
(repressors in blue and activators in red) as they appear in Figure 4.2B. Error bars are standard 
deviations of three isogenic strains. 
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Figure 4.4. Transcriptional regulation of a synthetic reporter by targeted chromatin regulators 
correlates with corresponding chromatin marks. 
(A) CRs grouped by gene ontology function terms and plotted according to the percentage of 
activators and repressors in each group. Dot colors correspond to the general activities of each 
complex. The reporter was integrated into the URA3 locus. 
(B) ChIP-QPCR measurements of the URA3-integrated target locus shows a range of CRs modify 
chromatin according to their expected activities. CRs chosen for analysis are those with known 
histone-modifying catalytic domains or activities. Pulldown epitopes indicated above each bar. 
Relative levels of histone modifications are for induced cells normalized to uninduced cells. Error 
bars are ± SEM with the number of biological replicates indicated on the bottom of each bar. 
(C) Quantification of protein levels for 35 CRs (in URA3-integrated reporter strains) evenly 
distributed with repressors, neutral factors, and activators. There is no negative linear correlation 
with reporter repression or positive linear correlation with activation strength. Protein levels 
obtained by quantifying Western blots of induced and uninduced cultures plotted against fold 
change GFP fluorescence. 
 
4.7. Engineering combinatorial transcriptional logic 
Native genes are simultaneously regulated by multiple proteins with different 
functions and activities, often giving rise to combinatorial transcriptional logic. Therefore, 
we next explored how corecruitment of factors affects transcription. In particular, we 
were interested in how different CRs modulate the activity of a corecruited VP16 domain. 
We fused VP16 to a second, orthogonal ZF protein (97-4, TTATGGGAG)20, which could 
be independently recruited to an operator placed directly downstream of the ZF-CR 
operator (Figure 4.5A). As expected, upon corecruitment of VP16 with the ZF-CR 
library, we found that transcriptional outputs generally increased as compared to 
recruitment of CRs alone (Table S3). The CRs divided into six distinct classes of 
combinatorial regulators based on transcriptional logic: CRs capable of (1) dominant 
(Sir2 and Mig1) or (2) partial (Ash1 and Dot1) inhibition of VP16-mediated activation; 
CRs with no regulatory roles on their own and either (3) no (Eaf7 and Rvb2) or (4) 
enhanced (Ies6 and Cdc73) effect on VP16-mediated activation; finally, CRs that act (5) 
additively (Taf14 and Med4) or (6) synergistically (Cac2 and Set1) with VP16 to increase 
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yEGFP expression (Figure 4.5B, Figure 4.6A and B). Synergy is the ‘‘cooperation’’ of 
factors to produce a total output and here it was defined as the fraction of total output in 
excess of summing the outputs from the individual components (Figure 4.5C-D, Figure 
4.6C-D). 
To develop insight into CR functions that may underlie these different, 
combinatorial logic behaviors, we clustered CRs by complex (Figure 4.5C and Figure 
4.6C) and function (Figure 4.5D and Figure 4.6D) and calculated the percentage of 
CRs in each cluster with strong synergy. When clustered by complex, we found that the 
majority of Mediator and TFIID subunits exhibited weak synergy with VP16 (Figure 4.5C 
and Figure 4.6C, purple bars). In contrast, complexes that remodel and assemble 
chromatin (Swr1, RSC, CAF-1), promote transcriptional elongation (Paf1), or modify 
histones to open chromatin structure (NuA4, Set1) were comprised primarily of CRs that 
synergistically enhanced activation (Figure 4.5C and Figure 4.6C, red bars). 
We observed the same general trend when we clustered activating CRs by 
function, as opposed to complex (Figure 4.5D and Figure 4.6D; Table S4); that is, CRs 
related to transcription factor and RNA PolII terms exhibited weak synergy with VP16 
(purple), while those associated with chromatin remodeling, modifying, and binding 
exhibited strong synergy (red). VP16 is believed to activate transcription by recruiting 
preinitiation and transcription complex factors along with the Mediator complex140. Thus, 
additive activation might occur through a corecruited CR that functions similarly to VP16 
or is part of either the transcription complex or Mediator. Importantly, we observed a 
simple additive relationship when we corecruited two identical VP16 domains (Figure 
4.5C, ‘‘VP16’’). In contrast, other functions such as remodeling nucleosomes, modifying 
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histones to alter chromatin accessibility, and promoting transcriptional elongation may 
synergistically amplify the output by increasing access of transcriptional machinery to 
DNA118, 119. 
  
93 
 
  
94 
Figure 4.5. Combinatorial recruitment reveals distinct classes of regulators for engineering 
transcriptional logic. 
(A) An engineered two-input system enabling the corecruitment of CRs and VP16 transactivating 
domain (ZF 43-8, gray; ZF 97-4, blue)20. 
(B) Representative transcriptional logic outputs of the two-input system divide CRs into six distinct 
classes (top to bottom): VP16-independent dominant repressors, repressors, CRs with no effect, 
VP16 enhancers, additive activators (purple), and synergistic activators (red). 
(C) Activating CRs clustered by complex and plotted by level of transcriptional synergy. 
Transcription/preinitiation complex regulators generated weak synergy, while chromatin assembly/ 
remodeling, chromatin-modifying, and transcription-elongation regulators generated strong 
synergy. Synergy is the ‘‘cooperation’’ of factors to produce a total output and here is defined as the 
fraction of total output not accounted for by summing the outputs from the individual components. 
Synergy = [(A – 1) – (B – 1) – (C – 1)]/(A – 1) where A = CR and VP16, B = CR only, and C =VP16 only. 
(D) Activators clustered by gene ontology function terms and plotted as percentage of CRs in each 
term group with ‘‘strong synergy’’ (greater than the average synergy of 0.2). Error bars are SD of 
three isogenic strains. 
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Figure 4.6. Transcriptional logic in alternative loci shows similar behavior. 
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(A and B) Representative ZF-CRs from Figure 4.5B show the same six classes of transcriptional 
logic when the reporter is integrated into the (A) LEU2 locus and (B) HIS3 locus. Vertical axes 
correspond to ‘‘Fold Change GFP.’’ 
(C) The same ZF-CRs from Figure 4.5C were clustered by complex and show similar trends in 
synergy when the reporter is integrated into the LEU2 locus. 
(D) All 223 CRs were targeted to the LEU2-integrated reporter. Activators were clustered by gene 
ontology function terms and plotted as the percentage of CRs in each term group with ‘‘strong 
synergy’’ (greater than the average synergy of 0.1). The trend is similar to that observed in Figure 
4.5D. Error bars are standard deviations of three isogenic strains. 
 
4.8. Revealing Spatially Encoded Regulatory Modes 
While transcriptional regulation is canonically focused at promoter regions, there 
is also considerable evidence for chromatin-mediated regulation at other locations 
relative to open reading frames (ORFs): (1) nucleosomes are arrayed over entire genes 
with distinct positioning at promoter and terminator regions118, (2) native CRs and 
transcription factors are often localized to spatially specific, nonpromoter regions to 
regulate genes141, and (3) histone mark gradients have been observed over genes114, 124. 
These observations suggest that CRs may asymmetrically and differentially regulate 
genes depending on their relative location to an ORF. 
We sought to explore spatially dependent regulatory behaviors using site-specific 
CR recruitment. We moved the ZF operators in the reporter locus from upstream of the 
coding sequence to downstream of the terminator (Figure 4.7 and Figure 4.8). The 
library of ZF-CRs was then inducibly recruited to the downstream element 
(Figure 4.8, blue and gold bars). No CRs were able to activate transcription from the 
downstream position, suggesting the importance of preinitiation/transcription complex 
assembly at promoters for activation. However, many CRs were able to repress 
transcription from the downstream position. Interestingly, several of these CRs exhibited 
‘‘asymmetric’’ regulatory modes; in other words, they had opposite regulatory functions 
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when targeted upstream versus downstream (Figure 4.8, gray bars). To develop insight 
into CR functions that may underlie these spatially encoded behaviors, we grouped CRs 
by their spatial regulatory profile (i.e., upstream-activating or –repressive and 
downstream-activating or -repressive) and obtained associated gene ontology function 
terms for each group (Figure 4.7; Table S5). Subsets of these terms were unique to 
each grouping (Figure 4.7). Interestingly, while many upstream-activating/downstream-
neutral CRs were associated with regulation of the transcriptional complex, factors that 
were upstream-activating/downstream-repressive appeared enriched in ATPase 
remodeling and DNA translocase activity. This suggests that remodeling activities can 
influence transcription from both ends of a gene, potentially by increasing RNA PolII 
accessibility at upstream regions while disrupting transcriptional elongation at 
downstream regions. 
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Figure 4.7. Engineering spatial regulation by targeting CRs upstream and downstream of a gene 
A gene locus was engineered to recruit 223 CR fusions to operators either upstream or downstream 
(downstream of a CYC1 terminator) of a reporter gene. CRs were grouped according to their 
upstream- and downstream-targeted regulatory profiles. Gene ontology function terms unique to 
each group are listed along with the number of CRs in the group associated with each term. 
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Figure 4.8. Engineering spatial regulation by targeting CRs upstream and downstream of a gene 
yields no activators when targeted downstream. 
Fold change in GFP expression for the library of 223 ZF-CR fusions, targeted either upstream (gray 
bars) or downstream (blue, gold, red bars) of the reporter gene. When targeted to the downstream 
position, CRs function either as repressors (blue bars, < 0.7 fold change) or neutral elements (gold 
bars, 0.7 < fold change < 2). None function as activators. Error bars are standard deviations of three 
isogenic strains. 
 
4.9. Simultaneous and differential regulation of multiple genes 
The spatial qualities of chromatin-based regulation could be exploited to engineer 
the simultaneous regulation of multiple genes. For example, based upon the comparison 
of upstream versus downstream targeting of the CR library (Figure 4.7), a single CR 
might simultaneously (and differentially) regulate two genes if recruited upstream of one 
ORF and downstream of another. To identify CRs capable of such simultaneous 
regulation, we constructed a dual-gene reporter system (Figure 4.9A) and recruited a 
small subset of ZF-CRs to it. The CRs exhibited a variety of dual-gene regulation profiles 
(Figure 4.9A, Figure 4.10A and E). Notably, these included factors that could activate 
expression of one reporter gene while repressing the other. To confirm that the local 
contexts of the genes were not responsible for the observed behaviors, the ZF operators 
were swapped 
between upstream and downstream positions at both genes (Figure 4.9B, Figure 
4.10B and F). As expected, the regulatory profiles were correspondingly inverted. 
Moreover, fusions of CRs to nonbinding ZFs did not appreciably modulate transcription, 
strongly suggesting that these engineered regulatory modes are the result of site-
specific targeting (Figure 4.10A, B, E and F, left). 
To test if we could shift the dynamic ranges of both reporter genes while 
qualitatively maintaining the same dual-gene regulatory profiles, we corecruited VP16 to 
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upstream positions in the dual-gene architecture (Figure 4.10, right columns). We were 
able to engineer increased dynamic ranges of both reporter genes while maintaining 
similar regulatory trends of the CRs. Because future applications may require the 
simultaneous regulation of two distinct promoters, we next added a second, different 
promoter to the reporter construct. Specifically, we replaced the downstream CYC1 
promoter that drives the expression of mCherry with the full-length BIO2 promoter, which 
has a similar intermediate basal level of expression as the CYC1 promoter (Figure 
4.9C, Figure 4.10C and D)5. Overall, we found that the regulatory output profiles were 
consistent with those from the reporter harboring two repeated CYC1 promoters, 
suggesting conservation in these forms of regulation. 
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Figure 4.9. Simultaneous and distinct regulation of two genes by individual chromatin regulators. 
(A) Top: schematic of the engineered, dual-gene reporter locus (CYC1 promoters and terminators 
used throughout). Bottom: fold change in GFP (green bars) and mCherry (red bars) expression for 
six targeted CR fusions. 
(B) Swapping operator locations results in inversion of transcriptional outputs. 
(C) Schematic of the same locus architecture as in (A) but containing two different promoters and 
terminators (BIO2 promoter and ADH1 terminator in purple). Error bars are SD of three isogenic 
strains. 
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Figure 4.10. Simultaneous, differential regulation of two genes 
(A–D) Left: schematics of the engineered, dual-gene reporter loci integrated into the URA3 locus 
(ZF43-8 operator, gray boxes; ZF97-4 operator, blue boxes). (AD, top) The combination of non-
targeting and targeting CRs expressed (ZF 43-8, gray; ZF 97-4, blue; truncated non-binding ZF, 
white). 
(E and F) Individual CRs show similar simultaneous regulation of two genes integrated into the LEU2 
locus. Non-targeted (left) and targeted (right) ZF-CR fusions. 
(A-F) Fold change in fluorescence (GFP, green bars; mCherry, red bars). Error bars are standard 
deviations of three isogenic strains. 
 
4.10. Long-range and multigene regulation 
Our results support the notion that spatial location and patterning of CRs 
influence regulatory function. To further explore spatial effects, we next asked if CRs 
could regulate genes from longer distances. Heterochromatic structures are known to 
spread over large regions of the genome through hypothesized self-reinforcing 
mechanisms32, 126, 142. We sought to harness this potential by constructing a three-color 
reporter system that could be used to identify factors capable of long-range transcription 
control (Figure 4.11A). We recruited a set of the strongest repressors and activators 
upstream of the first gene (Figure 4.11, Figure 4.12C, and Figure 4.14A). Most CRs 
modulated expression of only the proximal gene (yEGFP) without affecting downstream 
genes (Figure 4.11B), while nontargeting controls did not affect expression of any of the 
reporter genes (Figure 4.11B, Figure 4.12B, and Figure 4.14A). However, two CRs 
(Sir2 and Rph1) were able to robustly repress all three genes in the cluster. Intriguingly, 
Sum1 also showed evidence for multigene regulation but through a distinctive spatial 
pattern, in which repression was strongest for the most distal gene and weakest for the 
proximal gene. Yet, it should be noted that Sum1 was also unique in that it showed 
some (weak) repressive abilities in an inverted spatial pattern (strongest repression for 
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the proximal gene and weakest for the distal gene) when fused to a nontargeting ZF 
(Figure 4.11B and Figure 4.14A). 
Long-range regulation and epigenetic memory are both hypothesized to rely on 
self-reinforcing mechanisms that enable spreading of chromatin modifications from 
nucleosome to nucleosome126. To explore the engineering of memory via our targeted 
CRs, we chose three representative regulators (Med16, Isw2, Sir2) and tested their 
ability to sustain gene expression changes. We performed induction/wash-out 
experiments for these CRs and measured reporter output over time. While outputs for 
the activator Med16 and repressor Isw2 returned to basal levels post washout, Sir2 was 
able to stably repress the proximal gene (yEGFP) for 24 hr post washout (Figure 
4.13A). Interestingly, the reactivation rate of the downstream genes appeared to 
correlate with distance from the position of CR binding. To test for the possibility that ZF-
Sir2 was long-lived and still present post washout, we measured ZF-Sir2 occupancy at 
its operator, H4K16 acetylation levels at the yEGFP promoter, and yEGFP expression at 
several time points (Figure 4.14B and C). At 12 hr post washout, we observed ZF-Sir2 
occupancy had returned to preinduction levels while yEGFP expression and H4K16 
acetylation remained repressed for several cell divisions (between 24–30 hr), suggesting 
heritable reporter repression and histone modification. 
DNA sequences have been identified that block heterochromatin spreading by 
disfavoring nucleosome-binding through DNA conformation preferences and binding 
thermodynamics142, 143. These include a stretch of 100 deoxythymidines, a mix of 100 
deoxythymidines and deoxyadenines, and 32 repeats of CCGNN (where N is any 
deoxynucleotide). We asked if these sequence elements could be inserted into our triple 
reporter locus to insulate specific genes from long-range repression by Sir2, Rph1, and 
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Sum1 (Figure 4.13B). We found that only CCGNN repeats were able to fully block 
repression (Figure 4.13C and Figure 4.14D). Moreover, they could relieve repression 
of the proximal downstream gene (mCherry), but not the distal downstream gene (BFP). 
Similar effects were observed with Rph1 and Sum1. Thus (CCGNN)32 could be used to 
insulate genes, even those in the middle of an expression cassette, from the effects of 
long-range repressors (Figure 4.13D). 
 
 
Figure 4.11. Long-range and multigene regulation by targeted chromatin regulators. 
(A) Schematic of the engineered, multigene reporter locus. The 27 strongest repressors and 48 
strongest activators identified from the full ZF-CR library as well as all CRs with histone-modifying 
catalytic domains were targeted upstream of the first gene. 
(B) Heat map of the fold change in fluorescence for GFP, mCherry, and BFP, revealing classes of 
CRs that regulate only the proximal gene (left and middle) or that repress all three genes in the locus 
(right). 
  
108 
 
Figure 4.12. Long-range relation by nontargeting and targeting CRs 
(A) Expression of GFP (green bars), mCherry (red bars), and BFP (blue bars) was driven by tandem 
minimal CYC1, BIO2, and CHO1 promoters, respectively, all integrated into the URA3 locus. 
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(B and C) Fold change in fluorescence induced by the 27 strongest repressors, 48 strongest 
activators, and all CRs with histone-modifying catalytic domains when fused to a truncated, non-
targeting ZF control (B) or a targeting ZF (43-8) (C). Error bars are standard deviations of three 
isogenic strains. 
 
 
Figure 4.13. Epigenetic repression and insulation 
(A) Time courses of induction/wash-out experiments for three CRs. CR fusions were expressed at t = 
0 hr by the addition of the small molecule ATc, which was subsequently washed out at t = 12 hr (gray 
bars). Med16 and Isw2 show reversible activation and repression of GFP, respectively. Sir2 
maintains full repressive memory of the proximal gene and partial repressive memory of the 
downstream gene. 
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(B) Nucleosome-disfavoring sequences inserted between the GFP and mCherry genes as putative 
barrier or insulator elements. 
(C) Fold change in fluorescence for GFP, mCherry, and BFP induced by targeting (top) or 
nontargeting (bottom) multigene repressors (Sir2, Rph1, and Sum1 fusions). The (CCGNN)32 
sequence robustly insulates only the middle gene (mCherry) from repression by the CRs. 
(D) Schematic of the multigene regulatory circuit. 
Error bars are SD of three isogenic strains. 
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Figure 4.14. Multigene regulation and memory by targeted chromatin regulators. 
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(A) Heat map of fold change in fluorescence from the triple reporter integrated into the LEU2 locus 
for targeting (left) and non-targeting (right) ZF-CRs from Figure 4.11B. 
(B and C) FACS measurements of GFP (top), ChIP-QPCR measurements of 3xFLAG-ZF-Sir2 operator 
occupancy (middle), and H4K16ac promoter enrichment (bottom) normalized to uninduced cells 
harvested at hour 12 (dotted brown line). (B) Low time resolution experiment revealed a period 
between 24 and 30 hr where ZF-Sir2 is no longer present at the reporter while H4K16ac remains low. 
(C) Higher time resolution experiment showed H4K16 remains hypoacetylated for two cell divisions, 
between 26 and 30 hr, while ZF-Sir2 is no longer bound to the reporter. Error bars are standard 
deviations of three separate strains. 
(D) Fold change in fluorescence of LEU2-integrated triple reporters with ((CCGNN)32) or without 
(random) the (CCGNN)32 sequence inserted between GFP and mCherry. Change in multi-gene 
expression when expressing targeting (top) or nontargeting (bottom) multi-gene repressors (Sir2, 
Rph1, Sum1 ZF fusions). The (CCGNN)32 sequence robustly insulates only the middle gene 
(mCherry) from repression by the CRs. Error bars are standard deviations of three isogenic strains. 
 
4.11. Discussion 
Hundreds of CR proteins act on chromatin in complex and combinatorial ways to 
regulate gene transcription. Here, we took a synthetic biology approach to study and 
classify transcriptional behaviors emerging from engineered combinatorial, spatial, and 
temporal patterns of CRs. Our results provide us with components that can be used in 
synthetic biology and chromatin biology: (1) functional activators and repressors; (2) six 
classes of combinatorial regulators for programming multi-input logic: dominant 
repressors, repressors, neutral factors, VP16 enhancers, additive activators, and 
synergistic activators; (3) distinct classes of spatially encoded regulators (e.g., 
‘‘asymmetric’’ regulators), including CRs that can repress transcription from a 
downstream position; and (4) CRs capable of regulating only proximal genes, as well as 
CRs capable of regulating all genes simultaneously (long-range regulators), which in one 
case also produced robust gene expression memory. 
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4.11.1. New parts for synthetic biology and cellular engineering 
Synthetic biology offers a bottom-up approach for exploring the design and 
function of biological systems and for engineering cells and organisms to address a 
range of biomedical and industrial applications7, 131-134. Here, we decomposed chromatin-
based transcriptional regulation into minimal components—minimal promoters and 
individually targeted CRs—to provide a useful framework of parts and behaviors for 
broad applications in synthetic biology and cellular engineering. 
Targeted CRs could be used as synthetic transcriptional activators and 
repressors in eukaryotic organisms. Many CRs matched or exceeded the activation or 
repression levels achieved by commonly used regulatory domains, such as VP16 and 
Mig1 (Figure 4.2A and B). While the behavior of any individual CR may vary for different 
genomic contexts, the general regulatory properties revealed by this library-based 
approach will streamline selection and testing of relevant CRs. Moreover, we observed 
strong correlation between the relative activities of CRs in alternative loci (Figure 4.3, 
Figure 4.6, Figure 4.10E-F, Figure 4.14A and D; Tables S1 and S4), suggesting some 
conservation or robustness in the function of these factors across different genomic 
contexts. 
This work also has interesting implications for the design of synthetic gene 
circuits. First, our work demonstrates that chromatin-based components can vastly 
extend the regulatory potential of an individual genetic locus, thus expanding the 
regulatory possibilities of circuit nodes. A diverse range of transcriptional logic can be 
programmed by designing a genetic locus to recruit different combinations of CRs. As a 
result, circuits composed of CRs may represent a more efficient solution to information 
processing than those composed of canonical transcriptional components, like bacterial 
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transcription factors. In other words, a minimal number of CRs targeted to a single locus 
may perform similar logical or computational tasks as a network composed of many 
interacting transcription factors. This feature could be useful for biotechnology 
applications by helping to reduce the size of gene expression cassettes to be delivered 
into a cellular host. Yields from bioprocesses could also be increased by the reduction in 
metabolic load on production organisms. Second, quantitative control of transcriptional 
outputs, including the ability to program synergistic activation, could be useful in 
controlling the expression levels of enzymes in engineered metabolic pathways and of 
regulatory proteins in synthetic circuits. Chromatin-based control schemes could be used 
to tune the sensitivity of cellular sensors to multiple environmental factors, or to tune the 
expression range of signaling factors such as chimeric antigen receptors in T cell 
adoptive immunotherapy. The properties of synthetic circuits such as induction 
threshold, cycle period, and entrainment strength are known to be sensitive to 
expression levels144, which could in principle be tuned through corecruitment of 
synergistic CRs. Third, epigenetic regulation of specific sets of genomic loci 
fundamentally underlies the transition between distinct cellular states, including in 
response to stress145 or differentiation into cells of distinct tissue types146. The ability to 
establish epigenetic states at defined loci may enable construction of simplified synthetic 
systems to study the regulatory principles governing these processes. 
Chromatin-based systems also enable multigene regulation, providing interesting 
new strategies for precisely addressing individual genes within a locus. For example, an 
asymmetric spatial regulator could be used to simultaneously repress one gene while 
activating another, a property that could serve as the foundation for new bistable genetic 
switches. Furthermore, some of the components presented here (CRs, nucleosome-
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disfavoring sequences, etc.) may be used to mitigate undesired context effects of 
placing genes and regulatory elements in proximity to one another. Finally, long-range 
CR repressors could be deployed to stably silence entire genomic regions, for example, 
to inactivate a synthetic circuit or to regulate an entire secondary metabolite production 
cassette. Quantitative measurement of properties, such as the kinetics of activation or 
repression, distance-dependence of spatial regulators, and spreading kinetics of long-
range regulators, would greatly enhance the utility of CRs for these purposes. 
Finally, recent advances in programmable DNA targeting technologies are 
providing new opportunities for inducing epigenomic alterations at any desired locus, for 
example, to correct disease-associated epigenomic changes. ZFs, transcription 
activator-like effector (TALE) repeat domains, and the recently described CRISPR/Cas 
system147, 148 each provide unique benefits, and all are compatible with the approach 
outlined here. For example, ZFs are highly specific, small, and efficient for gene/DNA 
delivery applications149. TALE proteins are easier to engineer, have a larger targeting 
range, and have been shown to enable the targeting of CR domains129, 130. Lastly, the 
CRISPR/Cas system can be used to promote multiplex recruitment of effectors to 
numerous loci simultaneously147, 150, 151. 
4.11.2. Bottom-up approaches for chromatin biology 
In addition to applications in cellular engineering, the bottom-up approach 
presented here may complement current methods in chromatin biology, by providing 
tools and approaches to directly test the functional role of chromatin states in gene 
expression. Most methods for testing causality employ perturbations that globally affect 
activities of CRs (knock-down, overexpression, and chemical inhibition) with potential 
pleiotropic effects. Thus, these methods do not directly assess causal functional roles for 
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CRs at specific loci. By targeting CRs to specific gene loci, we provide functional 
evidence supporting the causative roles of certain chromatin complexes in regulating 
transcription, including activation by H3K4 methyltransferases and histone 
acetyltransferases, and repression by histone deacetylases. This approach could, in 
principle, be used to study the effects of DNA and histone modifications at specific 
endogenous loci and could be applied to the study of chromatin regulation in mammalian 
cells29, 129, 130. 
An interesting result that emerged from our CR library screens is that 
transcription can be repressed but not activated from downstream of a gene. 
Furthermore, activators do not appear to display the long-range properties that some 
repressors do, at least not within the spatial contexts studied (CRs targeted to 
enhancers may exhibit different properties130). This highlights an interesting 
‘‘asymmetric’’ property of transcriptional regulation by some CRs. Activation is generally 
controlled at specific locations (e.g., promoters and enhancers), while repression can be 
controlled throughout a gene presumably though spreading mechanisms or disrupting 
the synthesis of full length transcripts. Site-specific targeting of CRs could also be a 
useful tool in elucidating the mechanisms underlying long-range repression and 
spreading of chromatin modifications32, 152. In conjunction with chromatin modification 
mapping and protein domain knockouts, site-specific targeting of CRs could provide 
additional insight into the domains and protein activities required for heterochromatic 
spreading. 
Targeting specific domains that comprise CRs may also be useful in 
understanding the importance of protein-protein interactions and protein complex 
recruitment in chromatin-based regulation. In addition, use of minimal chromatin-
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modifying catalytic domains could provide supporting evidence of a histone code. In this 
study, we focused on targeting full-length proteins because it enabled the use of gene 
ontology annotations to garner insights into chromatin-based transcriptional regulation, 
such as the classification of distinct sets of combinatorial regulators in programming 
transcriptional logic. We found that CRs with distinct regulatory mechanisms from VP16 
were able to generate synergy. This suggests a general design principle in which protein 
complexes with distinct functions may interact to produce emergent properties and may 
be combined to execute myriad regulatory decisions. Future work may reveal many 
novel behaviors arising from the large interaction space between two or more chromatin 
complexes with distinct mechanisms of action. 
The complexity of chromatin arises from the large number of regulating 
complexes and their combinatorial and spatial modes of action. We show here that 
decomposing chromatin regulation into modular elements benefits our understanding of 
the function of individual components and complexes. Furthermore, diverse 
combinatorial and spatiotemporal regulatory modes can be encoded within synthetic 
gene architectures and executed by the site-specific recruitment of engineered 
chromatin regulators. This bottom-up approach may be a useful platform for both 
untangling and harnessing the complexities of chromatin control over cellular behaviors. 
 
4.12. Experimental procedures 
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4.12.1. Strains and media 
The background strain used for all experiments in this study was S. cerevisiae 
YPH500 (, ura3-52, lys2-801, ade2-101, trp163, his3200, leu21) (Stratagene). 
Culturing and genetic transformation were done as previously described20 using either 
the URA3, HIS3, or LEU2 genes as selectable markers. 
 
4.12.2. Plasmid construction 
Reporter plasmids were constructed from integrative plasmid pRS406 
(Stratagene) by cloning ZF (43-8 and/or 97-4) binding sequences at various 
locations within a previously described reporter construct20. ZF-CR and VP16 
fusion proteins were expressed from previously described TetR- or LacI 
regulated GAL1 promoters20. The ZF-CR expression constructs were cloned into 
single-integrating plasmid pNH603 (HIS3), and the VP16 fusion expression 
constructs into single-integrating plasmid pNH605 (LEU2). 
Our host strain was generated by genomically integrating into the 
background strain an expression cassette that constitutively expresses TetR, 
LacI, and GEV (cloned into single-integrating plasmid pNH607 [HO]). Constitutive 
expression of the repressors in glucose-containing media ensures low basal 
levels of expression of ZF-CRs from the engineered GAL1 promoters, which can 
be relieved by the respective addition of the chemical inputs, ATc and IPTG, 
along with β-estradiol to the medium. The negative control, truncated 
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(nonbinding) ZF amino acid sequence is PRHLKTHLR. pNH603, pNH605, 
pNH607, and BFP were kind gifts from the Lim Laboratory153. 
4.12.3. Library construction 
Primer sequences were obtained from the Saccharomyces Genome Database 
(SGD)154 (Table S6), synthesized (Integrated DNA Technologies), and used to amplify 
full length CR ORFs from wild-type yeast (BY4742). SbfI and NotI flanking restriction 
sites were used to ligate PCR products C-terminal to (3xFLAG)-(nuclear localization 
sequence)-(zinc finger array)-(17 amino acid glycine-serine linker). 
4.12.4. Induction experiments 
Three single yeast colonies for each strain were picked after genomic integration 
and used to inoculate 500 ml of SD-media (synthetic drop-out media containing 2% 
glucose with defined amino acid mixtures) in Costar 96-well assay blocks (V-bottom; 2 
ml max volume; Fisher Scientific). The cultures were grown at 30C with 900 rpm shaking 
for 24–48 hr. Cultures, with and without inducers, were inoculated in SD-complete media 
to an OD600 of 0.05–0.1 and grown at 30C with 900 rpm shaking for 12 hr. Cells were 
treated with 10 mg/ml cycloheximide to inhibit protein synthesis and then assayed for 
yEGFP, mCherry, and BFP expression by flow cytometry. 
 
4.12.5. Flow cytometry and data analysis 
For all experiments, 5,000–10,000 events were acquired using a BD 
LSRFortessa equipped with a High Throughput Sampler (BD Biosciences). Events were 
gated by forward and side scatter, and geometric means of the fluorescence 
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distributions were calculated in FlowJo. The autofluorescence value of S. cerevisiae 
YPH500 cells harboring no genomic integrations was subtracted from these values. 
‘‘Fold activation’’ values were calculated as the ratio of fluorescence values from induced 
cells to those from uninduced cells. All values obtained were the means of three isogenic 
strains. BFP and mCherry expression, driven by the CHO1 and BIO2 promoters, 
respectively, remained largely invariant between induced and uninduced cultures 
(Figure 4.12C); thus GFP values are not expected to vary significantly with any growth 
rate differences in strains. 
Gene ontology queries were submitted to the SGD database154 between July 10, 
2013 and August 17, 2013. Cluster and background frequencies are in Tables S2, S4, 
and S5. 
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5.1. Summary 
Protein aggregation is a hallmark of many diseases, but also underlies a wide 
range of positive cellular functions. These phenomena have been difficult to 
study in living cells due to a lack of quantitative and high-throughput tools. Here 
we develop a synthetic genetic tool to sense and control protein aggregation. We 
first apply the technology to yeast prions, developing sensors to track their 
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aggregation states, prion fusions to encode synthetic memories in yeast cells, 
and utilizing high-throughput screens to identify prion-curing mutants. We 
engineer these mutants into “anti-prion drives” that reverse the non-Mendelian 
inheritance pattern of prions and eliminate them from yeast populations. Next, we 
extend our technology to yeast RNA-binding proteins (RBPs) and track their 
propensity to aggregate. We search for co-occurring aggregates and uncover a 
group of coalescing RBPs through screens enabled by our platform. Our work 
establishes a quantitative, high-throughput, and generalizable technology to 
study and control diverse protein aggregation processes in cells. 
 
5.2. Individual contributions 
Gregory Newby, Szilvia Kiriakov, Erinc Hallacli, Susan Lindquist, and Ahmad 
Khalil conceived of the study. Gregory Newby, Erinc Hallacli, and Szilvia Kiriakov 
performed and analyzed all experiments with the exception of the following: Can 
Kayatekin, Peter Tsvetkov, Christopher Mancuso, and Sohini Chakrabortee 
assisted with the development of yTRAP methodology. Christopher Mancuso 
assisted with the development of reverse-yTRAP. Maeve Bonner aided in the 
development of expression systems. William Hesse and Sohini Chakrabortee 
developed the Htt-induction system. Anita Manogaran and Susan Liebman 
generated the [PSI+] prion variant strains. Susan Lindquist and Ahmad Khalil 
oversaw the study. Gregory Newby, Szilvia Kiriakov, Erinc Hallacli, and Ahmad 
Khalil wrote the paper with input from all authors. 
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5.3. Introduction 
Cellular aggregates are associated with many diseases, including 
neurodegeneration 156, type II diabetes157, systemic amyloidosis 158, and even 
aging 159. However, it is also becoming clear that protein aggregates have 
beneficial functions in many biological processes. These include signal 
transduction in the human immune system 160, 161, synaptic regulation and 
memory 83, RNA regulation in the cellular stress response 162, 163, melanin 
production 164, and microbial biofilm formation 165. 
Broadly, aggregation is the assembly of proteins into large complexes that 
can grow without a fixed endpoint. Aggregates can differ from one another in 
conformational diversity, size, and the diversity of components. All these factors 
render typical structural techniques inapplicable. Correspondingly, methods to 
describe protein aggregation in vivo are largely qualitative and ad hoc. 
Quantitative and high-throughput techniques to study aggregation are urgently 
needed to discover treatments for pathological aggregates and interrogate 
functional aggregates. 
Since their discovery as the causative agents of transmissible 
neurodegenerative disorders, prions have served as model protein aggregates. 
Prions are self-propagating protein conformations found across model 
organisms, from bacteria to mammals. Much of what we know about prions 
comes from studies in yeast, where some endogenous proteins can switch from 
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non-prion conformations to prion aggregate conformations, resulting in dramatic 
changes in protein activity. This switching produces new, heritable phenotypes 76, 
166. Because the aggregated prion conformation is transmitted through the 
cytoplasm, they and their associated phenotypes are inherited in a non-
Mendelian fashion 70. Tools to detect and manipulate prions in a variety of 
contexts are necessary to comprehensively explore their adaptive traits, and 
potentially exploit them to engineer new cellular functionalities. 
The ability of most yeast prions to adopt the prion state in cells is 
mediated by ‘prion domains’ (PrDs) that can nucleate and propagate amyloid 
conformations. The observation that many known yeast prions harbor PrDs rich 
in glutamine (Q) and/or asparagine (N) residues has motivated the development 
of algorithms to look for such sequences across all proteomes 53. 
In the human proteome, 240 genes contain prion-like, Q/N-rich sequences 
57. These genes are heavily enriched for RNA-binding and RNA-processing 
activity, including many aggregation-prone proteins associated with fatal 
neurodegenerative diseases 167. However, natural assemblies/aggregates of 
RNA-binding proteins (RBPs) are important for RNA storage, processing, and 
degradation 163. RBP assemblies are also involved in the regulation of synaptic 
long-term potentiation 83, memory in yeast 168, and the cellular stress response 
169. Factors involved in the transition of RBPs from their natural context into 
disease-associated aggregates remain poorly understood, as do the immediate 
consequences of aggregation. 
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Here, we use synthetic biology to develop a versatile genetic toolkit for 
quantitatively sensing and controlling protein aggregation states in cells. yTRAP 
(yeast Transcriptional Reporting of Aggregating Proteins) is based on coupling 
the solubility state of a protein-of-interest to the regulation of synthetic 
transcriptional outputs. We first use yTRAP to construct prion sensors and track 
prion states in live cells. Next, we use yTRAP in conjunction with a potent inducer 
of the [PSI+] prion to engineer synthetic memory in yeast cells. Additionally, using 
yTRAP to screen mutant libraries of prions, we select for mutant prion alleles that 
cure endogenous [PRION+] states. Using these alleles, we construct “anti-prion 
drive” systems to cure prions and reverse the dominant inheritance of prion 
states in mating partners and progeny. We then employ yTRAP as a screening 
platform to detect factors that influence the aggregation of yeast RBPs, including 
the closest yeast homolog of hnRNPA1, Hrp1, and investigate the consequences 
of its aggregation. Our results establish a generalizable cell-based technology to 
observe, screen, and manipulate protein aggregation phenomena. 
 
5.4. Development of a genetic tool that sensitively detects protein 
aggregation states 
To detect protein aggregation in living cells, we developed a genetic tool 
termed yTRAP (yeast Transcriptional Reporters of Aggregating Proteins). The 
yTRAP cassette is composed of: (1) a ‘yTRAP fusion’ of the protein-of-interest 
with a synthetic transcriptional activator (synTA), constitutively expressed at low 
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levels; (2) a reporter gene regulated by a synTA-responsive promoter (Figure 
5.1A and Figure 5.2A). The system functions by linking transcriptional activation 
of the reporter to the solubility of the yTRAP fusion. In the soluble state, the 
synTA binds to its cognate promoter and induces strong expression of the 
reporter gene. Aggregation of the fusion protein limits the availability of the 
synTA to regulate its promoter, thus reducing the transcriptional output of the 
system. The synthetic fusion can either join existing aggregates endogenous to 
the cell, or be the sole source of a heterologous aggregating protein. Moreover, 
the synTAs utilize engineered zinc finger proteins that target synthetic binding 
sequences (BS); the modular design of these regulators enables yTRAP fusions 
to be readily constructed for any protein and the customization of transcriptional 
outputs 20. 
 We first determined the yTRAP reporter output for different levels of 
soluble synTA. Using an estradiol-inducible system 97, we titrated synTA protein 
level in the cell and measured the corresponding reporter output using flow 
cytometry. This revealed a linear relationship between soluble synTA protein 
levels and reporter outputs across a ~50-fold dynamic range, with only 1.5% 
basal expression of the reporter gene in the absence of synTA (Figure 5.2B). 
 To validate the tool we applied yTRAP to detect the well-
established yeast prion [PSI+], formed by self-templating aggregates of Sup35. 
The yTRAP fusion consists of the Sup35 prion domain (NM) fused to a synTA. 
Sup35, like several other prion proteins, can adopt multiple self-templating 
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amyloid conformations, producing varied ratios of soluble/aggregated protein in 
the cell. We introduced the PSI sensor into three yeast strains representing 
variants of this prion: strong [PSI+], weak [PSI+], and [psi-]. Each variant was 
clearly distinguishable by a variety of visualization techniques, with stronger 
aggregation yielding less yTRAP signal (Figure 5.1 B, C, D, Figure 5.2C). We 
confirmed that the yTRAP fusion protein was incorporated into amyloid 
aggregates in cells harboring the [PSI+] prion but not in cells harboring the non-
prion [psi-] state using semi-denaturing detergent agarose gel electrophoresis 
(SDD-AGE) (Figure 5.1B) 170. Previous methods to detect a prion state have 
relied on the use of genetic backgrounds that change cellular phenotypes upon 
changes to the prion state. 76, 166. Uniquely, yTRAP allows batch or single-cell 
measurement of aggregation state independent of the genetic background 
(Figure 5.2E). Taken together, these results demonstrate that yTRAP is a highly-
sensitive genetic sensor that can quantitatively distinguish between prion states. 
  
130 
 
Figure 5.1 Development of a genetic tool to detect protein aggregation states in cells 
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(A) The yTRAP system functions by transmitting the aggregation state of proteins to synthetic 
transcriptional outputs. The system consists of a “yTRAP fusion” of a gene-of-interest (GOI) to a 
synthetic transcriptional activator (synTA), and a reporter gene controlled by a synTA-responsive 
promoter. The fusion functions as a cellular probe of protein solubility. It strongly activates the 
reporter in the soluble state (left), but not in an aggregated state (right). BS: ‘binding site’ of the 
synTA. 
(B) Top: Genetic design of the [PSI+] prion sensor. Bottom left: Histograms of the sensor output for 
yeast strains harboring different variants of the prion: strong [PSI+], weak [PSI+], and [psi-]. Bottom 
right: SDD-AGE analysis of prion aggregates in the same strains. 
(C) Fluorescence image of an agar plate showing the sensor output for yeast colonies harboring 
different variants of [PSI+]. 
(D) Top: Genetic design of the [RNQ+] prion sensor. Bottom left: Histograms showing the sensor 
output for [RNQ+] and [rnq-] cells. Bottom right: SDD-AGE analysis of prion aggregates in the same 
strains. 
(E) Left: yTRAP sensors were constructed for a panel of asparagine (N) or glutamine (Q) rich protein 
domains in a strain with inducible polyQ-expanded Huntingtin Exon1 (Htt-Q103). Right: Relative 
aggregation of each sensor was measured after overexpression of Htt-Q103 (n=3, error bars, SD). 
 
 
5.5. yTRAP enables interrogation of diverse prion and aggregation-prone 
elements 
Finding reliable, natural phenotypes for yeast prions other than [PSI+] has 
been challenging. yTRAP overcomes this challenge by coupling solubility to 
synthetic transcriptional outputs, rapidly enabling the construction of sensors for 
a variety of different proteins. To demonstrate the adaptability of yTRAP, we 
assembled a sensor for a second yeast prion, [RNQ+], by encoding a yTRAP 
fusion using Rnq1 (“RNQ sensor”, Figure 5.1D). Many wild and laboratory strains 
of yeast harbor the [RNQ+] prion, also known as [PIN+]. However, it has been a 
particularly difficult prion to track due to the lack of growth phenotypes conferred 
by the prion. When we introduced the RNQ sensor into a [RNQ+] strain, we 
observed a low-fluorescence state (Figure 5.1D). After curing the strain of the 
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[RNQ+] prion by transient inhibition of Hsp104 171, the sensor’s output switched to 
a high-fluorescence state. Incorporation of the yTRAP fusion protein into the 
amyloid state in [RNQ+], but not [rnq-] cells was confirmed by SDD-AGE analysis 
(Figure 5.1D). 
Extending this general approach, we built sensors for a panel of other yeast 
prion proteins: Swi1, Mot3-PrD, and New1-PrD 53, 172, 173. Importantly, with these 
sensors, we were able to not only detect existing prion states, but also to isolate 
newly-formed prion states and subsequently observe their curing by Hsp104 
inhibition (Figure 5.2C and F). These results establish a synthetic, “plug-and-
play” toolkit for detecting and isolating prion states, applicable for different prions 
and across genetic backgrounds. 
Next, we explored whether yTRAP could be used to interrogate the 
aggregation of human disease proteins using the huntingtin protein associated 
with Huntington’s disease as a model system. Individuals with longer 
polyglutamine (polyQ) tracts produce more aggregation-prone protein. We 
compared the solubility of yTRAP sensors for a highly polyQ-expanded huntingtin 
exon 1 (Htt-Q103, containing 103 glutamine residues) to a shorter expansion 
(Htt-Q25). Both yTRAP fusion proteins were expressed at the same level, yet 
yTRAP sensor outputs confirmed that Htt-Q103 was more aggregated than Htt-
Q25 (Figure 5.2G). 
PolyQ aggregates have been shown to sequester other cellular proteins, a 
property that likely contributes to their toxicity 174-176. We generated yTRAP 
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sensor strains for a panel of previously-characterized Q- and N-rich yeast protein 
fragments, pairs of which differ only in Q/N content 177, and measured the change 
in yTRAP signal in response to Htt-Q103 overexpression. Note that although 
both Q- and N-rich proteins are aggregation prone, only Q-rich proteins were 
previously observed to co-localize with Htt-Q103 178. As assessed by yTRAP, Q-
rich proteins showed a marked shift to an aggregated state when Htt-103Q was 
expressed, while matched N-rich control proteins were unaffected (Figure 5.1E).  
Our results support the model that Q-rich proteins are particularly susceptible to 
sequestration by polyQ-expanded huntingtin, and illustrate the potential of 
yTRAP to screen for factors that influence disease-relevant aggregation. 
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Figure 5.2 yTRAP design, characterization, and sensors for detecting yeast prions and disease 
aggregates. 
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(A) Schematic of the yTRAP sensor genetic construct. This consists of (1) a yTRAP fusion between a 
gene-of-interest (GOI) and a synthetic zinc finger (ZF)-based transcriptional activator (ZF-43-8) 
(Khalil et al., 2012), and (2) a reporter harboring 8x ZF binding sites upstream of a minimal promoter 
driving the expression of a mNeonGreen reporter gene. This plasmid is integrated as a single copy 
into the HO locus of the yeast genome. SV40 NLS, SV40 nuclear localization sequence; VP16, Herpes 
simplex virus VP16 transcriptional activation domain; PKI NES, protein kinase inhibitor nuclear 
export sequence; SUP35 term, SUP35 terminator; minCYC1, minimal CYC1 promoter; ADH1 term, 
ADH1 terminator.  
(B) yTRAP reporter output as a function of soluble synTA (no fusion), titrated using an estradiol 
induction system. Top: Western blot against synTA (green) and a loading control (red). RNQ sensor 
strains (synTA with fusion to Rnq1) in the [RNQ+] and [rnq-] states were also included for 
comparison of synTA levels (right lanes). Bottom: The relationship between soluble synTA (no 
fusion) protein level and yTRAP output, fit by a linear regression (R2 >0.95).  
(C) Diverse prions measured by fluorescence plate reader. Top: yTRAP output for prion and non-
prion strains containing the Rnq1, Swi1, Mot3-PrD, and New1-PrD yTRAP sensors. Green: Initial non-
prion state of the strain after transformation with the yTRAP sensor (W303 is already [RNQ+], no 
green bar). Gray: [PRION+] strains isolated after overexpression of the prion. Orange: [PRION+] 
strains cured of the prion by transient guanidine treatment. Bottom: yTRAP outputs of the variant 
PSI strains (from Figure 5.1B), which were also cured with guanidine treatment (‘cured’). (n=3, error 
bars, SD). 
(D) Fluorescence micrographs of PSI sensor cells.  
(E) Flow cytometry histograms of the PSI sensor in [PSI+] and [psi-] strains of yeast with diverse 
genetic backgrounds as indicated. 
(F) Top: Flow cytometry of the New1-PrD, Swi1, and Mot3-PrD sensors in [PRION+] and [prion-] 
states. Right: SDD-AGE analysis confirming that the Mot3-PrD yTRAP fusion was converted to an 
amyloid state in the low-fluorescence population. 
(G) Aggregation of polyQ-expanded Htt quantified by yTRAP. Left: Schematic of the Htt-PolyQ 
yTRAP sensors. Middle: Relative aggregation of Htt-Q25 vs. Htt-Q103 quantified by flow cytometry. 
Relative aggregation was calculated as the inverse of median fluorescence, normalized to the Htt-
Q25 sample (see Materials and Methods). Right: Western blot against the yTRAP fusions (synTA, 
green; loading control, red). 
 
 
5.6. Positive detection of aggregation and multiplex tracking of prion 
states 
The yTRAP tool is built from programmable synthetic components. As a 
result, yTRAP-based genetic circuits can be constructed to produce custom 
sensor programs. For example, we designed a sensor system with reverse 
output logic, which turns ON upon aggregate formation. In the ‘reverse-yTRAP’ 
scheme, the synTA-responsive promoter controls expression of a TetR repressor 
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(fused to mKate2), which in turn regulates a Tet-repressible reporter (Figure 5.4A 
and B). When the yTRAP fusion protein is soluble, TetR-mKate2 is expressed 
and the reporter is repressed. This repression is relieved when the yTRAP fusion 
is aggregated. We built and introduced a Rnq1 reverse-yTRAP sensor into 
[RNQ+] and [rnq-] cells, revealing strongly separated high green / low red and low 
green / high red fluorescent states, respectively (Figure 5.4). By adding a second 
fluorescent output, which gains signal upon aggregation, the reverse-yTRAP 
system enhances measurement sensitivity, especially in detection of the onset of 
aggregation. 
The study of prions in high throughput has been limited to interrogating the 
behavior of individual prions, partly because each yeast prion has required a 
tailored genetic background for detection. By unlocking additional synthetic 
transcriptional channels, yTRAP enables the tracking of multiple prion proteins at 
the single-cell level. To do this, we designed a ‘dual prion sensor’ by utilizing two 
orthogonal pairs of synTAs / responsive promoters 20. The dual prion sensor 
consists of two cassettes, each encoding (1) a yTRAP fusion comprising a 
protein-of-interest fused to a distinct synTA and (2) a corresponding synTA-
controlled unique reporter (Figure 5.3A and Figure 5.4C). We used this 
framework to develop a dual PSI / RNQ sensor (Figure 5.3A-B). With the 
availability of a suite of orthogonal synTA-promoter pairs 20, we envision these 
yTRAP combinations can be expanded to allow greater numbers of proteins to 
be simultaneously monitored. 
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We next sought to apply the dual PSI / RNQ sensor to simultaneously track 
the behavior of these two prions in response to a stimulus. We subjected a 
population of [PSI+] [RNQ+] cells to guanidine hydrochloride treatment, took 
samples at different durations of treatment, and allowed them to recover in 
growth media lacking guanidine for a minimum of six generations. We then 
assessed prion states using flow cytometry (Figure 5.3C, left). We could readily 
distinguish combinations of prion / non-prion states that were sampled by the 
population as it progressed from entirely [PSI+] [RNQ+] to [psi-] [rnq-] (Figure 
5.3C). At every time point, the number of cells cured of [RNQ+] was always 
greater than the number cured of [PSI+], indicating that [RNQ+] is more readily 
cured by guanidine hydrochloride, as has been previously reported 179. 
 138 
 
 
 
 
 
 
138 
138 
 
Figure 5.3 A dual prion sensor enables multiplex detection and isolation of [PSI+] and [RNQ+] states  
(A) Genetic design of the dual prion sensor for [PSI+] and [RNQ+]. Each prion protein is coupled to a 
distinct transcriptional output channel through orthogonal synTA / promoter pairs. 
(B) Flow cytometry measurements of the dual PSI / RNQ sensor for four yeast strains harboring all 
four combinations of the [PSI+] and [RNQ+] prions.  
(C) Left: Time course measurements of dual prion sensor cells tracking the conversion from a [PSI+] 
[RNQ+] population to a fully cured [psi-] [rnq-] population by Hsp104 inhibition (n=3, error bars, SD). 
Right: Overlaid fluorescence image of an agar plate showing the heterogeneous population of prion 
states following 16 hours of treatment. 
A B
C
mNeon fluorescence (a.u.)
m
Ka
te
2
flu
or
es
ce
nc
e 
(a
.u
.)
102
102
103
104
105
103 104 105
synTA 1
BS
Sup35
NM
synTA 1
synTA 2
BS
Rnq1 synTA 2
time in guanidine treatment (hrs)
0
0 12 16 20 24 36
20
40
60
80
100
%
 o
f p
op
ul
at
io
n
 
 
138 
138 
 
Figure 5.3 A dual prion sensor enables multiplex detection and isolation of [PSI+] and [RNQ+] states  
(A) Genetic design of the dual prion sensor for [PSI+] and [RNQ+]. Each prion protein is coupled to a 
distinct transcriptional output channel through orthogonal synTA / promoter pairs. 
(B) Flow cytometry measurements of the dual PSI / RNQ sensor for four yeast strains harboring all 
four combinations of the [PSI+] and [RNQ+] prions.  
(C) Left: Time course measurements of d al prion sensor cells tracking the c nversion from a [PSI+] 
[RNQ+] populatio  to a fully cured [psi-] [rnq-] population by Hsp104 inhibition (n=3, error bars, SD). 
Right: Overlaid fluorescence image of an agar plate showing the heterogeneous population of prion 
states following 16 hours of treatment. 
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Figure 5.4. Reverse-yTRAP and dual yTRAP sensor systems.  
(A) The reverse-yTRAP sensor turns ON in the aggregated state. Top: Schematic of reverse-yTRAP. 
In the soluble state, the yTRAP fusion drives expression of TetR (fused to mKate2), which represses 
expression of the mNeonGreen reporter from an engineered, Tet-controlled ADH1 promoter (pADH1). 
In the aggregated state, TetR is not produced and repression of mNeonGreen is relieved. Bottom: 
Histograms of red (left) and green (right) fluorescence of [RNQ+] and [rnq-] cells harboring a reverse-
yTRAP RNQ sensor.  
(B) Schematic of the reverse-yTRAP sensor genetic constructs. 
(C) Schematic of the dual sensor genetic constructs. This system has two yTRAP cassettes, each 
using a distinct, orthogonal synTA / promoter pair (ZF-43-8 and ZF-37-12). 
 
5.7. A hyper-inducing prion fusion enables construction of synthetic 
memory 
yTRAP transmits the heritable prion state of the cell into distinct 
transcriptional outputs. To harness this property as synthetic cellular memory, we 
required a means to engineer “programmed” prion switching. We sought to 
control [PSI+] prion induction by cross-seeding Sup35 with pre-existing Rnq1 
amyloids. 
Cross-seeding has previously been shown to increase [PSI+] induction 
efficiency to ~10% using a Sup35NM-Rnq1 fusion (NM-Rnq1)180. We sought to 
improve its efficiency by tethering the two amyloid-forming domains even closer 
together, creating N-Rnq1-M (Figure 5.5A). We transiently expressed this fusion 
in cells harboring the dual PSI / RNQ sensor, and compared its efficiency in 
inducing [PSI+] with NM-Rnq1 and Sup35NM alone (NM). Strikingly, N-Rnq1-M 
was able to induce [PSI+] in >99% of the population, as compared with 2% of 
cells for NM and 10% for NM-Rnq1 (Figure 5.5B, Figure 5.6A, B). Moreover, 
unlike NM-Rnq1 overexpression which cured [RNQ+] in most cells, N-Rnq1-M 
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overexpression showed very little curing of the [RNQ+] prion (Figure 5.6C). This 
unexpected [RNQ+] curing effect by NM-Rnq1, but not N-Rnq1-M, may explain 
their large difference in [PSI+] induction potential, and highlights the importance 
of tracking multiple prions at once. 
Equipped with a hyper-inducing prion fusion, we next sought to build a 
synthetic memory device based on [PSI+] induction. We hypothesized that by 
linking expression of N-Rnq1-M to the presence of an environmental signal, we 
could create and heritably store signals in the prion state of cells. Using 
temperature as a proof-of-principle, we constructed strains that express N-Rnq1-
M or NM under the control of the heat-responsive SSA4 promoter (Figure 5.5C). 
We subjected cultures of these strains to a two-hour stimulus of elevated 
temperature between a range of 30°C–38°C. We then recovered the cells for 
over 10 generations at 25°C and measured the percentage of the population that 
switched to [PSI+]. As the temperature increased, so did the proportion of the N-
Rnq1-M expressing population that had induced and maintained the [PSI+] prion 
(Figure 5.5C). In contrast, the NM-inducing control strain showed no [PSI+] 
induction for any temperature. 
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Figure 5.5. Designing a hyper-inducing prion fusion to encode synthetic cellular memory 
(A) Architecture of the hyper-inducing prion fusion, which is a fusion of the Sup35 N domain, the full 
Rnq1 protein, and the Sup35 M domain.  
(B) Left: Yeast strains were constructed to harbor the dual PSI / RNQ sensor and a construct for 
induction of [PSI+]-inducing proteins N-Rnq1-M, NM-Rnq1, and NM. Right: Histograms of the PSI 
sensor output before (light purple) and after (dark purple) transient expression of prion-inducing 
fusions. 
(C) Left: A synthetic thermal memory circuit. N-Rnq1-M is placed under the control of the 
temperature-responsive SSA4 promoter in a Sup35NM [psi-] sensor strain. Middle: Heat treatment 
during the thermal memory experiment. Right: Percentage of the population converted to the [PSI+] 
state after transient exposure to different temperatures. NM (gray bars) expression was used as a 
negative control for the N-Rnq1-M fusion (red gradient). (n=3, error bars, SD). 
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Figure 5.6. A hyper-inducing prion fusion induces [PSI+] specifically in [RNQ+] cells but does not 
affect the [RNQ+] prion. 
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Figure 5.6. A hyper-inducing prion fusion induces [PSI+] specifically in [RNQ+] cells but does not 
affect the [RNQ+] prion. 
  
144 
(A) Induction of [PSI+] by the hyper-inducing prion fusion, N-Rnq1-M, confirmed by the red/white 
assay, in which [psi-] colonies are red and [PSI+] are pink or white. Agar plate of yeast cells 
harboring estradiol-inducible N-Rnq1-M grown without estradiol (uninduced, left) and with estradiol 
(induced, right). 
(B) Flow cytometry histograms of the PSI sensor output with and without expression of the hyper-
inducing fusion N-Rnq1-M in a [psi-] [rnq-] strain.  
(C) Flow cytometry histograms of the RNQ sensor output with and without expression of [PSI+]-
inducing factors. 
 
5.8. A high-throughput genetic screen identifies prion-curing alleles 
On account of the many disease-associated protein aggregates 156, 
identifying means to prevent aggregation or remove aggregates is of paramount 
importance. yTRAP coupled with fluorescence-activated cell sorting (FACS) 
enables rapid high-throughput screening of pooled libraries of mutants for rare 
alleles that prevent aggregation in trans. To demonstrate this, we used yTRAP to 
screen for mutant prion alleles that cure [PSI+] and [RNQ+] (Figure 5.7A). We 
mated cells containing libraries of Sup35 and Rnq1 mutants 181 to the respective 
[PSI+] and [RNQ+] yTRAP sensor strains and performed two successive rounds 
of FACS enrichment for highly fluorescent cells. We then isolated and sequenced 
the enriched plasmids (Table S1). We re-tested each prion-curing mutant allele 
by transiently overexpressing it in a [PSI+] [RNQ+] strain harboring the dual prion 
sensor. 
We recovered many of the previously reported prion-curing alleles of 
Sup35 182, including Q10R, Q15R, and Q24R (Figure 5.7B). We also recovered 
several new alleles, notably the first that do not involve the introduction of a 
charged residue: Q61L and the double mutant Y46C, Q95L. 
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The screen for [RNQ+]-curing alleles yielded two variants: Δ288-298, and a 
nonsense mutation resulting in a truncated protein at amino acid 313 (stop313; 
Figure 4C). The Δ288-298 deletion spans an oligopeptide repeat and was 
previously identified as a naturally occurring allele in S. cerevisiae 183. In the 
Yeast Genome Database, 4 of 45 sequenced genetic backgrounds of S. 
cerevisiae possessed this allele. None of the strains harbored the stop313 
mutation, nor any of the discovered Sup35 mutations. Interestingly, following 
transient expression, both of the RNQ1 mutations caused an increase in yTRAP 
signal that did not overlap with the [rnq-] control (Figure 5.7C). These mutants 
heritably remodeled the prion to a more soluble state. A small percentage of the 
population that had overexpressed Rnq1 stop313 were cured of [RNQ+], 
indicated by a small high-fluorescence peak. The Δ288-298 mutation caused an 
overall shift in the population, with a very broad profile indicating a diversity of 
inherited weaker [RNQ+] or [rnq-] states. 
Because these experiments were conducted in the PSI / RNQ dual prion 
sensor, we could evaluate the effect of each variant on the other prion protein as 
well. The wild type Sup35 and the majority of the [PSI+]-curing Sup35 mutants 
also cured [RNQ+] (Figure 5.8). The two exceptions were the double mutant 
S17R, Q56R and the double mutant Q10R, Q24R. Our results illustrate the 
potential of yTRAP to enable high-throughput screens for aggregation-modifying 
factors. 
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Figure 5.7. Prion-curing mutations identified using a high-throughput genetic screen  
(A) yTRAP FACS screen for prion-curing alleles. Two successive rounds of sorting for enriched for 
mutant prion alleles that cure endogenous prions. 
(B) Curing efficiencies of [PSI+]-curing mutants (n=2, error bars, range between duplicates). 
(C) Flow cytometry histograms of yTRAP signal following transient expression of [RNQ+]-curing 
mutants. 
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Figure 5.8. Sup35NM induction cures [RNQ+], but some mutants do not. 
Percentage of cells cured of [RNQ+] after overexpression and recovery of the indicated Sup35NM 
mutant alleles in dual PSI / RNQ sensor strains. Red denotes the allele used in the anti-PSI drive. 
 
5.9. Anti-prion drive systems engineered using prion-curing alleles 
Gene drives are genetic systems that bias the standard Mendelian 
inheritance of a particular gene to increase its prevalence in a population 184. 
Prion-curing mutant alleles offer a unique opportunity to reverse the typical 4:0 
phenotypic inheritance of the [PSI+] and [RNQ+] prions. If a strain is engineered 
to express a prion-curing mutant, it will cure the prion that is present in its mating 
partner instead of acquiring a prion state, and future progeny will not inherit the 
prion (Figure 5.9A). We term this mode of inheritance an “anti-prion drive” (APD), 
as it biases the inheritance of prion phenotypes from 4:0 toward 0:4. 
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We used the Sup35 S17R, Q56R double mutant to construct an “anti-PSI 
drive” due to its efficient and highly selective [PSI+]-curing potential (Figure 5.7B 
and Figure 5.8), and the stop313 Rnq1 mutant to construct an “anti-RNQ drive”. 
We cloned each prion-curing allele or a wild type control into a plasmid with 
strong constitutive expression, and integrated these into the genome of a strain 
harboring the respective yTRAP sensor (Figure 5.9B and C). We then mated 
these strains to the corresponding [PRION+] strain also harboring the yTRAP 
sensor. We selected for diploids, sporulated them, and dissected tetrads to 
determine the segregation frequency of the phenotype (Figure 5.9B and C). 
The anti-PSI drive cured every tetrad of the prion state (“full drive”): spores 
had the same fluorescence as prion-cured controls (Figure 5.9B and Figure 
5.10B). The anti-RNQ drive also caused curing of the [RNQ+] prion, but acted as 
a “semi drive”. The spores that segregated with the APD cassette exhibited 
intermediate yTRAP fluorescence (Figure 5.9C), indicative of acquiring a weaker 
variant of the [RNQ+] prion; these spores could be further cured to a [rnq-] state 
(Figure 5.10D). In contrast, spores that no longer had the anti-RNQ construct 
were completely cured of the [RNQ+] prion, and were not further cured on 
guanidine hydrochloride-containing media (Figure 5.10D). This unusual 
inheritance pattern was confirmed by western blotting for Rnq1 following 
supernatant/pellet fractionation of cell extracts (Figure 5.10E). For both the anti-
PSI and anti-RNQ drives, all dissected tetrads showed the expected 2:2 
segregation of the APD cassette, which allows growth on medium lacking leucine 
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(Figure 5.9B, -Leu). These results suggest a mechanism of [RNQ+] curing by the 
stop313 mutant, whereby the mutant causes a change in the prion conformation 
to one that requires the stop313 Rnq1 protein to propagate. Once that mutant 
allele is removed and only the wild type Rnq1 protein remains, the new prion 
variant is no longer propagated. 
One of the RNQ1 mutant alleles identified in our screen, Δ288-298, is a 
naturally-occurring variant (Figure 5.7). To explore the effect of this natural allele 
when mated with [RNQ+] partners, we tested it in the same context as the drives 
above. Interestingly, we found that this allele did not cure any prions in progeny 
cells, but rather functioned as a “prion-remodeling drive” (RD), capable of altering 
the solubility of Rnq1 in all progeny (Figure 5.10F and G). Specifically, spores 
that did not inherit the Δ288-298 RNQ1 allele were heritably changed to a more 
soluble state of [RNQ+] (Figure 5.10G). Spores that did inherit the drive cassette 
showed an even greater degree of solubility. This process is reminiscent of 
genetic recombination, where two different parental chromosomes are mixed to 
produce a new, diverse haplotype. In an analogous manner, two parents with 
different prion alleles or conformations may interact to produce a new prion 
conformation that was not present in either parent. 
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Figure 5.9. Engineered anti-prion drive systems eliminate prions from mating partners and progeny 
(A) Diagram of typical, dominant prion inheritance (left) and anti-prion drive inheritance (right) 
through mating and sporulation. Rather than 4:0 inheritance typical for [PSI+] and [RNQ+], an anti-
prion drive will cause reversal of this inheritance pattern, resulting in 0:4 segregation (“full drive”) or 
curing of the prion in spores that do not inherit the drive expression cassette (“semi drive”). 
(B) Left: Genetic design of the anti-PSI drive system. The drive strain harbored a PSI sensor and a 
cassette encoding constitutive expression of a [PSI+]-curing allele (Sup35NMAPD=S17R, Q56R). Right: 
Three dissected tetrads after mating the anti-[PSI+] drive strain to a [PSI+] strain. Fluorescence 
images of spores showed the prion state via yTRAP. Wild type Sup35 was used as a negative control 
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in place of the prion-curing mutation. Guanidine curing of the wild type spores (“Cured”) was used 
as a positive control for curing. -Leu media selected for spores containing the drive cassette. 
(C) Left: Genetic design of the anti-RNQ drive system. The drive strain harbored a RNQ sensor and a 
cassette encoding constitutive expression of a [RNQ+]-curing allele (Rnq1APD=stop313). Right: The 
drive eliminated [RNQ+] from spores that do not inherit the drive cassette (“semi drive”). As above 
for Sup35NM, wild type Rnq1 and its guanidine-cured derivatives were used as controls. 
 
Figure 5.10. Anti-prion and prion remodeling drive systems. 
(A) Table of dissected tetrads enumerating spores that exhibited the anti-PSI drive phenotype, 
conferred by either Sup35APD (S17R, Q56R mutant) or wild type Sup35NM control. (APD: anti-prion 
drive). 
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(B) Flow cytometry histograms measuring the [PSI+] state of spores produced by the anti-PSI drive 
and wild type control. Top Left: One set of spores from a single tetrad harboring wild type Sup35NM. 
Bottom Left: Those same spores after treatment with guanidine to test for further curing. Top Right: 
One set of spores from a single tetrad harboring the anti-PSI drive. Bottom Right: Those same 
spores after treatment with guanidine to test for further curing. * denotes spores that inherited the 
drive cassette (LEU+). 
(C) Table of dissected tetrads enumerating spores that exhibited the anti-RNQ drive phenotype, 
conferred by either Rnq1APD (stop313) or wild type Rnq1 control.  
(D) Flow cytometry histograms measuring the [RNQ+] state of spores produced by the anti-RNQ 
drive and wild type control. Top Left: One set of spores from a single tetrad harboring wild type 
Rnq1. Bottom Left: Those same spores after treatment with guanidine to test for further curing. Top 
Right: One set of spores from a single tetrad harboring the anti-RNQ drive. Bottom Right: Those 
same spores after treatment with guanidine to test for further curing. * denotes spores that inherited 
the drive cassette (LEU+). 
(E) Western blot analysis of supernatant/pellet fractions from anti-[RNQ+] drive spores. Total cell 
lysate (T), lysate supernatant (S), or pelleted cell lysate (P) were fractionated for each spore and a 
guanidine-cured control. Rnq1 in its prion state is known to readily pellet, while in the non-prion 
state it remains in the lysate supernatant185.  
(F) Table of dissected tetrads enumerating spores that exhibited the RNQ remodeling drive 
phenotype, conferred by Rnq1RD (Δ288-298). (RD: remodeling drive)  
(G) Flow cytometry histograms measuring the [RNQ+] state of spores produced by the RNQ 
remodeling drive, compared to control [RNQ+] (light gray) and [rnq-] (dark gray) strains. * denotes 
spores that inherited the drive cassette (LEU+). 
 
5.10. Generation of a yTRAP sensor library for RNA-binding 
proteins 
The phenomenon of protein aggregation extends to many areas of biology 
beyond the amyloid-like aggregation observed with yeast prions—from aberrant 
aggregates of disease-associated misfolded proteins to controlled phase 
transitions in cellular droplets. yTRAP has allowed us to overcome challenges 
associated with traditional methods of analyzing yeast prions. We next sought to 
address challenges in studying protein aggregation more broadly with yTRAP. 
The aggregation of RBPs has gained recent attention as a causal agent in 
neurodegeneration 186 and in the formation of functional, membraneless RNP 
bodies 57. To enable quantitative analysis of RBP aggregation, we created a 
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yTRAP sensor library encompassing every known yeast RBP with an 
experimentally confirmed physical interaction with RNA (Table S2), constituting 
~150 sensor strains (Figure 5.12A). We observed that the relative protein 
abundance of these RBP-synTA fusions does not correlate with their yTRAP 
signal (Figure 5.12B), confirming that yTRAP signal is not merely a readout of 
protein concentration. We also determined that none of the RBPs are likely to be 
in a prion state by default in this strain, as transient chaperone inhibition did not 
cause a heritable change in yTRAP signal (Figure 5.12C). With this collected 
panel of sensors, one experiment can quantitatively compare the aggregation of 
each RBP after chemical or genetic perturbation. 
 
5.11. Screening for aggregation propensity of RNA-binding proteins 
We first tested the intrinsic aggregation propensity of each RBP by 
measuring changes in its yTRAP signal upon overexpression of the protein 
(Figure 5.11A). Increasing the concentration of an aggregation-prone protein 
favors its aggregation as per the law of mass action. Hrp1, a component of the 
cleavage and polyadenylation factor (CPF) complex, showed the greatest signal 
loss when overexpressed. We confirmed that this loss of yTRAP signal for Hrp1 
and another top candidate, Ngr1, was accompanied by microscopic foci 
formation (Figure 5.11B). Hrp1 is the closest yeast homolog of human hnRNPA1, 
the aggregation of which is associated with both MSP and ALS 167. Thus, we 
decided to focus on Hrp1 for further analysis. 
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We observed aggregation of Hrp1 during a short burst of overexpression, 
however its sustained overexpression was detrimental to cell growth (Figure 
5.12D). Hrp1 is predicted to possess two separate PrDs (Figure 5.11B), which 
may be responsible for the observed aggregation 53 and toxicity. To test this, we 
deleted each region separately and overexpressed them with fluorescent tags. 
Overexpression of Hrp1 in which the downstream PrD was deleted resulted in 
almost no aggregation or toxicity (Figure 5.11B and Figure 5.12D). In contrast, 
removal of the upstream PrD increased both aggregation and toxicity. 
Furthermore, Hrp1 missing the upstream PrD sequestered endogenous Hrp1 into 
co-localized aggregates (Figure 5.12E) (we confirmed that fluorescent channel 
“bleedthrough” was negligible and not confounding (Figure 5.12F). Thus, the 
upstream PrD acts as a solubilizing element, while the downstream PrD is 
responsible for both aggregation and toxicity. 
Next, we utilized the yTRAP RBP sensor library to identify co-occurring 
aggregates in high throughput. We examined the effect of Hrp1 overexpression 
on every member of the RBP yTRAP sensor library (Figure 5.11C). Top hits that 
aggregated during Hrp1 overexpression were tagged at their endogenous locus 
with mNeonGreen to track their localization. Microscopic imaging showed distinct 
foci formation of Nsr1, Cbf5, and Nop58 – all factors involved in ribosome 
biogenesis – upon Hrp1 overexpression (Figure 5.11D). These results 
demonstrate that yTRAP can be used to efficiently identify proteins and pathways 
that are perturbed upon a proteotoxic stress without a priori knowledge. 
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Figure 5.11. Hrp1 is a particularly aggregation-prone RBP that can induce the aggregation of others 
(A) A screen for the aggregation propensity of yeast RBPs. Top: Diploids were formed to 
overexpress each RBP in a strain that detects its own yTRAP signal. Bottom left: Heat map of 
aggregation propensity. Bottom right: Bar chart of the top hits (n=4, error bars, SD). 
(B) Microscopy of aggregation-prone RBPs. Top: Overexpression of mKate2-tagged Ngr1 and Hrp1 
compared to an untagged mKate2 control. Middle: The domain architecture of Hrp1. Q/N-rich 
domains resembling prion domains (PrDs) are indicated by purple boxes. Bottom: Microscopy of 
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overexpressed, mKate2-tagged Hrp1 harboring the indicated deletions of upstream or downstream 
PrDs. Scale bar=10 μm. 
(C) High throughput measurement of RBP aggregation in response to Hrp1 overexpression. Left: 
Diploids were formed to overexpress Hrp1 in each yTRAP RBP sensor. Right: Bar chart of the 
sensor strains showing the most significant aggregation hits in response to Hrp1 overexpression 
(n=3, error bars, SD). 
(D) Microscopy of Hrp1-induced aggregation. Indicated proteins were tagged with mNeonGreen at 
their endogenous locus for visualization. Sof1, which showed no change in yTRAP signal following 
Hrp1 overexpression, was used as a negative control. Uninduced and induced fluorescent images 
for each RBP were identically contrast-scaled. White arrows indicate foci. Scale bar=5 μm. 
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Figure 5.12. A library of RBP yTRAP sensors and deletion analysis of aggregation-prone RBP, Hrp1 
(A) Fluorescent photographs of the RBP sensor library. Each strain was spotted on an agar plate 
and grown two days before imaging. Indicated in red boxes are [RNQ+] and [rnq-] controls and a 
control lacking the yTRAP fusion, harboring only the mNeonGreen reporter cassette (reporter only).  
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Figure 5.12. A library of RBP yTRAP sensors and deletion analysis of aggregation-prone RBP, Hrp1 
(A) Fluorescent photographs of the RBP sensor library. Each strain was spotted on an agar plate 
and grown two days before imaging. Indicated in red boxes are [RNQ+] and [rnq-] controls and a 
control lacking the yTRAP fusion, harboring only the mNeonGreen reporter cassette (reporter only).  
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(B) Quality control on a representative set of RBP sensors. Left: Four different colonies were 
patched onto fresh plates after transformation of each yTRAP plasmid. Photographs of the resulting 
patches were collected in the green fluorescent channel. Right: Western blots of cell lysate from 
each colony were conducted against the HA epitope, present on the synTA of the yTRAP fusion. 
Ponceau S stain was used as a loading control (bottom). The same process was conducted for every 
RBP sensor strain (data not shown). 
(C) yTRAP fluorescence of RBP sensors during treatment with chaperone inhibitors and subsequent 
recovery. Each member of the library was subjected to transient genetic inhibition of Hsp104 and 
Hsp70 via the induction of a dominant-negative allele. Radicicol was used to transiently inhibit 
Hsp90. 
(D) Determination of toxicity during overexpression of Hrp1 or deletion mutants. Yeast growth was 
measured by absorbance at 600nm every 15 minutes. Top: Growth curves without induction of Hrp1 
or indicated mutants. Bottom: Growth curves during overexpression of wild type Hrp1 (red), 
Hrp1Δ32-146 (light purple), Hrp1Δ332-409 (dark purple), or mKate2 (gray) as a negative control (n=6, 
error bars, SD).  
(E) Microscopy of endogenous Hrp1 with (right) and without (left) Hrp1Δ32-146 overexpression. Top: 
Black-and-white image of the green fluorescent channel detecting endogenously-tagged Hrp1-
mNeonGreen. Bottom: Overlay of green (endogenous Hrp1-mNeonGreen) and red (Hrp1Δ32-146-
mKate2) fluorescence channels. Uninduced and induced fluorescent images were identically 
contrast-scaled. Scale bar = 10 μm. 
(F) Analysis of red to green fluorescence channel bleed-through. Ngr1-mKate2 was overexpressed in 
a strain harboring no other fluorescence construct. Micrographs were collected in red (top) and 
green (bottom) fluorescence channels to test the extent to which red fluorescence from an 
overexpressed, aggregating protein bleeds in to the green channel. Scale bar = 10 μm. 
 
 
 
5.12. Genome-wide screen for modulators of Hrp1 aggregation 
 We hypothesized that the cell may utilize the ability of Hrp1 to 
aggregate as a natural way to modulate its function. We therefore conducted a 
genome-wide overexpression screen in the context of the Hrp1 yTRAP sensor to 
identify genes that could be involved in this pathway and affect Hrp1 aggregation.  
We used an estradiol-inducible system to express all yeast ORFs in the 
FlexGene library, over 5,500 in total 187. We mated each overexpression strain 
with the Hrp1 yTRAP sensor in an arrayed format, and measured the change in 
yTRAP signal (Figure 5.13A). 
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We subsequently validated hits that we identified as reducing the Hrp1 
yTRAP signal by more than three standard deviations (Figure 5.14A-C and Table 
S3). Nab2 emerged as the most potent inducer of Hrp1 aggregation that also 
caused no change in total levels of Hrp1 (Figure 5.14B and C). Fluorescence 
microscopy of overexpressed Nab2-mKate2 and endogenous Hrp1 (tagged with 
mNeonGreen) showed strong aggregation and co-localization of both proteins 
(Figure 5.13B). In contrast to the toxicity of Hrp1 aggregation induced by its own 
overexpression (Figure 5.12D), Nab2 overexpression led to non-toxic Hrp1 
aggregation (Figure 5.14D). This effect is specific for Hrp1 and Nab2 
overexpression had no effect on two physical interactors of Hrp1 in the CPF 
complex, Rna14 and Rna15 (Figure 5.14E). 
Hrp1 binds UA-rich elements in transcribed mRNAs and aids in orienting 
the CPF complex to proper mRNA cleavage/polyA sites. We therefore predicted 
that Nab2-induced aggregation of Hrp1 could affect its function and cause an 
alteration in 3’ mRNA cleavage sites, and thus their 3’ UTR lengths. To test this 
prediction, we chose eight genes that have been reported to generate transcripts 
harboring variable 3’ UTRs 188, 189 and assessed their 3’ UTR length with and 
without Nab2 overexpression. Indeed, five of these transcripts had differential 
cleavage patterns (Figure 5.13C). These results suggest that Nab2 
overexpression can sequester Hrp1 and lead to a change in its activity. 
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Figure 5.13. A genome-wide screen identifies Nab2 as a potent inducer of Hrp1 aggregation, 
perturbing its 3’ UTR processing function 
(A) A genome-wide screen for factors that influence Hrp1 aggregation. Top: The Hrp1 yTRAP sensor 
strain was mated in arrayed format to an inducible library comprised of nearly every yeast ORF. 
Bottom: Fold-change in Hrp1 yTRAP signal following induction of each ORF, ranked from lowest to 
highest.  
(B) Microscopy of endogenous Hrp1 with (right) and without (left) Nab2 overexpression. Top: Nab2-
mKate is visualized in the red fluorescent channel. Middle: Endogenous Hrp1 was tagged with 
mNeonGreen and visualized in the green fluorescent channel. Bottom: Green and red channels 
overlay. Uninduced and induced fluorescent images were identically contrast-scaled. Scale bar=10 
μm. 
(C) The effect of Nab2 overexpression on 3’ cleavage of selected mRNAs. Top: Primers were 
designed to amplify from the end of each ORF to the start of the polyA tail, amplifying the entire 3’ 
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UTR. A control primer pair amplified a 250 base pair region inside the ORF. Bottom: Agarose gel 
electrophoresis of PCR reactions from strains with or without Nab2 overexpression. New bands or 
altered band intensities are marked with red arrows. 
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Figure 5.14. Validation of hits from genome-wide screen for factors that modulate the aggregation of 
Hrp1 
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(A) Comparison of the expression level of hits following estradiol induction. The top eleven hits that 
decreased Hrp1 yTRAP signal without altering its steady-state level were tagged with mKate2 and 
induced with estradiol. Red fluorescence was measured using flow cytometry to determine the total 
level of induction (n=2, error bars, SD).  
(B) Retesting effects of genome-wide screen hits on Hrp1 steady-state levels and yTRAP signal. 
mKate2-tagged proteins were overexpressed in either Hrp1 yTRAP sensor strains or strains 
harboring an endogenous Hrp1 mNeonGreen tag. Flow cytometry was used to measure fluorescence 
before and after induction, and fold-change was calculated. Fold change of the Hrp1 yTRAP sensor 
is shown in green. Fold change of steady-state levels of Hrp1 is shown in black (n=2, error bars, 
range). 
(C) Flow cytometry on Nab2 overexpression. Red fluorescence generated by Nab2-mKate2 is plotted 
on the x-axis. Top: Green fluorescence due to an mNeonGreen tag on endogenous Hrp1 is plotted 
on the y-axis to track changes in steady-state levels of Hrp1. Bottom: Hrp1 yTRAP signal is plotted 
on the y-axis to track changes in Hrp1 aggregation. Uninduced samples are colored gray. Samples 
overexpressing Nab2-mKate2 are colored red. 
(D) Determination of toxicity when overexpressing Nab2. Yeast growth was measured by absorbance 
at 600 nm every 15 minutes. Red denotes Nab2-mKate2-expressing cells. Gray denotes mKate2-
expressing control cells (n=6, error bars, SD). 
(E) Comparing Nab2-induced aggregation of itself and CPF complex members Hrp1, Rna15, and 
Rna14. Nab2-mKate2 (green) or mKate2 (control, black) was overexpressed in the indicated yTRAP 
sensor strains. The fold-change in soluble protein measured by flow cytometry on yTRAP signal is 
plotted (n=3, error bars, SD). 
 
 
5.13. Discussion 
5.13.1. yTRAP: a genetic, high-throughput tool for protein 
aggregation 
We have developed a modular, genetic tool that enables quantitative 
monitoring of cellular aggregates. yTRAP represents a significant advance over 
existing methods to assay protein aggregates on account of its simplicity, 
sensitivity, speed, and low cost. A key advantage is the capability to design high-
throughput screens on protein aggregation phenomena. As we demonstrated, 
there are many possible modes of screening. Large panels of sensors can be 
generated to screen for aggregation or solubilization in response to genetic or 
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other perturbations; alternatively, one can screen the effects of entire genomes 
on the aggregation of individual sensors. We envision these studies could be 
further scaled up to screen large libraries of yTRAP sensors against large 
libraries of genetic or chemical perturbations. In this manner, networks of 
aggregation and assembly interactions can be mapped out to give a 
comprehensive view of the cellular “aggregome”. 
 yTRAP features a synthetic biology design that couples protein 
solubility to transcriptional activity. This excludes certain proteins, such as 
integral membrane proteins, from compatibility with the current system. Yet, an 
advantage of the modular design is that it enables a standard framework for all 
aggregation events, circumventing the need to construct novel assays for each 
protein of interest. Outputs can be customized with desired genetic or enzyme-
based reporters. yTRAP functionality does not rely on genetic background, 
specific growth media, or additional reagents. Moreover, yTRAP is an in vivo tool 
and so does not introduce artifacts associated with lysis or reconstitution of 
components out of a cellular context. Finally, the orthogonal components of 
yTRAP should be readily portable to cells of other species. We envision that the 
generation of transgenic animals containing yTRAP sensors will eventually 
enable the detection and tracking of aggregation in live animal models. 
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5.13.2. Probing yeast prions and modulating prion switching 
Prion-like mechanisms serve diverse cellular functions in many organisms 
190. We used yTRAP to study yeast prions and uncovered several new insights. 
First, we constructed the first hyper-inducing prion fusion that is able to convert 
the each cell to the prion state after transient induction. This demonstrates that 
prion nucleation can be deterministically controlled. As more prion-like elements 
continue to be discovered, it will be interesting to see whether there exists any 
similar cross-seeding behavior that may act as natural mechanisms for cellular 
memory. Second, by screening large libraries of random mutants, we identified 
many prion-curing alleles that are able to cure wild type prions in trans. Third, we 
found that a naturally-occurring RNQ1 allele, Δ288-298 183, can remodel the wild 
type prion after transient exposure. This “protein conformation recombination” 
process could occur in nature to generate additional phenotypic diversity and 
enhance adaptation in yeast. Similar processes could be at work in humans as 
well – a natural allele of the human prion protein, PRNP, appears to be protective 
against prions and grants immunity to prion disease in mice 191. It will be exciting 
to test more broadly how various alleles and even separate protein components 
of prion-like assemblies affect their conformations. 
 
  
166 
5.13.3. Probing the RNA-binding protein aggregome 
The speed and ease with which quantitative data can be collected using 
yTRAP combined with genetic screens in yeast makes it an unparalleled platform 
for discovery in both pathological and functional aggregation. A 
disproportionately high number of RBPs in the yeast and human genome contain 
low complexity domains that resemble the amyloid forming regions of prions 57. 
The functions and interactions of these low complexity domains have remained 
mysterious. Mutations in low complexity sequences have emerged as causal 
factors in neurodegenerative diseases including ALS and MSP 167. Recently, 
several ground-breaking papers have demonstrated that these low complexity 
domains function in phase transitions or liquid-liquid phase separations in the cell 
169, 192. 
We are only beginning to understand the difference between functional 
aggregation and its harmful counterpart. This is partly because we lacked 
quantitative in vivo assays of aggregation. Herein we demonstrated that yTRAP 
can serve as a platform for deciphering aspects of this biology. We performed an 
unbiased screen for RBP aggregation propensity. The top hit was Hrp1, the 
homolog of hnRNPA1 in humans for which aggregation is associated with MSP 
and ALS. Both hnRNPA1 and Hrp1 harbor tandem RNA recognition motifs 
followed by a low complexity region and a PY (Pro-Tyr) nuclear import sequence. 
Additionally, both of these proteins shuttle in and out of the nucleus and 
aggregate almost exclusively in the cytoplasm, similar to other disease-causing 
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RBPs, such as TDP-43 and FUS 167. Furthermore, pathogenic mutations have 
been identified in the low complexity regions and nuclear localization sequences 
for both TDP-43 and FUS. Thus, Hrp1 may resemble its human homologs not 
only functionally, but also in its mode of aggregation and toxicity. 
We used several yTRAP screening techniques to interrogate Hrp1 
interactions. We examined the consequences of Hrp1 overexpression across the 
RBP yTRAP library and found that proteins involved in ribosome biogenesis 
(Nsr1, Nop58, Cbf5) became aggregated. This could be indicative of natural 
cross-talk or co-assembly of these proteins with Hrp1 as part of their normal 
function or regulation. The same screening methodology can be applied to any 
aggregation-prone protein of interest to identify putative interaction partners. We 
also performed a genome-wide overexpression screen to identify genes that 
could modulate Hrp1 aggregation. We observed that Nab2 can induce Hrp1 
aggregation in a non-toxic manner with biological consequences, causing 
alterations in mRNA cleavage. Considering that these altered processing events 
elicited no growth defects, an interesting possibility to consider is that Nab2-
induced Hrp1 aggregation occurs naturally to regulate its activity and lead to a 
different set of 3’ UTR processing sites. 
 
5.13.4. yTRAP and prion synthetic biology 
In addition to facilitating new studies and screens for protein aggregation, 
we propose yTRAP as a platform for synthetic biology, enabling programmable 
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cellular devices to be constructed using prions. To demonstrate this capability, 
we produced two types of prion-based devices: a synthetic memory device and 
anti-prion drives. 
We demonstrated that a yeast cell can produce and store the memory of 
heat. Prions have a number of advantages over existing synthetic methods to 
store information in cells. Their background switching rate can be very low – 
without overexpression, the spontaneous induction of the [PSI+] prion is 
approximately 10-7  193, on the order of DNA mutations, allowing for high-fidelity 
storage of information. Furthermore, prion domains can be designed de novo 194, 
allowing for the potential expansion to many orthogonal prion memories. yTRAP 
screens could assist in the selection of multiple orthogonal prion domains and 
specific prion-switching genes. Using dual or further multiplexed yTRAP, a 
different function could be assigned to each prion switch. This could allow for a 
rapid expansion in available tools for the construction of complex cellular 
devices. The input could be reprogrammed using promoter-based logic to detect 
other desired stimuli, for example environmental contaminants. The output of 
yTRAP is also fully programmable – any gene could be used to report on the 
prion-encoded memory. 
Anti-prion drives are capable of regulating and curing prion propagation in 
wild type populations. Just as gene drives bias the inheritance of DNA so that the 
drive itself is inherited at an increased frequency 184, phenotypic drives increase 
the rate at which a phenotype is inherited by progeny. Yeast prions inherently act 
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as phenotypic drives, converting other proteins of the same kind to their own self-
templating conformation and being inherited by all meiotic progeny. The diverse 
phenotypes conferred by microbial prions could be controlled using anti-prion 
drives. As more prions are discovered and designed de novo, the toolkit of 
synthetic biology components will grow. 
 
5.13.5. Concluding remarks 
It is becoming increasingly clear that protein aggregation plays key roles in 
cellular processes, as wide ranging as disease initiation and progression, 
signaling, and evolution. yTRAP serves both as a means for engineering new 
tools and a platform for discovery in natural aggregation phenomena. 
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5.16. Methods 
Contact for Reagent and Resource Sharing 
Further information and requests for resources and reagents should be directed 
to and will be fulfilled by the Lead Contact, Ahmad Khalil (khalil@bu.edu). 
 
Experimental Model and Subject Details 
Saccharomyces cerevisiae strains used in this study are described in Table S5. 
Unless otherwise stated, strains were grown with shaking at 30oC in standard 
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growth media. YPD was 1% yeast extract, 2% peptone, 2% glucose. Complete 
supplement mixture (CSM) media and CSM drop out media was purchased from 
Sunrise Science Products and made up as per their instructions, supplemented 
with 6.7g/L yeast nitrogen base and 2% glucose unless otherwise stated. 
 
Method Details 
Cloning and vector construction 
Plasmids used in this study are listed in Table S4. The basic yTRAP 
plasmid pGAN147 was constructed by PCR and subsequent Gibson assembly of 
components into pDML112 195 (Figure 5.2A). Gateway cloning was used to insert 
genes-of-interest into pGAN147 to form yTRAP fusions. Gateway cloning was 
also used to insert genes, such as mutant prion-curing alleles, into pAG-series 
vectors 196 and their derivatives. 
Reverse-yTRAP and dual yTRAP plasmids were constructed with 
standard cloning techniques and Gibson assembly. Reverse-yTRAP required a 
TetR-repressible promoter (Figure 5.4A). To obtain a suitable promoter, we 
generated and screened a small panel of nine variant promoters. Each variant 
was created by inserting tetO2 sites at the vicinity of promoter control elements 
such as TATA-box, transcription factor binding sites and the transcriptional start 
site of the S. cerevisiae ADH1 promoter. [RNQ+] and [rnq-] yeast strains carrying 
the tetR-mKate2 yTRAP circuit (pGAN230) were used to screen this panel, and 
the promoter with the greatest dynamic range was selected for use (pSK221). 
To enable dual yTRAP, we constructed a second yTRAP sensor plasmid 
using a second engineered zinc finger and its paired DNA binding site 20 (Figure 
5.4C). This second plasmid was generated from pGAN147, exchanging sites of 
homology from the HO locus to the LEU2 locus to re-target the integration, and 
NATr resistance for KanMX. 
Prion-inducing fusions were generated by PCR and subsequent Gibson 
assembly into the estradiol-inducible plasmid pHES835 (Aranda-Díaz et al., 
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2016). pJMB101 harbors the estradiol-responsive transcription factor composed 
of the chimeric ZEM regulator (Zif268 - Estradiol Receptor ligand binding domain 
- Msn2 activation domain) 97. For heat-inducible expression, the estradiol-
responsive promoter was swapped for the SSA4 promoter by standard cloning 
techniques. 
RBP yTRAP sensors were constructed using Gateway cloning. Individual 
plasmids were prepared from the yeast MORF collection (movable ORF; GE 
Dharmacon, Cat# YSC3867) and cloned into the yTRAP destination plasmid 
pGAN147. The 48 genes that were not available in the MORF collection were 
amplified from the yeast genome by PCR and cloned separately. 
Estradiol-inducible Hrp1 was constructed using pHES835 as above and 
induced using the ZEM regulator. To induce the GAL1 promoter using estradiol, 
as was done for the aggregation propensity screen and genome-wide screen for 
modulators of Hrp1 aggregation, the GEM regulator (Gal4 DNA binding domain - 
Estradiol Receptor ligand binding domain - Msn2 activation domain) was used 
instead 97.  
 
Yeast strains and growth conditions 
 Yeast strains used in this study were primarily derived from YJW508 
(MATα, leu2-3,112; his3-11,-15; trp1-1; ura3-1; ade1-14; can1-100; [PSI+]; 
[RNQ+]), YJW584 (MATa, leu2-3,112; his3-11,-15; trp1-1; ura3-1; ade1-14; can1-
100; [psi-]; [RNQ+]) 173, and standard laboratory W303 (MATα, leu2-3,112; his3-
11,-15; trp1-1; ura3-1; ade2-1; can1-100; [psi-]; [RNQ+]). A complete list of strains 
generated in this study is shown in Table S5. Growth media was complete 
supplement mixture (CSM) media or CSM lacking certain amino acids with either 
2% glucose, 2% galactose, 2% raffinose, or 2% glycerol supplemented as the 
carbon source (glucose was used unless otherwise specified below). YPD plates 
used for prion curing contained 5 mM guanidine hydrochloride. Media was 
supplemented with 50 µg/mL adenine hemisulfate (Sigma Aldrich, A9126) to 
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eliminate the color of ade- cells, which otherwise interferes with fluorescence 
readings. Yeast transformations were conducted using a lithium acetate 
competent cell protocol as previously described 197. 
The construction of variant [PSI+] strains in W303, [PSI+] in 74D-694 
(MATa ade1-14 leu2-3,112 ura3-52 trp1-289 his3-200) 198, and [PSI+] in 10B-
H49a (MATa ade2-1 SUQ5 lys1-1 his3-11,15 leu1 kar1-1 ura3::KANMX) 199, 
which were used to characterize the sensor, was done as follows: Strains were 
cured of all prions by passing cells on rich media containing 5 mM guanidine 
hydrochloride. Prion loss was verified by mating strains to [psi-] tester strains 
carrying a copper-inducible Sup35NM-GFP plasmid. Diploids containing diffuse 
fluorescence after a four-hour incubation with 50 µM CUSO4 verified that the 
original strains did not contain [PSI+]. Prion variants were introduced into recipient 
strains through cytoduction. To generate cytoductants, the above recipient 
strains were made rho0 by streaking cells on rich media containing 10 µg/ml 
ethidium bromide and verified by no growth on glycerol-containing media. 
Recipient strains were mated in excess to the donor strain (C10B-H49a: Matα 
SUQ5 ade2-1 lys1-1 his3-11,15 leu1 kar1-1 cyhR) 199 that contained the 
appropriate prion variant and a defective kar1 allele, which inhibits nuclear 
fusion. Cytoductants were distinguished from donor or diploids by the presence 
of auxotrophic markers, ability to mate to MATa strains, and growth on media 
containing glycerol as the sole carbon source. The presence of [PSI+] or [RNQ+] 
were confirmed by the presence of cytoplasmic aggregates using tester strains. 
The [PSI+] strains were also confirmed to display a change in color on rich media 
and grow on SD-Ade media. 
 Endogenous tagging of yeast genes with mNeonGreen was achieved by 
homologous recombination with long homology regions (~300 bp) generated by 
PCR, as previously described 195. mNeonGreen was amplified with a NAT 
resistance cassette and assembly PCR was used to add the relevant homology 
regions at the terminus before transformation. Proper integration was confirmed 
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by colony PCR. 
 
Flow cytometry 
Cells were diluted 100-fold from overnight cultures in CSM media into 
fresh media, and incubated 6 hours at 30°C to reach exponential growth before 
measurement. Unless otherwise stated, 10,000 – 50,000 events were acquired 
using a MACSQuant VYB cytometer with a 96-well plate platform (Miltenyi 
Biotech), and data was processed using FlowJo. Events were gated by forward 
and side scatter, and median fluorescence values were calculated. In order to 
exclude dead cells from analysis, 10 ug/mL propidium iodide (Sigma Aldrich Cat. 
No. P4864) or 1 ug/mL DAPI (Roche Diagnostics Cat. No. 10236276001) stain 
was used. The B1 channel (525/50 filter) was used to measure green 
fluorescence. The Y3 channel (661/20 filter) was used to measure red 
fluorescence or propidium iodide stain. The V1 channel (450/50 filter) was used 
to measure DAPI. 
 
Western blotting and densitometry 
1OD unit of log phase cells were collected by centrifugation and protein 
was extracted with the following TCA extraction method. Cells were resuspended 
in 1 mL dH2O, followed by the addition of NaOH to a final concentration of 0.25 M 
and 2-mercaptoethanol to a concentration of 1% (v/v), and were incubated on ice 
15 minutes. TCA was added to a concentration of 6.5% (w/v) and samples were 
incubated a further 10 minutes on ice before centrifugation at 12,000 rcf to collect 
precipitated protein. Precipitate was dissolved in HU buffer (200 mM Tris HCl pH 
6.8, 8 M urea, 5% SDS, 1.5% DTT, bromophenol blue) and incubated at 65oC for 
approximately one hour.  
Samples were separated by SDS-PAGE and transferred to nitrocellulose 
membranes using the Invitrogen iBlot2 (7-minute transfer). For primary 
antibodies, Santa Cruz Mouse monoclonal anti-HA (sc-7392) was used to blot 
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against the 6xHA epitope on the synTA. Rabbit polyclonal anti-PGK1 
(ABIN568371; antibodies-online.com) was used as a loading control. For 
fluorescent secondary antibodies, LI-COR IRDye 800CW donkey anti-mouse 
(product 926-32212) and LI-COR IRDye 680RD donkey anti-rabbit (product 926-
68073) were used. Blots were imaged with the LI-COR Odyssey system. Band 
quantification / densitometry was performed using the Image Studio Lite 
software. 
 
SDD-AGE 
SDD-AGE was adapted from previous protocols 170. Saturated 4mL 
cultures of yeast grown in YPD were centrifuged and resuspended in 250 µL of 
lysis buffer (100mM Tris pH 8.0, 20mM NaCl, 10mM beta-mercaptoethanol, 1:50 
diluted protease inhibitors (Fisher xyz), 0.025 units/µL benzonase). 
Approximately 250 µL of acid-washed beads were added, and samples were 
lysed by bead-beating in a QIAgen sample lyser (10 minutes, 60Hz) using frozen 
tube holders. Supernatant was collected after a 5 minute centrifugation at 500 
rcf, 4oC. 4x sample buffer (2xTAE, 20% glycerol, 8% SDS, bromophenol blue) 
was diluted 4-fold into lysate, incubated at room temperature for 4 minutes, and 
loaded into SDD-AGE gels (1.5% agarose, 1x TAE, 0.1% SDS). Gels were run 
for 4-6 hours at 40 volts, and transferred to nitrocellulose membranes by 
overnight liquid transfer. Membranes were treated as western blots above. Santa 
Cruz Mouse monoclonal anti-HA (sc-7392) was used as the primary antibody, 
and Sigma Aldrich HRP-conjugated rabbit anti-mouse IgG (A-9044) was used as 
the secondary antibody. 
 
Agar plate fluorescence photography 
Photographs were collected using a Bio-Rad Chemi-Doc MP. Colonies 
were grown for 2 days at 30oC on agar yeast CSM plates and imaged on the 
second day. For green fluorescence, the blue LED was used for excitation, and 
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the 530/28 nm filter for emission. For red fluorescence, the green LED was used 
for excitation, and the 605/50 nm filter for emission. The Bio-Rad Image Lab 
software was used for false-coloring. Overlays were assembled using the 
transparency parameter in Adobe Photoshop. 
 
Epifluorescence microscopy 
Epifluorescence images of Sup35 yTRAP sensors were taken at 100x 
magnification (Plan Apo 100x oil objective, NA 1.4) using an Eclipse Ti-E inverted 
microscope (Nikon Instruments, Inc.). Images were acquired in DIC and in 
fluorescent (GFP) channels. Filters and light sources were automatically 
controlled by the supplier’s software (NIS-Elements Advanced Research).  
For microscopy on induced / uninduced RBPs the following protocol was 
used: overnight cultures were diluted into CSM media at OD = 0.1 and grown for 
2 hours at 30oC prior to induction with 100 nM estradiol. Induction was continued 
for at least 4 hours before imaging. Cells were imaged live within ten minutes of 
their preparation on glass slides. Epifluorescence images were taken at 100x 
magnification (Plan Apo Lambda 100X oil objective, NA 1.45) using an 
Eclipse Ti-E inverted microscope and a CCD camera (Andor technology). Bright 
field (BF) images were collected along with images in green and red 
fluorescence channels. Images were processed with ImageJ, and linear intensity 
transformations were set identically for induced and uninduced samples. 
 
Fluorescence plate reader measurements 
Measurements were performed using an Infinite M1000 PRO microplate 
reader (Tecan Group Ltd.). Cells were grown to saturation in CSM media. 200 µL 
of triplicate saturated cultures were added to clear-bottom, flat, black microtiter 
plates (Corning Product #3631). Absorbance at 600 nm was collected to 
measure cell density, raw fluorescence (ex. 488/5 nm, em. 520/5 nm) was 
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collected to measure yTRAP signal, and fluorescence was calculated by 
normalizing raw fluorescence by absorbance. 
 
Isolation of Swi1, Mot3-PrD, and New1-PrD prion states 
 Galactose-inducible plasmids for Swi1, Mot3-PrD, and New1-PrD were 
introduced into sensor strains for the same protein. Cells were grown overnight in 
CSM ura drop-out media supplemented with galactose to induce expression. 
Subsequently, cultures were plated on glucose agar plates. Colonies on agar 
plates were photographed in the green fluorescent channel to assess prion state. 
Low-fluorescence colonies were picked and streaked for further testing. Colonies 
were confirmed to contain a prion by streaking on guanidine hydrochloride plates 
– those that were cured and returned to a bright fluorescent state were [PRION+] 
switched cells. 
 
Relative aggregation measurement 
To measure relative aggregation of Htt-Q25 and Htt-Q103 (Figure 5.2G), 
triplicate sensor strains for each protein (yGAN016-017) were diluted 100-fold 
from overnight CSM media cultures and grown for 6 hours at 30oC. yTRAP signal 
was measured by flow cytometry. Relative aggregation was calculated as the 
average of the least-aggregated samples divided by each sample: Relative 
aggregation = (average Htt-Q25 yTRAP signal) / (yTRAP signal). 
To measure relative aggregation of Q-/N-rich proteins in response to Htt 
overexpression (Figure 5.1E), yTRAP sensor plasmids for these protein domains 
were transformed into cells containing integrated galactose-inducible Huntingtin 
exon 1 harboring 103 glutamine residues (Htt-Q103) or into an identical strain 
lacking Htt-Q103 overexpression constructs (producing yGAN018-029). Triplicate 
cultures were grown overnight to saturation in CSM media containing raffinose as 
a carbon source. The following day, each strain was diluted 50-fold into raffinose 
media and, separately, media containing galactose to induce Htt-Q103. Cells 
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were grown for 6.5 hours at 30oC and then fluorescence was measured by flow 
cytometry. Aggregation in Htt-Q103-induced samples was calculated by dividing 
median fluorescence of each strain in raffinose by median fluorescence in 
galactose. To normalize for the effect of carbon source, the raf/gal ratio of Htt-
expressing cells was divided by the raf/gal ratio of control cells, yielding the final 
relative aggregation value: Relative aggregation = (yTRAP signal of Htt-
expressing cells in raffinose / yTRAP signal of Htt-expressing cells in galactose) / 
(yTRAP signal of no-Htt cells in raffinose / yTRAP signal of no-Htt cells in 
galactose). 
 
Guanidine-curing time course 
The dual PSI / RNQ sensor strain (ySK293) was diluted to OD 0.001 into 
triplicate 50 mL cultures of CSM media with 5mM guanidine hydrochloride. The 
zero time point negative control was diluted to OD 0.001 without guanidine 
hydrochloride. After 12 hours of shaking at 30oC in 500 mL baffled flasks, 50 µL 
samples were collected from each of the curing flasks and diluted 100-fold into 5 
mL of fresh CSM medium lacking guanidine hydrochloride to halt prion curing. 
Additional samples were collected every two hours until 22 hours after guanidine 
treatment started. In addition to collecting final, 22-hour samples by dilution into 
medium lacking guanidine hydrochloride, samples were also diluted 100-fold into 
fresh media containing 5 mM guanidine hydrochloride to continue curing. The 
following day, after a total of 36 hours of growth, all samples had grown to 
stationary phase and were diluted another 100-fold in fresh medium lacking 
guanidine hydrochloride. After 6 hours of growth, the prion status was assessed 
by flow cytometry as described above, gating to distinguish populations of prions. 
One recovered culture that had been treated with guanidine hydrochloride for 16 
hours was spread on an agar plate for photography.  
 
Inducing [PSI+] with transient expression of prion fusions 
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Duplicate colonies harboring estradiol-inducible prion domains and fusions 
were picked into 500 µL of non-inducing CSM media and grown overnight at 
30oC with shaking in a deep-well 96 well plate. Saturated cultures were diluted 
100x into 500 µL CSM media with or without 100 nM estradiol. After 24 hours of 
growth, cultures were centrifuged 5 min at 2000 rcf, and media was beat off. 
Cultures were resuspended in 500 µL of fresh media, then diluted 100x into non-
inducing media and grown 24 hours further. Cultures were then diluted 100-fold 
and grown 6 hours to reach log phase before measurement by flow cytometry to 
assess prion state. This allows for 8 to 12 generations of growth in non-inducing 
conditions, so that only heritable changes in prion state were assessed. 
 
Heat induction and memory experiments 
 Cultures were grown at 25oC in CSM media. Cultures were pre-screened 
with flow cytometry for background switching because of leakiness of the SSA4 
promoter. Only [psi-] cultures were used in the experiment. Saturated cultures 
were diluted to OD600 of 0.02 in 96-well PCR plates. Cultures were grown for 4 
hours at 25oC, then transferred to an Eppendorf PCR instrument (Mastercycler 
Pro) incubating a gradient of temperatures for 2 hours. After heat treatment, 
samples were returned to 25oC for overnight growth. The next day, cultures were 
diluted 1000x into fresh media and grown 24 hours at 25oC. After this, cultures 
were diluted 100x further into fresh media and grown 6 hours at 25oC to log 
phase before flow cytometry measurement as above to assess prion state. 
 
Selection of prion-curing alleles 
We used a previously described variomics library 181. The mutant libraries 
for Sup35 and Rnq1 were grown and sporulated in liquid media. To sporulate, 
diploids were inoculated to a final OD600 of 0.5 in 50mL of sporulation media (1% 
potassium acetate, 0.005% zinc acetate). They were incubated with shaking for 5 
days at 25oC. MATa spores containing the mutant plasmid and chromosomal 
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deletion were selected by growing in liquid media (CSM media -arg-his-leu-ura + 
60 ug/mL canavanine + 200 ug/mL G418, supplemented with glucose) for 5 
generations. For each step, at least 2 million viable cells were used to maintain 
10-fold coverage of the theoretical diversity of 200,000 mutants. The libraries of 
mutant SUP35 or mutant RNQ1 spores were mated with the respective Sup35 or 
Rnq1 sensor strains harboring the [PSI+] and [RNQ+] prions. 6 million mutant 
spores were mixed with 2-fold excess of yTRAP sensor cells to mate. These 
were plated on YPD agar plates and incubated at 30oC for 16 hours. Cells were 
then scraped from the plate and collected in dH2O. Aliquots were plated on 
diploid- and haploid-selective media to determine the mating efficiency. Diploid 
selective media was CSM media lacking uracil +100 µg/mL nourseothricin + 200 
µg/mL G418, supplemented with glucose (nourseothricin selects for the yTRAP 
sensor, G418 selects for the chromosomal deletion, media lacking uracil selects 
for the mutant plasmid covering the chromosomal deletion). Haploid selective 
media was CSM media -his-leu-ura+200 µg/mL G418, supplemented with 
glucose. Diploid cells containing both the mutant plasmid and the yTRAP sensor 
were present in larger numbers than haploids containing only the mutant 
plasmid, so we estimated that mating was greater than 50% efficient. The pool of 
scraped cells was diluted in diploid-selective media and grown 6 hours to OD 1.0. 
At this point, cells were diluted 100-fold into diploid-selective media and grown a 
further 13 hours until FACS sorting (OD ~ 1.0). 
FACS sorting was performed using a FACS Aria II (BD Biosciences). The 
top 0.005% of most fluorescent cells (indicating a non-prion state) were collected 
(300-400 cells). 5 million – 9 million cells were examined in each pool. After 
sorting, cells were recovered for 2.5 hours in CSM media lacking ura. 100 µg/mL 
nourseothricin and 200 µg/mL G418 were then added to maintain selection for 
diploid cells. Cultures were shaken 2 days at 30oC until reaching saturation. 
Plasmids were purified from each sample as previously described 200. Plasmids 
were amplified by electroporation into bacteria followed by subsequent miniprep. 
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Mutant plasmids were retransformed into haploid [PSI+] or [RNQ+] yTRAP 
sensor strains for a second round of selection. Empty plasmids were also 
transformed separately to serve as negative controls. Transformants were grown 
in selective liquid media for 40 hours with intermittent dilution to keep cells from 
reaching stationary phase, and then subjected to a second FACS sort. Collection 
gates were set so that all cells from control strains containing empty plasmids 
would be excluded, and only cells with greater fluorescence were collected. 
20,000 cells were collected for both libraries and recovered as before. Plasmids 
were purified from yeast and transformed into bacteria. 24 clones of each library 
were prepped and sequenced (Table S1).  
 
Prion-curing by transient expression of mutant alleles 
Estradiol-inducible mutant plasmids were transformed into the PSI / RNQ 
dual-sensor strain yGAN036. The strain also contains a pAG303GPD-Sup35C 
plasmid, which eliminates toxicity from Sup35NM expression. Estradiol induction 
was performed as follows: overnight cultures in CSM media lacking uracil were 
diluted 1000x into CSM media lacking uracil supplemented with 5 nM estradiol. 
After 24 hours of induction, cultures were measured by flow cytometry to 
determine effects on solubility during overexpression (Table S1). Cultures were 
also diluted 1000x into fresh media lacking estradiol to recover and examine 
heritable effects. After 24 hours of recovery, cultures were diluted 100x into fresh 
media and grown 6 hours before measurement by flow cytometry (Figure 5.7B 
and C, Table S1). 
 The Saccharomyces Genome Database was used to search for known 
strains that harbor our selected mutant prion-curing alleles in SUP35 and RNQ1. 
The Rnq1 Δ288-298 mutation was harbored in 4 of the 45 available yeast strains: 
217_3, PW5, DBVPG6044, and YJM789.  
 
Anti-prion drive mating, sporulation, and tetrad dissection 
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Plasmids harboring the ‘drive cassettes’ (pGAN257-261) or wild type 
controls were transformed into MATa sensor strains for the respective prion 
(forming yGAN060-064). The anti-PSI drive was derived from a clone with high 
expression of the drive cassette. Strains used to test the anti-PSI drive strain 
harbored a constitutive Sup35C construct to prevent toxicity from overexpression 
of Sup35NM. To test drives, anti-prion drive strains were mated to ‘tester strains’ 
(yGAN065 for PSI or yGAN066 for RNQ). Mating was conducted by spreading a 
water-suspended colony of the tester strain onto agar YPD plates and letting it 
dry. A separate plate with large, spotted colonies of the drive-containing strains 
was replica plated onto the same YPD plate, and incubated for 6 hours at 30 oC 
to allow for mating. The YPD plate was then replica plated onto his and leu drop-
out agar plates, allowing only diploids to grow. Diploid colonies were streaked 
once onto the same media, then picked into 5mL pre-sporulation media (20 g/L 
bacto-peptone, 10 g/L yeast extract, 40 g/L glucose, 100 mg/L adenine 
hemisulfate) and grown at 30oC overnight. 
Overnight cultures in pre-sporulation media were centrifuged and 
resuspended in 5 mL dH20 to wash. This process was repeated for a total of 3 
washes before cells were resuspended in 200 µL of dH20. 50 µL was spotted 
onto agar SPO plates (1 g/L potassium acetate, 50 µM uracil, 100 µM tryptophan, 
50 mg/L leucine, 25 mg/L of every other natural amino acid, 25 mg/L adenine, 
2.5 mg/L p-aminobenzoic acid, and 20 g/L agar). Plates were incubated 2 nights 
at 30oC to sporulate. 
 Following this incubation, a few mg of cells were picked with a pipet tip 
and resuspended into enzyme mix (1 M sorbitol, 0.1 M EDTA, 10 mg/mL 
zymolyase). This was quickly vortexed to mix and left at room temperature 5-10 
minutes. A sterile loop was used to streak a line of cells onto an agar YPD plate. 
Tetrads were dissected using a Singer MSM dissection microscope. Dissected 
spores were grown 2 days at 30oC and then arrayed into cultures in 96 well 
plates. Spores were spotted onto CSM media agar plates to image fluorescence, 
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indicative of prion state. They were also spotted on CSM agar plates lacking 
leucine to determine whether or not each haploid inherited the gene drive 
cassette (Figure 5.9B and C). Spores were also streaked onto guanidine 
hydrochloride plates to cure their prions and spotted likewise to compare to 
uncured cultures. All samples were measured by flow cytometry, only three sets 
of spores for each sample were spotted and photographed. 
  
Supernatant/pellet fractionation of Rnq1 
Supernatant/pellet fractionation and blotting was conducted as previously 
described for Rnq1 185. 100 mL YPD cultures were inoculated with overnight yeast 
cultures to OD 0.1, and grown 6 hours to OD 1.0. Cells were resuspended in 100 
µL lysis buffer (50 mM Tris pH8.0, 150 mM NaCl, 0.2% Triton X-100, and Halt 
protease inhibitors (ThermoFisher Scientific 78430)). 750 µL of lysis buffer / glass 
bead slurry was added, and cells were vortexed 8 times for 10 seconds each to 
lyse. Between each vortex cycle, cells were incubated on ice for 2 minutes. 
Tubes were centrifuged 10 minutes at 10,000 g at 4oC. The supernatant was 
taken as the total lysate. BCA assays were conducted to determine protein 
concentration and normalize samples with lysis buffer. 1 mg of protein was 
added to centrifuge tubes and samples were centrifuged for 30 minutes at 
280,000 g at 4oC. The supernatant fraction was collected, and the pellet was 
resuspended in lysis buffer before loading on an SDS-PAGE gel. Western blots 
were probed with a polyclonal rabbit antibody against Rnq1 185 and an anti-rabbit 
HRP-conjugated secondary antibody (Sigma Aldrich A0545). 
 
Screen of RBP sensor library members for aggregation propensity 
Each member of the yTRAP RBP sensor library was transformed with a 
high copy-number plasmid containing an expression cassette for the same RBP, 
regulated by the GAL1 promoter. yEHA122, which harbors an integrated 
estradiol-sensitive transcription factor that binds and activates the GAL1 
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promoter in the presence of estradiol (from plasmid pEHA840), was mated to 
each sensor strain. Diploids were selected on agar plates lacking leucine and 
uracil, supplemented with 100 µg/mL nourseothricin. Colonies were pinned one 
more time on selective agar plates to purify diploids. Four individual diploid 
patches were picked for measurement. Each strain was grown to saturation in 
CSM media lacking uracil to select for the overexpression plasmid. Overnight 
cultures were diluted 100-fold in fresh media and grown for 3 hours to log phase. 
Cultures were then split, 50 µL was diluted 1:1 into non-inducing media, and 50 
µL diluted 1:1 into inducing media (final estradiol concentration of 100 nM). 
Cultures were grown for a further 4 hours at 30oC, and measured using flow 
cytometry as described above. Induced samples were measured immediately 
following uninduced controls to minimize time delays in measurement. 
 
Screen for aggregation of RBP sensor library during HRP1 overexpression 
The HRP1 ORF was cloned into the estradiol-inducible plasmid using 
Gibson assembly, yielding pEHA655. This plasmid was integrated into the yeast 
genome to produce yEHA125, which also contains the estradiol-responsive 
transcription factor ZEM. yEHA125 was mated to the RBP sensor library in 96-
well plates and diploids were selected on agar plates lacking leucine and uracil, 
supplemented with 100 µg/mL nourseothricin. Colonies were re-streaked one 
more time on selective agar plates to purify diploids. Diploids were picked into 
CSM media and grown overnight. Cultures were then diluted 100-fold into CSM 
media supplemented with 100 nM estradiol, or media lacking estradiol as a 
negative control. After 6 hours of growth and induction at 30oC, cultures were 
measured using flow cytometry as described above.  
 
Yeast growth curve assays  
Cultures were grown independently in 96-well plates overnight, then 
diluted to an OD of 0.03 in media with or without estradiol. 70 µL of each diluted 
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culture was added to a 384-well plate and measured using a Biotek Epoch2 
microplate reader at 30oC. Absorbance at 600nm was collected every 15 minutes 
to track cell growth.  
 
Genome-wide screen for Hrp1 modulators  
The Hrp1 yTRAP sensor strain (yEHA415) was transformed with the 
estradiol-sensitive transcription factor GEM (pEHA840) to generate yEHA244. 
This strain was mated in an arrayed format to the yeast Flexgene library 187. The 
Flexgene library consists of yeast strains harboring every ORF under an 
inducible promoter in a low copy number plasmid (pBY011). All Flexgene strains 
were grown to log phase in CSM media lacking uracil and mixed 1:1 with a log-
phase yEHA244 culture. After 3 hours of incubation at 30oC to allow for mating, 5 
µL of the cell mixture was spotted on selective plates lacking leucine and uracil, 
supplemented with 100 µg/mL nourseothricin. After 2 days of growth the mated 
library was pinned once again on selective agar plates to purify diploids. After 
another day of growth, colonies were pinned into selective liquid media lacking 
leucine and uracil and grown to saturation. 
To measure the change in Hrp1 solubility, 4 µL of saturated diploid 
cultures were diluted into 200 µL of selective media lacking uracil supplemented 
with 100 nM estradiol and grown for 15 hours at 30oC. After that period, a further 
100-fold dilution was made in the same media to continue induction of the library. 
After 4 more hours of induction, Hoechst 33342 was added to a final 
concentration of 2 ng/µL to stain dead cells for exclusion. 96-well plates were 
measured by flow cytometry as described above (6000 events were collected per 
sample). Results are summarized in Table S3. 
Out of a total of 5,737 flow cytometry measurements on library members, 
85 readings showed low cell counts indicative of particularly poor growth and 
were discarded. Of the remaining 5,652 readings, 47 were found to be 
statistically significant hits falling 3 standard deviations from the mean. 30 of 
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these yielded a drop in yTRAP signal and 17 showed an increase in yTRAP 
signal. 13 strains showing no significant change in Hrp1 yTRAP signal were used 
as controls for the immediate secondary validation of hits. These 60 strains were 
picked freshly from the frozen yeast Flexgene library and mated to the Hrp1 
yTRAP sensor strain (to re-test their effect on aggregation) and, separately, to a 
strain harboring an mNeonGreen tag on its endogenous Hrp1 (to test their effect 
on total Hrp1 levels). Growth curves were collected for these 60 diploids during 
induction of the ORF library member in technical quadruplicates (Table S3). 
Proteins causing severe growth defects upon overexpression or changes in the 
total levels of Hrp1 were excluded from future analysis. Additionally, proteins with 
an annotated role in nuclear/cytoplasmic transport were excluded because they 
were likely false positives that affected yTRAP signal without affecting 
aggregation.  
 This left us with 11 proteins that caused a drop in Hrp1 yTRAP sensor 
signal. These proteins were tagged with mKate2 by Gibson assembly and 
integrated into the yeast genome under an estradiol-inducible promoter to reduce 
the noise coming from episomal expression. Three proteins (Sto1, Tfb1, and 
Yil055c) that increased Hrp1 yTRAP signal upon overexpression were also 
included in microscopy experiments. These 11 overexpression strains, along with 
a strain expressing mKate2-only as a control, were mated with the Hrp1 yTRAP 
sensor strain and strain harboring an mNeonGreen tag on endogenous Hrp1. 
Diploids were induced for a third round of validation to confirm the effect of the 
overexpressed protein on Hrp1 yTRAP signal and lack of effect on total levels of 
Hrp1. Microscopy was conducted on these strains to observe the effect of 
overexpression of the hits on endogenous Hrp1. This procedure is summarized 
in Table S3. 
 
3’ UTR PCR (RACE) experiments 
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Rapid Amplification of cDNA Ends (RACE) was used to detect alterations 
in mRNA polyadenylation sites in the presence of Nab2 overexpression. A strain 
harboring estradiol-inducible Nab2-mKate2 (yEHA173) and a control strain 
harboring estradiol-inducible mKate2 (yEHA188) were grown overnight in CSM 
media. They were diluted 100-fold into fresh CSM media supplemented with 100 
nM estradiol and grown for 6 hours at 30oC. 5 OD units of cells were harvested 
and frozen in liquid nitrogen. RNA was extracted using the YeaSTAR RNA kit 
(Zymo Research, Cat# E1004). cDNA was prepared using the SuperScriptIII kit 
(ThermoFisher Scientific, Cat# 18080051), using dT18NV- as the primer to amplify 
from the start of polyA tails. 1 µL of cDNA was used in each RACE PCR reaction. 
Internal control primer pairs were amplified in separate reactions simultaneously. 
 
Quantification and Statistical Analysis 
FlowJo was used to extract median fluorescence values from flow cytometry 
measurements. Microsoft Excel and GraphPad Prism software were used to 
process data. Statistical details such as N and error calculations are provided in 
figure legends. 
 
Data and Software Availability 
Requests for additional data should be directed to and will be fulfilled by the Lead 
Contact, Ahmad Khalil (khalil@bu.edu). 
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6. PRION SWITCHING 
The prion protein conformation is self-perpetuating, moreover, it can 
interconvert between the native and prion conformations. Prions act as 
epigenetic elements of inheritance59 in yeast since the prion conformation is 
faithfully inherited from mothers to daughters through mitosis and meiosis. Prions 
are present in wild populations of yeast166. Proteins with asparagine / glutamine 
rich regions, indicative of aggregation propensity, are frequently associated with 
regulatory roles such as kinases, RNA processing proteins, transcription and 
translation associated proteins201. Some examples of the verified bona fide yeast 
prion proteins are regulators of translation termination202, nitrogen catabolism70, 
carbon source utilization203. Such pieces of evidence led to the compelling idea 
that regulatory proteins capable of forming prions may act as switches between 
different phenotypes while the genome stays unaltered. A couple hypotheses on 
the potential evolutionary roles of prions in yeast include stress sense-response 
elements, evolutionary capacitors and environmental bet-hedging devices59. The 
bet-hedging hypothesis is based on the stochastic switching of prions between 
their native and prion conformations. If these two “states” represent opposite 
levels of stress resistance in different environments, it is beneficial for a 
population of cells to diversify into prion bearing and non-prion cells in case of an 
unexpected sudden environmental change190. 
In this chapter we characterized the switching dynamics of [RNQ+] prion in 
response to an environmental change. We characterized the environmental and 
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genetic determinants of this prion switching and built a mathematical model to 
describe its dynamics. 
Next we synthetically reconstituted prion conformation linked fitness cost-
benefit circuits. We used the [RNQ+] prion which has no known growth 
phenotype as a stochastic switch. And we linked the [RNQ+] and [rnq-] 
conformations to different expression levels of an environmental sensitivity and a 
resistance gene. The full circuit provides strong fitness benefit in one synthetic 
environment and strong fitness detriment in another synthetic environment to 
[rnq-] cells, and the opposite is true of [RNQ+] cells. This enables us to test the 
underlying hypothesis that prions act as stochastic switches and quantify prion 
switching under stress. Moreover, future experiments could directly test the prion 
bet-hedging hypothesis using this system. 
Prion proteins have been shown to participate in stabilization of long term 
memory in sea slug82, fruit flies83 and humans85-87. Since the prion conformation 
is inherited in yeast via the action of the chaperone machinery, the conformation 
of a prion protein could serve as a long term memory storage unit204. Our goal 
was to add synthetic control elements to change the prion protein conformation in 
response to external stimuli, which would create an epigenetic erasable synthetic 
memory device. Memory devices in microbial production are useful to eliminate 
the need for continuous administration of expensive inducer molecules into the 
feed of the bioreactor. Prion-based long term memory devices have a couple 
appealing features over transcriptional circuit based devices such as indifference 
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to growth phase, persistence under mildly stressful conditions and faithful 
propagation through a large number of generations. 
 
6.1. Dynamics and determinants of prion switching 
 
Prions proteins are dynamically switching between their prion and native 
conformations. When prion switching is linked to differential survival, prions act 
as environmental bet-hedging devices or stress-response elements. Such 
hypotheses have been extremely difficult to study due to the challenges of real 
time prion protein conformation detection, long timescales, often low frequency of 
prion switching and strong dependence of phenotypes on the genetic 
background. 
Our goal in this subchapter was to discover stressful environments that 
induce prion switching and to observe the dynamics of prion conformation 
switching in a population of cells. We identified sodium chloride stress as a 
potent eliminator of [RNQ+], [MOT3+], [SWI+] and [PSI+] prions in cells. We found 
that the level and duration of stress determine the transiently and heritably cured 
fractions of cells. Using a chaperone deletion and over-expression screen we 
identified the SSA1 chaperone as the key player in the elimination of [RNQ+] from 
the population. Our methods could be useful in identifying determinants of 
dynamic prion switching. 
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6.1.1. Introduction 
There exist a number of hypotheses about the evolutionary role of yeast 
prions in environmental stress resistance. Some studies identified certain stress 
conditions that favor cells in the prion or native conformation in a given genetic 
background66, 76, 172. These conditions were not conducive to dynamic 
observations of prion switching. 
RNQ1 is the gene encoding Rnq1p a bona fide prion protein of unknown 
function and with no known growth phenotype. In its prion form [RNQ+] enhances 
prion formation of other prions and aggregation of other aggregation prone 
proteins. In the case of Sup35p, [RNQ+] acts as a nucleating factors for [PSI+] 
prion. Sis1p Hsp40 cochaperone directly binds to [RNQ+] aggregates and is 
necessary for their maintenance. RNQ1 has no known growth phenotype, and no 
stress conditions were identified to date that switch the [RNQ+] prion. 
 
6.1.2. [RNQ+] is dynamically cured in a population of cells in sodium 
chloride stress 
To identify an environmental condition that results in prion switching, we 
screened a library of stress conditions77. We found that high concentrations of 
sodium chloride in galactose media affects the [RNQ+] prion. To test if salt 
treatment results in [RNQ+] switching, we treated [rnq-] and [RNQ+] cells of RNQ1 
yTRAP sensor with 1.5M NaCl in synthetic galactose media along with yTRAP 
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controls (Figure 6.1). We found that controls and [rnq-] cells were unaffected, 
while the [RNQ+] population gradually switched to [rnq-]. 
 
Figure 6.1 [RNQ+] is cured from a population of cells upon salt treatment. 
yTRAP sensor reporter only, constitutive synTA controls and [rnq-] are stable over time, and 
unaffected by treatment. Cells were growing in continuous culture where the starting medium is 
synthetic complete media supplemented with 2% galactose, and the feed media is supplemented 
with 1.5M NaCl. No significant growth differences were observed between [rnq-] and [RNQ+] cells 
upon treatment. [RNQ+] cells gradually became [rnq-] that was not due to reporter or sensor fusion 
protein changes as all controls remained steady throughout the experiment. 
Due to the dynamic nature of prions, any population of [RNQ+] cells also 
contains 3x10-6 fraction of [rnq-] cells49. The next question was whether the 
population level prion switching was due to competition between [rnq-] and 
[RNQ+] cells or true prion switching. We tested this question by labeling [rnq-] and 
[RNQ+] cells with constitutively expressed BFP and mixing them with the 
opposite prion type in continuous culture (Figure 6.2). We found that the 
percentage of cells in the population with [rnq-] and [RNQ+] prion states stayed 
constant over time if no stress was applied. The fraction of population with BFP 
label stayed approximately constant over time under treatment and no treatment 
conditions. This meant that there was no growth competition between [rnq-] and 
[RNQ+] cells. However, all populations switched to [rnq-] by 50 hours of 
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treatment. We concluded that salt induced prion switching is direct switching and 
not a result of growth competition. 
 
 
Figure 6.2. Environmental stress induced [RNQ+] to [rnq-] switching is direct switching and not due 
to growth competition. 
Cells expressing RNQ1 yTRAP were either labelled or left unlabeled with constitutively expressing 
mTagBFP, and mixed with the opposite prion type in continuous culture. The graphs on the left are 
no stress condition, while cells were treated with 1.5 M NaCl for the graphs on the right. The top 
graphs show yTRAP signal as a function of time, while the graphs on the bottom show the 
constitutive BFP label as % of the population labelled as a function of time. Grey and black lines 
denote control cells, and red lines denote experimental samples where 50% [RNQ+] and 50% [rnq-] 
cells were mixed, and one of these populations was labeled. The graphs on the left show that both 
the label and the [RNQ+] population fraction was stable over time when no stress was applied, 
suggesting that the label does not cause excessive fitness effect under these conditions and that 
neither [rnq-] nor [RNQ+] is more fit when no stress is applied. The top graph on the right shows that 
pure [RNQ+] and 50% mixes as well switch to 90% [rnq-] by the end of the experiment, independently 
of starting population composition. The graph on the right bottom shows that the labeled population 
fraction is constant over time with a slight drop in the fraction of labeled cells independently 
whether [rnq-] or [RNQ+] were labeled. Therefore, the label may carry some fitness disadvantage in 
stressful conditions, but [RNQ+] switching is not due to competition by [rnq-] cells, it is direct 
switching. 
The next question was whether the switching outcome could be 
modulated by changing treatment parameters such as duration and amplitude of 
treatment (Figure 6.3). When we varied sodium chloride concentrations, we 
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found that the equilibrium population composition and the time it took to reach 
equilibrium changed. At higher NaCl concentrations equilibrium was reached 
faster and contained a higher percentage of [rnq-] cells in the population. We 
grew cells in YPD medium for 15 generations following treatment, and found that 
a large fraction of the dynamic switching is heritable, and that there is a fraction 
of cells that revert to their original prion state. 
 
Figure 6.3. [RNQ+] to [rnq-] switching is sodium chloride concentration and treatment time 
dependent. 
Cells were exponentially grown in synthetic complete medium with 2% galactose supplemented with 
NaCl at the listed concentrations in continuous culture. Samples were collected for flow cytometry 
measurement every 8-16 hours, and allosteric sigmoidal curves were fitted on the traces. 
Left. The y axis shows yTRAP signal as the percentage of [rnq-] cells in the population as a function 
of treatment time. The increasing depth of color signifies increasing level of stress applied to the 
sample from 0 to 1.5 M NaCl. We found that equilibrium population composition is dependent on the 
level of stress applied. 
Right. Visual representation of the fit parameters from the graph on the left. The axis on the left 
corresponds to the grey curve and shows equilibrium population composition as a function of the 
stress applied. We can only detect the effects of the treatment above 0.5 M NaCl, and equilibrium 
population composition contains increasingly more [rnq-] cells with increasing level of stress. The 
axis on the right showing the time required to reach half maximum response as a function of stress 
levels, and it corresponds to the red curve. With increasing level of stress, equilibrium population 
composition is reached faster, but this speed saturates above 1.2 M NaCl. In summary, the level of 
stress determines both equilibrium population composition and the time it takes to reach this 
equilibrium. 
Previously known prion associated phenotypes76 and prion switching 
inducing environmental conditions77 are strongly dependent on the genetic 
background. We tested if salt induced dynamic [RNQ+] switching is also 
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dependent on the genetic background. We treated RNQ1 yTRAP W303 and 
BY4741 strains of S.cerevisiae with 1.5M NaCl (Figure 6.4). And found that both 
backgrounds heritably switched to [rnq-], and that they followed the same 
switching dynamics. We concluded that this environmental condition yields 
dynamic prion switching independent of genetic background. 
 
 
Figure 6.4. [RNQ+] to [rnq-] switching and its dynamics is identical in S.cerevisiae W303 and BY4741 
genetic backgrounds. 
Cells were exponentially grown in synthetic complete medium with 2% galactose supplemented with 
1.5M NaCl at the listed concentrations in continuous culture. Samples were collected for flow 
cytometry measurement, and allosteric sigmoidal curves were fitted on the traces. Recovered 
samples were grown for minimum 15 generations YPD media. The lightest and medium red curve 
show that BY4741 [rnq-] cells maintain their prion state over the course of treatment. The red curve 
shows that BY4741 [RNQ+] cells turn [rnq-] as a result of treatment, and the dark red curve shows 
that most of this conversion is heritable at any given timepoint. The black curve shows that W303 
cells lose [RNQ+] with the same dynamics as BY4741 cells do, suggesting that both [RNQ+] loss and 
its dynamics is a phenomenon independent of the genetic background, contrary to most prion 
switching conditions known to date. 
We next asked the question whether salt induced switching is specific to 
the carbon source, galactose. We first grew cells on a variety of carbon sources 
in continuous culture, and determined that [RNQ+] and [rnq-] states are stable 
under these conditions. Next, we added the stress agent on the varied carbon 
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sources and took samples over time (Figure 6.5 left). Then we grew the cells in 
YPD media for 15 generations and re-assayed them via flow cytometry to 
determine if the observed prion state changes were heritable (Figure 6.5 right). 
We found transient switching to variable degrees on all four carbon sources that 
we tested. Galactose and raffinose resulted in most complete switching, which 
was also heritable in the majority of the population. Sucrose and glucose yielded 
less switching. Since galactose and raffinose are carbon sources where growth is 
significantly slower than on glucose or sucrose, we hypothesized that other 
poorer carbon sources such as glycerol, acetate, ethanol, mannose, fructose 
might also result in [RNQ+] switching. We concluded that switching is not specific 
to galactose as a carbon source. 
 
Figure 6.5 [RNQ+] to [rnq-] switching in response to NaCl treatment is carbon source dependent. 
Cells were grown in continuous culture in synthetic complete media supplemented with 1.5M NaCl 
and the sugar sources listed at 2% final concentration. 
Left. yTRAP signal as the percentage of the population that is [rnq-] during treatment, as a function 
of time. [rnq-] cells are shown in light colors, [RNQ+] cells in dark colors. Data shown in blue 
corresponds to cells grown on glucose carbon source in the presence of 1.5 M NaCl stress. By 170 
hours, 30% of the [RNQ+] population switched to [rnq-]. Data shown in green corresponds to cells 
grown on 2% sucrose as a sole carbon source in the presence of 1.5 M NaCl. [RNQ+] to [rnq-] 
switching is less than 20% of the population, and [rnq-] to [RNQ+] switching is shown in 40% of the 
population. Data shown in red corresponds to cells grown on 2% galactose as a sole carbon source 
in the presence of 1.5 M NaCl, similarly to the previous figures. [RNQ+] to [rnq-] switching reaches 
90%, and [rnq-] cells maintain their initial population composition. Data shown in purple corresponds 
to cells grown on 2% raffinose as a sole carbon source in the presence of 1.5 M NaCl. [RNQ+] to [rnq-
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] switching is reaches 85% by the end of the experiment, and [rnq-] to [RNQ+] switching changes 
over time and is 20% by the end of the experiment. 
Right. yTRAP signal as the percentage of the population that is [rnq-] after 15 generations of growth 
post treatment, showing the heritably switched cells as a function of time. Colors correspond to the 
same conditions as on the graph on the left. None of the [rnq-] to [RNQ+] switching observed in the 
transient signal translated to heritable changes. [RNQ+] to [rnq-] switching in glucose (blue) was not 
heritable, and only a minor fraction of the [RNQ+] to [rnq-] switched cells in sucrose (green) switched 
heritably. However, in galactose (red) and raffinose (purple), 70% of the [RNQ+] cells heritably 
switched to [rnq-]. Since doubling times associated with growth on galactose and raffinose are 
longer than on glucose and sucrose, [RNQ+] to [rnq-] switching may be affected by doubling time. 
Our next question was if prion switching in this stress condition was 
specific to [RNQ+] prion. To test this, we first treated cells that have prions in 
combination with [RNQ+], and next we focused on other prions in [RNQ+] cells 
(Figure 6.6). Confirming published findings65, 172, [SWI+] cells lost [SWI+] purely 
from growth in galactose media. [MOT+] was not stable in the W303 background, 
therefore our pure [MOT+] population contained about 30% [mot-] cells prior to 
treatment, which makes the interpretation of results more difficult. [MOT+] was 
only stable in no stress without recovery. [PSI+], [RNQ+], [MOT+] and [SWI+] were 
all cured when treated with 1.5M NaCl, and with the exception of [PSI+], the 
curing was heritable. Therefore, the treatment affects [RNQ+] and other prions as 
well. 
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Figure 6.6. [PSI+], [MOT3+], [SWI+] and [RNQ+] are all cleared from cells in response to salt treatment 
in galactose. 
Cells were grown in continuous culture in synthetic complete media supplemented with 2% 
galactose and 0 (left) or 1.5M (right) NaCl. yTRAP signal read out as the percentage of population 
without prions is shown as a function of treatment time. 
Top. [RNQ+] and [rnq-] cells expressing PSI (blue), RNQ1 (green) and SWI1 (red) yTRAP sensor 
cassettes and reporter show loss of [SWI+] in non-stress media (left). [SWI+] cells cannot utilize 
galactose as a carbon source172, therefore [SWI+] cells switch to [swi-] in galactose media. This 
switching is slowed down upon the addition of 1.5M NaCl to the media, and [RNQ+] is lost from 80% 
of the population (right). The treatment did not affect PSI sensor cells, as they all showed [psi-] 
phenotype throughout the experiment. [swi-] cells were transiently affected, but returned to 100% 
[swi-] by the end of the experiment. In conclusion, the loss of [SWI+] in galactose is slower during 
treatment. 
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Middle. Four prions, [PSI+] (green), [MOT3+] (red), [SWI+] (purple) and [RNQ+] (blue) were investigated 
in the absence (left) and presence (right) of stress. In no stress, [SWI+] is lost, similarly to the 
previous experiment. In the [MOT3+] population there was 30% of [mot-] cells as [MOT3+] is unstable 
in the W303 genetic background used throughout this subchapter. Over time, in no stress, the [mot-] 
population fraction stabilized at 20%. In stress, [prion-] populations remained steady, while all 
[PRION+] populations were converting to [prion-] to some extent. [RNQ+] was lost in 90% of the 
population, [MOT3+] was lost in 100% of the population, [PSI+] was lost in 75% of the population, and 
[SWI+] was lost in 40% of the population compared to 100% loss in no stress for [SWI+]. 
Bottom. yTRAP signal from cells grown in YPD media for 15 generations post treatment, measuring 
the percentage of population that heritably switched prion states. In no stress conditions 100% of 
[SWI+] by 70 hours and 90% of [MOT3+] were heritably lost by 160 hours. In stress, 100% of [MOT3+] 
was heritably lost by 60 hours, which is significantly faster than in no stress. 40% of [RNQ+] was 
heritably lost, while [PSI+] switching was only heritable at 40 hours. 
Last, we were interested in the genetic determinants of [RNQ+] switching 
in response to this environmental change. We integrated the RNQ1 yTRAP 
sensor into SSA1, PUB1, ECM10 chaperone deletion strains and HOG1 
kinase deletion strain. HOG1 is the osmoregulation MAPK and therefore the key 
response molecule to salt stress. We eliminated prions in these cells by growing 
them on 3 mM guanidine hydrochloride to yield their isogenic [rnq-] derivatives as 
controls. First we grew these strains in continuous culture without stress to 
establish that [RNQ+] and [rnq-] are stable (Figure 6.7 left). To test if these genes 
are important for environmental change induced [RNQ+] switching, we cultured 
the deletion strains in 1.5M NaCl media (Figure 6.7 right). HOG1 deletion caused 
the cells to decrease in size, grow slower and decrease expression overall. 
Analyzing the cells following recovery, it was clear that HOG1 cells lost [RNQ+]  
at the same rate as wild type. Therefore, the environmental change induced 
[RNQ+] loss is not due to Hog1p signaling. [RNQ+] was maintained despite the 
environmental change in SSA1 strain, and had a slower dynamics of loss in the 
ECM10 strain. We concluded that Ssa1 protein is necessary for environment 
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induced [RNQ+] loss. The mitochondrial Hsp70 Ecm10 might have a minor role in 
the process. 
We tested if over-expression of Hsp104p, Sis1p or Ssa1p affect 
environmental change induced [RNQ+] loss. [rnq-] and [RNQ+] RNQ1 yTRAP 
strains were transformed with GAL1 promoter based over-expression plasmids. 
Untreated cells were grown in SGal-Ura media, and treated cells were shifted to 
SGal-Ura media supplemented with 1.5M NaCl (Figure 6.8). We found that all 
strains switched with the same dynamics as the empty plasmid control except for 
the Hsp104p over-expression strain, where switching was eliminated. The 
dynamics of heritable switching –following recovery– was faster in the Sis1p and 
Ssa1p over-expression strains. We concluded that Hsp104p over-expression and 
SSA1 deletion abolish [RNQ+] switching, and therefore the environmental change 
is creating a chaperone imbalance that leads to prion switching. 
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Figure 6.7. ECM10 and SSA1 chaperone deletions alter the dynamics and extent of [RNQ+] to [rnq-] 
switching in salt treatment. Deletion of SSA1 abolishes heritable [RNQ+] to [rnq-] switching in salt 
treatment. 
BY4741 cells from the deletion library were grown in continuous culture on 2% galactose as the sole 
carbon source with (right) and without (left) 1.5 M NaCl stress. The cells were grown for 15 
generations in rich glucose medium following each timepoint (bottom). Light traces correspond to 
initially [RNQ+] cells, and dark traces correspond to initially [rnq-] cells. Green color represents 
SSA1 genotype, purple color represents PUB1, orange corresponds to ECM10, blue corresponds 
to HOG1. Following genomic PCR verification of PUB1 cells, they turned out not to have the 
PUB1 deletion, therefore these samples were evaluated as wild-type cells. 
Left. In no stress media there was no switching observed, RNQ1 yTRAP signal was stable in all 
deletions over time. 
Right. In stress, PUB1 cells lose 95% of [RNQ+] within 80 hours (top, light purple), ECM10 cells 
lose 80% of [RNQ+] in 120 hours (top, light orange). ECM10 cells indeed show slower heritable 
[RNQ+] loss as well (bottom, light orange). HOG1 cells became significantly smaller and decreased 
their growth rate and reporter expression, which erroneously shows as a transient signal of [rnq-] to 
[RNQ+] switching (top, dark blue). After recovery in non-stress glucose media, this effect disappears 
(bottom, dark blue) and heritable [RNQ+] loss becomes apparent with the same dynamics as PUB1 
control cells (bottom, light blue). SSA1 cells show 20% [RNQ+] to [rnq-] (top, light green) and 20% 
[rnq-] to [RNQ+] switching in 60 hours (top, dark green), neither of which is heritable (bottom, light 
and dark green). 
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Figure 6.8. Hsp104p over-expression abolishes heritable [RNQ+] to [rnq-] switching in salt treatment, 
Ssa1p and Sis1p over-expression speed up heritable [RNQ+] to [rnq-] switching in salt treatment. 
BY4741 cells from the over-expression library were grown in continuous culture on 2% galactose as 
the sole carbon source in selective media to maintain the over-expression construct with (right) and 
without (left) 1.5 M NaCl stress. The cells were grown for 15 generations in selective glucose 
medium following each timepoint (bottom). Light traces correspond to initially [RNQ+] cells, and dark 
traces correspond to initially [rnq-] cells. Green color represents the empty plasmid control, purple 
color represents Hsp104p over-expression, orange corresponds to Ssa1p over-expression, blue 
corresponds to Sis1p over-expression. 
Left. In no stress media there was no switching observed, RNQ1 yTRAP signal was stable in all over-
expression strains over time. 
Right. Hsp104p over-expression abolished the [RNQ+] to [rnq-] switching phenotype in both 
transient (top, light purple) and heritable (bottom, light purple) measurements. Ssa1 and Sis1 over-
expression did not change [RNQ+] switching equilibrium fractions or switching dynamics compared 
to empty plasmid control (top, light orange, light blue and light green), but they did speed up the 
dynamics of heritable switching (top, light orange and light blue compared to light green). 
6.1.3. Next steps and limitations 
In this chapter we explored an environmental change induced prion switching 
event and its dynamics. We found that it is active switching, not population level 
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growth competition. The dynamics and outcome are modulated by stressor 
concentration and treatment duration. The switching is heritable and independent 
of genetic background. Switching happens the fastest on galactose and raffinose 
carbon sources at 1M and higher NaCl concentrations. 
Sea water has 0.6M NaCl, therefore, this particular stress may not be 
common in the natural environment. Salt stress is known to decrease protein 
synthesis205, which, combined with chaperone imbalances, could be the 
mechanism behind prion curing. To test this hypothesis, we would monitor 
[RNQ+] state while treating cells with cycloheximide translation inhibitor to slow 
growth without adding NaCl. 
The environmental change in this subchapter was purely a step function from 
non-stressful environment to a stressful one. Environmental sensors and bet-
hedging devices in the natural environment encounter environmental changes 
frequently, and often in an unpredictable manner. To better mimick the natural 
environmental changes, multiple rounds of stress and non-stress cycles should 
be carried out. The question, whether or not the cells respond to the amplitude of 
stress or the relative changes in stressor agent, still remains. It could be 
addressed by starting the experiment in a couple of the milder stresses where 
[RNQ+] switching does not yet occur, and shifting the environment to higher NaCl 
levels. Another question that is unanswered is how the fraction of heritable 
switching changes in response to the parameters of environmental change and 
how recovery is executed. To more accurately determine if other prions are also 
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affected by this environmental change, additional tests at different salt 
concentrations in other carbon sources and a larger library of yTRAP sensors 
would be necessary. 
Some of these questions are easier to answer in environments where the 
switching counterpart, i.e. [rnq-] to [RNQ+] is also available. 
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6.2. Deterministic synthetic prion switching – synthetic prion-based 
memory devices 
Synthetic memory can be either reversible or irreversible. Such synthetic 
memory circuits have successfully been built in vitro using hybridizing nucleic 
acids and interlocked negative and positive feedback loops. In vivo memory 
circuits have diverse strategies. Recombination based memory excises or inverts 
DNA sequences, transcriptional memory circuits are based on positive feedback 
or double negative feedback loops. Proposed but not yet built non-DNA based 
circuits involve RNA editing or protein phosphorylation206. Recombinase based 
cellular memory was realized in E.coli and mammalian cells. Transcriptional 
circuits were readily built in E.coli even from the conception of synthetic biology3, 
but there only a few examples in yeast15, 207 and mammalian cells. 
In this subchapter we proposed the use of prion protein conformations as 
synthetic memory states and prions as memory storage elements. Our ultimate 
goal was to build reversible synthetic memory that is regulated by two orthogonal 
small molecules with the potential for multi-bit memory once the principle is 
expanded to multiple prion bits. The maintenance of the prion memory happens 
naturally by the yeast chaperone network. 
Our approach was to identify prion switching genetic controllers, and then 
place them under the control of small molecule inducible systems. Finally, we 
would integrate the two directions of prion switching in the same cell. 
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6.2.1. Controlled reversible prion switches form the basis of new 
synthetic long term memory devices 
Prions are mitotically stable in yeast. We were interested if prion 
propagation or the yTRAP sensor circuit would break after many 
generations (Figure 6.9). We found that strong [PSI+], [psi-], [rnq-] and 
strong [RNQ+] were all mitotically stable for more than 150 generations, 
and produced reliable sensor output. This suggests that if we can apply 
synthetic control mechanisms to switch prion state, the devices will be 
suitable for applications where long term memory is necessary. The cells 
underwent all phases of growth in the above experiment, suggesting that 
retaining prion memory is resilient to growth phase perturbations. 
 
Figure 6.9. The yTRAP sensor, [PSI+], [RNQ+] prions are stable over many generations. 
Cells were grown on YPD plates, and streaked on a fresh plate every two days. Fifteen generations 
were assumed between transfers. yTRAP signal as the percentage of the population that is [prion-] 
0 3 0 6 0 9 0 1 2 0 1 5 0 1 8 0
0
2 0
4 0
6 0
8 0
1 0 0
g e n e ra tio n s
%
 [
p
r
io
n
- ]
[P S I
+
]
[p s i
-
]
[R N Q
+
]
[ rn q
-
]
  
207 
as a function of generations is plotted. Light colors denote the trajectories of initially [prion-] cells, 
bold colors represent initially [PRION+] cells. All four populations are stable over 175 generations. 
To be able to deterministically control prion state, we needed domains that 
induce prion formation or elimination. No efficient reversible prion switching 
domains have been previously published in the literature. Mass action of prion 
polymerization suggests that over-expression of prion inducing domains might 
induce prion formation. Mutant prion domains however, by getting incorporated 
into the fibers and inducing their disassembly, could control prion elimination. 
Another way to control prion clearance is the imbalance of chaperone proteins. 
Specifically, it is known that over-expression of Hsp104p cures198 weak [PSI+]208 
from a population of cells by inhibiting fiber growth. Inhibition of Hsp104 action by 
either its inhibitior guanidine·HCl or its dominant negative mutant leads to 
clearance of all prions. We tested all of these strategies (Figure 6.10, Figure 
6.11) by over-expressing prion domains, their sequence variants and chaperone 
proteins. We found that [PSI+] can be induced by over-expressing the N domain 
of Sup35p, and it can be cured by over-expressing SUP35NM domain mutant 
10,24, and the KT218,260 dominant negative209, A503I potentiated210 mutants of 
Hsp104p. Potential inducers of [RNQ+] were all toxic, which could be an 
indication for efficient [RNQ+] induction as Rnq1p over-expression is toxic in 
[RNQ+] cells. We found that the dominant negative mutant of Hsp104p and Ydj1p 
over-expression cured [RNQ+]. 
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Figure 6.10. Prion domain mutants are efficient prion switching agents. 
SUP35 NM domain variants and RNQ1 variants were expressed constitutively from TDH3 promoter, 
and prion status was quantified based on yTRAP sensor signal. Wild type domains are prion 
inducers (grey), the specific mutants analyzed here are prion curing agents (black). The y axis 
shows the percentage of population switched in response to prion domain over-expression. For 
example, the NM 10,24 over-expression cassette was transformed into [PSI+] cells with PSI yTRAP 
sensor. The transformants were re-analyzed for their yTRAP signal, and the fraction of [psi-] cells is 
shown. NM 10,24 was the most efficient [PSI+] curing mutant as it cured 82% of the population, while 
NM 17,56 only cured 10%. RNQ1 stop 313 cured 30% of [RNQ+] cells, RNQ1288 cured 35% of 
[RNQ+]. Neither NM nor RNQ1 wild type domains could efficiently induce [PSI+] or [RNQ+], 
respectively. 
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Figure 6.11. Prion domains and chaperones are efficient prion switching agents. 
The domains were integrated in a single copy under the control of GAL1 promoter. Cells were grown 
in YEP media supplemented with 2% galactose for 16 hours (grey bars), followed by 15 generations 
of growth in recovery YPD medium (black bars). 
Top left. A screen to identify efficient [PSI+] inducing agents found that SUP35 N domain induced 
[PSI+] in 70% of the population, 40% of which was heritable. SUP35NM and its prion repeat 
expansion R2E2 version achieved less than 10% [PSI+] induction. 
Top right. A screen of RNQ1 prion domain fractions did not identify efficient [RNQ+] inducers. Full 
RNQ1 or its prion domain induced less than 5% of the population to the [RNQ+] state. 
Bottom left. A chaperone over-expression screen identifies HSP104 KT218,260 dominant negative 
mutant as a potent [PSI+] curing agent, which eliminates [PSI+] from over 90% of the population in a 
heritable manner. The hyperactive HSP104 A503I and A503V cured 30% and 20% of the population, 
and YDJ1 cured 10% of the population in a heritable manner. Wild type HSP104, SIS1 and SSA1 had 
no effect on [PSI+] state. 
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Bottom right. A chaperone over-expression screen identifies HSP104 KT218,260 dominant negative 
mutant as a potent [RNQ+] curing agent, which eliminates [RNQ+] from 90% of the population in a 
heritable manner. YDJ1 is the second best [RNQ+] curing agent with 65% heritable [RNQ+] curing. 
Over-expression of HSP104, its hyperactive variants, SIS1, SSA1 did not result in heritable [RNQ+] 
curing. 
To establish synthetic reversible prion memory, we tested the dynamics of 
the memory set process. We followed a population of [psi-][RNQ+] cells over-
expressing SUP35N domain (Figure 6.12), and it took 50 hours to convert 80% of 
the population to [PSI+]. We took away the inducer at this point, and found that 
20% of the population heritably retained [PSI+]. Overall, 20% of the population 
remained [psi-], 20% established the heritable [PSI+] state and 60% gained [PSI+] 
transiently, but lost it when SUP35N over-expression ceased. This suggests that 
there is transiently aggregated state that eventually leads to stable aggregation. 
The transiently aggregated state might correspond to the recently discovered 
phase separated liquid droplets74 of Sup35 in the yeast cytoplasm. 
 
Figure 6.12. Sup35 protein prion domain over-expression induces [psi-] to [PSI+] switching. 
Cells were grown in continuous culture conditions in YEP medium supplemented with 2% glucose or 
galactose. Flow cytometry samples were taken at different time intervals. After 48 hr of induction, 
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the feed media was switched to YPD to stop induction, and to determine the fraction of cells that 
heritably switched prion state. The y axis shows yTRAP signal as the percentage of population that 
is [psi-]. The grey curves show uninduced samples that do not express SUP35N prion domain, and 
as expected, 100% of the population remains [psi-]. The black curves show induced cells, and the 
fraction of [psi-] cells decreases as [PSI+] is induced in 80% of the population, 20% of which is 
heritable (equilibrium after the dotted line). 
 
We tested memory reset on two prion bits, [PSI+] and [RNQ+] (Figure 
6.13). We found that over-expression of the same variant of Hsp104p resulted in 
different kinetics for the two different prions. [RNQ+] was cured within the first 18 
hours of induction, while [PSI+] took twice as long. Comparing signal from 
recovered cells and cells under induction, we found that some of the transient 
signal reverts back to the [RNQ+] state or proceeds to [psi-] after recovery. This 
also suggest the presence of a transient state that bridges the two stable 
conformations. 
 
Figure 6.13. Hsp104p KT218,620 over-expression induced [PSI+] to [psi-] and [RNQ+] to [rnq-] 
switching with different dynamics. 
Cells were grown in continuous culture conditions in YEP medium supplemented with 2% raffinose 
or galactose. Flow cytometry samples were taken at different time intervals. Recovery was 
performed by growing cells in YPD non-inducing media for minimum 10 generations. 7, 15 and 21 
generation recovery data showed no differences. The light blue and light red lines depict uninduced 
cells that maintained [PSI+] and [RNQ+] state transiently and heritably as read out by yTRAP on the y 
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axis as a function of time. Red circles show how a population of 100% [RNQ+] cells is dynamically 
cured by dominant negative Hsp104p to 100% [rnq-]. Dark red squares represent data after recovery, 
and 100% of the population heritably switches, but with slower dynamics. Blue triangles show how a 
population of 100% [PSI+] cells is dynamically cured by dominant negative Hsp104p to 100% [psi-]. 
Dark blue rhomboids correspond to data following recovery, which shows that 100% of the 
population is heritably cured and with faster dynamics than the transient signal but slower than 
[RNQ+] curing. In conclusion, the dominant negative Hsp104p is an efficient curing agent for the 
elimination of [PSI+] and [RNQ+]. Using this protein would only allow for the construction of a single 
use PSI memory circuit as elimination of [RNQ+] prohibits de novo reestablishment of [PSI+]. 
 
We observed the dynamics of [PSI+] curing (Figure 6.14), and found that 
once conversion to [psi-] is complete, all cells retain [psi-]. This meant that the 
prion memory can be reset with 100% efficiency in 50 hours. A caveat with this 
method is that HSP104 KT218,620 eliminates [RNQ+] as well as [PSI+]. Since the 
presence of a PIN factor, most frequently [RNQ+], is necessary for de novo 
establishment of [PSI+], it is questionable if [PSI+] could be reestablished in the 
cured cells. 
 
Figure 6.14. The prion curing induced by Hsp104p variant is heritable over many generations. 
Cells were grown in continuous culture conditions in YEP medium supplemented with 2% glucose 
(grey) or galactose (black). Flow cytometry samples were taken at different time intervals. After 48 hr 
of induction, the feed media was switched to YPD to stop induction, and to determine the fraction of 
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cells that heritably switched prion state. The y axis is yTRAP output as a measure of population 
composition that is depicted as percentage of cells that are [psi-]. A population of 100% [PSI+] cells 
is expressing the dominant negative mutant of Hsp104p (black line), or not being induced to express 
it (gray line). Over time, the population converts to 100% [psi-] in 45 hours, and then stably maintains 
this state even when the inducer is removed. In summary, we built a circuit where PSI elimination is 
induced by a small molecule inducer, and the system has memory. 
To better understand the dynamics and the molecular processes ongoing, 
we developed a mathematical model. Most models accurately describing protein 
aggregation kinetics introduce a large number of constants that are given values 
later on arbitrarily. Since our readout is a single reporter, we aimed to develop a 
simple model that describes the biological behavior but does not introduce 
parameters that are impossible to measure. A state model has recently 
successfully been used to describe the kinetics of gene silencing by a synthetic 
chromatin modifier31. In that case, the active state could convert back and forth to 
a transiently inactivated state, which eventually gets converted into the inactive 
state. We compared two state, three state and four state model (Figure 6.15) 
outputs to the prion switching dynamic signal from the previous figures. We found 
that the four state model is the one that describes the behavior of the data the 
most accurately: conversion is preceded by a “lag phase” when the transient 
state is being populated. Some of the transient signal converts back to the initial 
state. Fitting this model to the data will provide us with the kinetic constants 
describing prion switching dynamics. 
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Figure 6.15. A four state mathematical model describes prion switching dynamics. 
Four state model with certain conversions only allowed when prion induction or curing is ongoing. A 
= aggregated state (red), S = soluble state (blue), TA = transiently aggregated state (green), TS = 
transiently solubilized state (black). Switching between states is described by first order kinetics. In 
steady state (no inducer added, recovery) only the following conversions are permitted: TA to S and 
TS to A. 
When aggregation is induced, S to TA and TA to A conversions are added to the steady state model. 
This allows for the accumulation of protein in the transiently aggregated state (green) and the 
conversion from there to the aggregated state (red). This can be seen as a function of time on the 
graph on the left, where 100% soluble protein is being converted to 80% aggregated protein. 
When prion elimination is induced, A to TA and TA to S transitions are added to the steady state 
model. This enables conversion of the aggregated protein to transiently solubilized (black) and 
eventually soluble (blue) protein. This can be seen on the graph on the right, where 100% 
aggregated protein (red) is converted to transiently soluble (black) and finally soluble (blue) form. 
In summary, the four state model accurately describes the dynamic behavior of the experimental 
data with initial delay in the response due to the accumulation of a transient state and conversion 
that is proportional to induction time. 
 
6.2.2. Advantages and limitations of prions as synthetic memory 
devices 
Currently the best long term synthetic memory devices are DNA sequence 
based, mostly using recombinase or CRISPR-Cas9 technologies. Here we were 
developing long term, reversible epigenetic memory encoded in protein 
conformation that can be retrieved noninvasively. Prion-based synthetic memory 
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has the advantage of long term stability, resilience to growth rate and growth 
phase, and to certain, milder stresses. 
The [PSI+] inducing domains we identified have not yielded full conversion of 
the population, which could limit the number of set-reset cycles the [PSI+] 
memory may go through. Setting and resetting the memory took 50 hours each, 
which might be too long for certain applications. A third limitation is that dominant 
negative HSP104 over-expression cured [RNQ+], which prohibits reestablishment 
of [PSI+] in the next memory set cycle. Therefore, using the proteins 
demonstrated, we get a single use memory unit. The full memory circuit would 
encompass both memory set and reset control systems in the same cell, 
activated by different small molecule inducers. So far our experiments utilize a 
single inducer, and therefore cannot be multiplexed. 
Prion memory could be expanded to multiple bits with each bit corresponding 
to a different prion. The current limitation to realizing multibit prion memory is 
identifying domains that efficiently induce prions and domains or chaperones that 
are prion specific in eliminating the aggregates. 
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6.3. Stochastic synthetic prion switching – synthetic bet-hedging 
circuitry 
 
Yeast is a highly evolved organism due to its short generation time and 
high rate of homologous recombination. The frequent occurrence of 
‘nonfunctional’ unstructured protein domains in important regulatory molecules in 
such a microbe suggests that these domains do serve evolutionary functions. 
Prion aggregation involves partial functional inactivation of an important 
regulatory molecule, represents a phenotypic switch, similar to differentiation in 
mammalian cells. Fate decisions in cells are carried out by bistable switches to 
ensure full commitment after the cellular level decision has been made. 
In this subchapter we reconstituted such a decision process by linking 
fitness in two opposing synthetic environments to the switch-like prion state 
decision of a prion that has no fitness effects on its own. We verified the 
phenotypic consequences of the synthetic circuits by growth and survival 
differences. Next, we applied population level selective pressure to bias 
population composition or even force an entire population of cells of the opposing 
prion type to switch. We observed reversible stochastic prion switching when 
alternating the synthetic environments. Such synthetic circuits could test 
hypotheses about the evolutionary roles of prions in yeast. 
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6.3.1. Stochastic prion switching as a synthetic cell fate decision 
The basic mechanism behind a bet-hedging strategy is a stochastic switch 
the state of which is linked to differential fitness in different environments. This 
way a population is diversifying at any given point in time, so that when an 
unpredictable change in environment occurs, there are members of the 
population that display the fitter phenotype in the new environment. One of the 
hypotheses on the environmental role of yeast prions is that they act as bet-
hedging devices. For example, [MOT+] regulates flocculation and [MOT+] cells 
become more abundant during wine fermentation66. It is unclear if (1) this is true 
of other yeast prions (2) if it is indeed a bet-hedging mechanism or an 
environmental sense-response mechanism. Addressing these questions 
experimentally proved to be very challenging in the natural context. We aimed to 
explore these questions in a synthetic context where phenotype regulation and 
stochastic switching are decoupled. To achieve this, we hypothesized that 
[RNQ+] prion of no known growth phenotype behaves as a stochastic switch. The 
next step was to link [RNQ+] prion state to fitness in different environments. Since 
the links to fitness were synthetic, we could design two synthetic environments 
with opposing effects on fitness, in addition to the nonselective environment that 
has no growth effect (Figure 6.16). This is something very difficult to do with 
natural environments as it requires screening and identifying two natural 
environments with opposing effects on prion state. In our synthetic system, we 
fused RNQ1 to a synthetic transcription factor. This fusion is called the synthetic 
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master regulator. We controlled the expression of a canavanine sensitivity gene, 
hygromycin resistance gene and a reporter gene with this regulator. The activity 
of the synTF depended on the aggregation state of Rnq1p, as it was fully active 
in [rnq-] cells; and sequestered to the aggregate and inactive in [RNQ+] cells. 
 
Figure 6.16. Synthetic circuitry designed to link stochastic switching to opposing fitness cost-
benefit in two synthetic environments. 
RNQ1, a prion of unknown function, is fused to a synthetic transcription factor (right). This synthetic 
master regulator controls the expression of mNeonGreen reporter gene, CAN1 canavanine 
sensitivity gene and hph hygromycin resistance gene depending on the prion state of Rnq1p. 
Since RNQ1 stochastically forms a prion and stochastically loses prion state (left), the synthetic 
master regulator stochastically switches between high fitness in environment 1 tied to low fitness in 
environment 2 and low fitness in environment 1 tied to high fitness in environment 2. Environment 1 
corresponds to canavanine treatment, which negatively affects CAN1 expressing, sensitized cells. 
Environment 2 corresponds to hygromycin treatment, which negatively affects hph non-expressing, 
sensitive cells. 
First, we validated that the synthetic circuits affect growth in the synthetic 
environments, and we aimed to determine the effective concentrations of 
canavanine and hygromycin (Figure 6.17). We found that [RNQ+] on its own 
provides no fitness benefit or disadvantage in the synthetic environments. The 
synthetic master regulator on the other hand favors the growth of [RNQ+] in 
environment 1 (canavanine) and [rnq-] in environment 2 (hygromycin). We also 
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concluded that 10 µg/ml canavanine and 500 µg/ml hygromycin are the lowest 
concentrations of drug that achieve maximum difference in fitness without 
affecting the growth of the fit population. 
 
 
Figure 6.17. The synthetic master regulator circuit favors the growth of [RNQ+] cells in canavanine 
and [rnq-] in hygromycin treatment, while [RNQ+] causes no fitness effects in the synthetic 
environments. 
Cells were grown in microwell plates in the presence of varying amount of canavanine in SD-Arg 
liquid media (left) and hygromycin in liquid YPD media (right) for 24 hours before optical density 
measurements. The y axis depicts optical density that corresponds to cell growth in the presence of 
increasing amount of selective agent. Light curves correspond to [rnq-] cultures, dark curves to 
[RNQ+] cultures. Black and grey curves show control cells that don’t have any other circuit present 
besides RNQ1 yTRAP. Red and light red curves correspond to cells that express the synthetic 
master regulator and all three of its target genes, mNeonGreen, CAN1 and hph. 
Left. In environment 1 control cells grow uninhibited independent of canavanine concentration as 
they do not express CAN1. [RNQ+] cells expressing the synthetic master regulator circuit (red) grow 
better than isogenic [rnq-] cells (light red) in the 10-100 ng/µl canavanine concentration range. The 
biggest difference between the two prion states is in the 10-40 ng/µl range, while above 40 ng/µl 
canavanine [RNQ+] cells are also becoming inhibited in their growth. 
Right. In environment 2 control cells are equally inhibited by hygromycin, independent of their prion 
state, as they do not express hph. [RNQ+] cells expressing the synthetic master regulator circuit 
(red) grow worse than isogenic [rnq-] cells (light red) in the 100-1000 ng/µl hygromycin concentration 
range. The biggest difference between the two prion states is in the 500-1000 ng/µl range. 
Next we were interested if environmental changes affected survival, not 
purely growth. We switched environments according to a step function: grew 
cells in nonselective media, and plated them on plates containing the synthetic 
environments (Figure 6.18). We found that [RNQ+] alone does not affect survival 
in the synthetic environments. The synthetic master regulator affected survival in 
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these environments such that [RNQ+] cells survived better in environment 1 and 
[rnq-] cells survived better in environment 2. 
 
Figure 6.18. The synthetic master regulator promotes survival of [RNQ+] cells in environment 1 and 
[rnq-] in environment 2, while [RNQ+] causes no fitness effects in the synthetic environments. 
Left. Cells were grown in nonselective media, washed and resuspended in PBS, serially diluted 
fivefold, and spotted on selective plates. Images were taken after four days of growth at 30°C on a 
blue light box using a DSLR camera. 
Middle. Cells that express the synthetic circuits show even growth on nonselective plates, and 
[RNQ+] state dependent growth on selective environment 1 and 2 plates. 
Right. Control cells that only express RNQ1 yTRAP sensor survive on nonselective and canavanine 
containing plates, and are eliminated on hygromycin containing plates, independent of [RNQ+] state. 
 
Our next question was whether we can bias population composition in a 
mixed population of cells with the synthetic environments. We mixed cells in 
different ratios, exposed them to the synthetic environments briefly in liquid 
culture, and plated on neutral plates (Figure 6.19). Even pure populations of [rnq-
] and [RNQ+] cells contain 3x10-6 of the opposite prion type49. We found that the 
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brief exposure to the synthetic environments purified the populations to a single 
prion state, except when a pure population of opposing prion state cells were 
subjected to the environment. We concluded that population level selections are 
possible, but in this experiment we did not observe de novo [RNQ+] switching, 
probably due to the small number of cells plated. To investigate the switching 
frequencies of the strains even further, we would repeat this experiment with 
mixtures of cells closer to the natural switching frequency (1:103, 1:104, 1:105, 
1:106, 1:107, 1:108). 
 
Figure 6.19. In a mixed population of cells, synthetic environment 1 selects for [rnq-] and synthetic 
environment 2 selects for [RNQ+] cells. 
Top left. A pure population of [RNQ+] cells was mixed with a pure population of [rnq-] cells in 0:100, 
1:99, 10:90 50:50, 90:10, 99:1, 100:0 ratios. These populations were treated for 12 hours in liquid 
culture followed by washing with PBS, fivefold serial dilutions, spotting on YPAD plates, 3 days of 
growth at 30°C, and imaging on a blue light box. 
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The initial population composition (bottom left, [rnq-] colonies look yellow, [RNQ+] colonies look 
orange) corresponds to the theoretical mixes, and this composition is maintained in nonselective 
plates (middle column). Following treatment in environment 1 (top right), [rnq-] cells survived, while 
following treatment 2 (bottom right), [RNQ+] cells survived. This suggests that the environments 
select efficiently for the corresponding prion type in cells expressing the synthetic circuits. 
Finally we probed the hypothesis that the [RNQ+] prion is a stochastic 
switch. We switched cells from neutral environment to environment 1, from there 
to neutral environment, and to environment 2. We completed this cycle in both 
directions (Figure 6.20). Environment 1 and 2 surviving colonies displayed a 
diversity of reporter levels, supporting the notion that even a pure population of 
cells with a certain prion contains stochastically switched cells. The concentration 
of selective agents was chosen such that they provide the best separation 
between survival of [rnq-] and [RNQ+] with minimal killing of the desired 
population, some colonies may have escaped the selection. Since colonies of the 
opposite prion type appeared in all cases, [RNQ+] indeed switches to [rnq-] and 
[rnq-] switches to [RNQ+] in a stochastic manner. 
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Figure 6.20. The synthetic environments select for heritably prion switched cells. Pure populations 
of [rnq-] and [RNQ+] cells were grown in nonselective media, and plated on environment 1 (SD-Arg 
with 10 µg/ml canavanine) and environment 2 (YPD with 500 µg/ml hygromycin) selective plates. 
Surviving colonies were grown in nonselective media. These cultures were then plated on 
environment 2 and environment 1 selective plates. Selective plates were imaged on blue light box 
after 4 days of growth at 30°C, and the green channel of the images corresponding to mNeonGreen 
reporter signal is shown at the corresponding step, where [rnq-] colonies are bright and [RNQ+] 
colonies are dark. 
The top middle and bottom right images show that surviving colonies on environment 1 from a 
purely [rnq-] population are a mixture of [RNQ+] and [rnq-] colonies. The top right and middle bottom 
images show that when a pure [RNQ+] population is plated on environment 2 plates, a mixture of 
[RNQ+] and [rnq-] colonies grow up. This diversification would support the stochastic switching 
hypothesis. The surviving colonies from the original prion type may originate from cells that were 
not eliminated at this level of selective agent. 
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6.3.2. Advantages of the current system in testing the yeast prion 
bet-hedging hypothesis, and its limitations 
To determine if the stochastic switching of [RNQ+] is beneficial, and therefore 
could be part of an evolutionary strategy, we would compare the fitness of a bet-
hedging population to one that is not linked to a stochastic switch in the same 
synthetic environments. The prion bet-hedging hypothesis would suggest that the 
bet-hedging population is more fit when a sudden environmental change occurs. 
In the case of bet hedging, the frequency of stochastic switching is fine tuned 
to the frequency at which the population experiences the sudden environmental 
change. Therefore, more complicated environmental changes and change 
profiles could be designed to probe this aspect of the bet-hedging hypothesis. 
One disadvantage of the synthetic environments that they do not gain 
understanding about the types of stresses governing natural prion switching. And 
environment 1 poses some technical difficulties such that the selection can only 
be performed successfully on solid medium as the CAN1 transporter is a high 
affinity arginine permease that causes fitness effects on its own when over-
expressed. 
To our knowledge this is the first synthetic cell fate decision system 
implemented with prions and one of the few experimental setups where bet 
hedging can be verified and studied. 
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7. DISCUSSION 
Epigenetics in synthetic biology is an emerging field with great potential for 
new functions to be encoded using epigenetic elements. In the previous chapters 
of this dissertation we introduced some of the tools and applications that start this 
process. 
First we described control elements that can allow precise regulation and 
titration of epigenetic regulators. These inducible systems enable simultaneous 
regulation of multiple regulators as well, which is important as protein-protein 
interactions and multiple member complexes are essential in epigenetic systems. 
These tools enable individual regulation of complex members. The inducible 
systems could also regulate transcription factors to build more complex (more 
than two input) transcriptional circuitry than what was possible previously. 
Next we applied the control elements to control members of chromatin 
editing complexes to understand the direct transcriptional consequences of CR 
recruitment at a specific location. We also explored how CRs synergize with a 
transcriptional activator upon co-recruitment, the effects of CR recruitment 
location with respect to the transcriptional unit, epigenetic memory and insulation 
against spreading. Based on the properties of CRs discovered, circuits with new 
functions such as multigene repression and memory could be constructed in 
future studies. The CRs that synergize with VP16 could be used as coactivators 
if gene expressions needed to be further increased. Based on the different 
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behaviors with VP16 interaction, new type of chromatin logic can be implemented 
without the need of multilayered circuitry. 
In chapter five we developed a tool to detect the different states of an 
often overlooked epigenetic system. Prions in yeast are heritable protein 
conformations and therefore act as epigenetic elements of inheritance. Our 
sensor detects aggregation of proteins and provides a transcriptional output. We 
conducted library screens to identify modulators of prion and RNA binding protein 
aggregation. These discoveries broadened the basic understanding of these 
phenomena. We demonstrated some synthetic biology applications of the sensor 
by building a heat sensor that remembers a previous high temperature event, 
and anti-prion drives that reverse prion inheritance in a population of cells. Future 
steps in this work could explore other suspected aggregation-prone proteins from 
humans, plants and other animals. The sensor may be able to sense the phase 
separation of proteins without FRET assays which would speed up the proteins 
that can be studied this way. Since many regulatory proteins such as 
transcription factors, RNA binding proteins and kinases contain unstructured 
domains, phase separation or transient aggregation might be part of their regular 
function upon stress or protein or energy imbalances. 
In the last chapter we used the sensor in synthetic biology studies. We 
conducted the first dynamic study of an environmental shift induced prion 
switching. And we engineered stochastic and deterministic synthetic prion 
switches. These can be used to test ecological hypotheses about the 
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evolutionary roles of yeast prions and to build long term memory elements in 
yeast. These are the first synthetic biology studies where prions as protein-based 
epigenetic elements are harnessed. 
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